Viewing Study NCT01307267

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:41 AM
Ignite Modification Date: 2025-12-25 @ 10:52 PM
Study NCT ID: NCT01307267
Status: COMPLETED
Last Update Posted: 2020-03-17
First Post: 2011-02-28
Is NOT Gene Therapy: False
Has Adverse Events: True
Brief Title: A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab
Sponsor:
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Raw JSON

{'hasResults': True, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D008228', 'term': 'Lymphoma, Non-Hodgkin'}, {'id': 'D008224', 'term': 'Lymphoma, Follicular'}, {'id': 'D016403', 'term': 'Lymphoma, Large B-Cell, Diffuse'}, {'id': 'D002289', 'term': 'Carcinoma, Non-Small-Cell Lung'}, {'id': 'D002292', 'term': 'Carcinoma, Renal Cell'}, {'id': 'D000077195', 'term': 'Squamous Cell Carcinoma of Head and Neck'}, {'id': 'D008545', 'term': 'Melanoma'}], 'ancestors': [{'id': 'D008223', 'term': 'Lymphoma'}, {'id': 'D009370', 'term': 'Neoplasms by Histologic Type'}, {'id': 'D009369', 'term': 'Neoplasms'}, {'id': 'D008232', 'term': 'Lymphoproliferative Disorders'}, {'id': 'D008206', 'term': 'Lymphatic Diseases'}, {'id': 'D006425', 'term': 'Hemic and Lymphatic Diseases'}, {'id': 'D007160', 'term': 'Immunoproliferative Disorders'}, {'id': 'D007154', 'term': 'Immune System Diseases'}, {'id': 'D016393', 'term': 'Lymphoma, B-Cell'}, {'id': 'D002283', 'term': 'Carcinoma, Bronchogenic'}, {'id': 'D001984', 'term': 'Bronchial Neoplasms'}, {'id': 'D008175', 'term': 'Lung Neoplasms'}, {'id': 'D012142', 'term': 'Respiratory Tract Neoplasms'}, {'id': 'D013899', 'term': 'Thoracic Neoplasms'}, {'id': 'D009371', 'term': 'Neoplasms by Site'}, {'id': 'D008171', 'term': 'Lung Diseases'}, {'id': 'D012140', 'term': 'Respiratory Tract Diseases'}, {'id': 'D000230', 'term': 'Adenocarcinoma'}, {'id': 'D002277', 'term': 'Carcinoma'}, {'id': 'D009375', 'term': 'Neoplasms, Glandular and Epithelial'}, {'id': 'D007680', 'term': 'Kidney Neoplasms'}, {'id': 'D014571', 'term': 'Urologic Neoplasms'}, {'id': 'D014565', 'term': 'Urogenital Neoplasms'}, {'id': 'D052776', 'term': 'Female Urogenital Diseases'}, {'id': 'D005261', 'term': 'Female Urogenital Diseases and Pregnancy Complications'}, {'id': 'D000091642', 'term': 'Urogenital Diseases'}, {'id': 'D007674', 'term': 'Kidney Diseases'}, {'id': 'D014570', 'term': 'Urologic Diseases'}, {'id': 'D052801', 'term': 'Male Urogenital Diseases'}, {'id': 'D002294', 'term': 'Carcinoma, Squamous Cell'}, {'id': 'D006258', 'term': 'Head and Neck Neoplasms'}, {'id': 'D018358', 'term': 'Neuroendocrine Tumors'}, {'id': 'D017599', 'term': 'Neuroectodermal Tumors'}, {'id': 'D009373', 'term': 'Neoplasms, Germ Cell and Embryonal'}, {'id': 'D009380', 'term': 'Neoplasms, Nerve Tissue'}, {'id': 'D018326', 'term': 'Nevi and Melanomas'}, {'id': 'D012878', 'term': 'Skin Neoplasms'}, {'id': 'D012871', 'term': 'Skin Diseases'}, {'id': 'D017437', 'term': 'Skin and Connective Tissue Diseases'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'C577122', 'term': 'utomilumab'}, {'id': 'D000069283', 'term': 'Rituximab'}], 'ancestors': [{'id': 'D058846', 'term': 'Antibodies, Monoclonal, Murine-Derived'}, {'id': 'D000911', 'term': 'Antibodies, Monoclonal'}, {'id': 'D000906', 'term': 'Antibodies'}, {'id': 'D007136', 'term': 'Immunoglobulins'}, {'id': 'D007162', 'term': 'Immunoproteins'}, {'id': 'D001798', 'term': 'Blood Proteins'}, {'id': 'D011506', 'term': 'Proteins'}, {'id': 'D000602', 'term': 'Amino Acids, Peptides, and Proteins'}, {'id': 'D012712', 'term': 'Serum Globulins'}, {'id': 'D005916', 'term': 'Globulins'}]}}, 'resultsSection': {'moreInfoModule': {'pointOfContact': {'email': 'ClinicalTrials.gov_Inquiries@pfizer.com', 'phone': '1-800-718-1021', 'title': 'Pfizer ClinicalTrials.gov Call Center', 'organization': 'Pfizer Inc.'}, 'certainAgreement': {'otherDetails': 'Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.', 'restrictionType': 'OTHER', 'piSponsorEmployee': False, 'restrictiveAgreement': True}}, 'adverseEventsModule': {'timeFrame': 'Up to approximately 4 years.', 'description': 'The same event may appear as both an AE and an SAE. However, what is presented are distinct events. An event may be categorized as serious in 1 participant and as non-serious in another participant, or 1 participant may have experienced both a serious and non-serious event during the study.', 'eventGroups': [{'id': 'EG000', 'title': 'Portion A: PF-05082566 0.006mg/kg', 'description': 'Participants received PF-05082566 0.006 milligrams per kilogram (mg/kg) intravenously once every 4 weeks (q4wks) as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.', 'otherNumAtRisk': 4, 'deathsNumAtRisk': 4, 'otherNumAffected': 3, 'seriousNumAtRisk': 4, 'deathsNumAffected': 4, 'seriousNumAffected': 0}, {'id': 'EG001', 'title': 'Portion A: PF-05082566 0.03mg/kg', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.', 'otherNumAtRisk': 3, 'deathsNumAtRisk': 3, 'otherNumAffected': 3, 'seriousNumAtRisk': 3, 'deathsNumAffected': 3, 'seriousNumAffected': 0}, {'id': 'EG002', 'title': 'Portion A: PF-05082566 0.06mg/kg', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.', 'otherNumAtRisk': 6, 'deathsNumAtRisk': 6, 'otherNumAffected': 5, 'seriousNumAtRisk': 6, 'deathsNumAffected': 5, 'seriousNumAffected': 2}, {'id': 'EG003', 'title': 'Portion A: PF-05082566 0.12mg/kg', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.', 'otherNumAtRisk': 4, 'deathsNumAtRisk': 4, 'otherNumAffected': 4, 'seriousNumAtRisk': 4, 'deathsNumAffected': 3, 'seriousNumAffected': 1}, {'id': 'EG004', 'title': 'Portion A: PF-05082566 0.18mg/kg', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.', 'otherNumAtRisk': 3, 'deathsNumAtRisk': 3, 'otherNumAffected': 3, 'seriousNumAtRisk': 3, 'deathsNumAffected': 1, 'seriousNumAffected': 0}, {'id': 'EG005', 'title': 'Portion A: PF-05082566 0.24mg/kg', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.', 'otherNumAtRisk': 42, 'deathsNumAtRisk': 42, 'otherNumAffected': 36, 'seriousNumAtRisk': 42, 'deathsNumAffected': 27, 'seriousNumAffected': 13}, {'id': 'EG006', 'title': 'Portion A: PF-05082566 0.3mg/kg', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.', 'otherNumAtRisk': 3, 'deathsNumAtRisk': 3, 'otherNumAffected': 3, 'seriousNumAtRisk': 3, 'deathsNumAffected': 2, 'seriousNumAffected': 0}, {'id': 'EG007', 'title': 'Portion A: PF-05082566 0.6mg/kg', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.', 'otherNumAtRisk': 4, 'deathsNumAtRisk': 4, 'otherNumAffected': 4, 'seriousNumAtRisk': 4, 'deathsNumAffected': 2, 'seriousNumAffected': 0}, {'id': 'EG008', 'title': 'Portion A: PF-05082566 1.2mg/kg', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.', 'otherNumAtRisk': 31, 'deathsNumAtRisk': 31, 'otherNumAffected': 23, 'seriousNumAtRisk': 31, 'deathsNumAffected': 21, 'seriousNumAffected': 8}, {'id': 'EG009', 'title': 'Portion A: PF-05082566 2.4mg/kg', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.', 'otherNumAtRisk': 5, 'deathsNumAtRisk': 5, 'otherNumAffected': 4, 'seriousNumAtRisk': 5, 'deathsNumAffected': 2, 'seriousNumAffected': 1}, {'id': 'EG010', 'title': 'Portion A: PF-05082566 5mg/kg', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.', 'otherNumAtRisk': 6, 'deathsNumAtRisk': 6, 'otherNumAffected': 5, 'seriousNumAtRisk': 6, 'deathsNumAffected': 3, 'seriousNumAffected': 2}, {'id': 'EG011', 'title': 'Portion A: PF-05082566 10mg/kg', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.', 'otherNumAtRisk': 11, 'deathsNumAtRisk': 11, 'otherNumAffected': 9, 'seriousNumAtRisk': 11, 'deathsNumAffected': 9, 'seriousNumAffected': 3}, {'id': 'EG012', 'title': 'Portion B: PF-05082566 0.03mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks in combination with rituximab (375 milligrams per square meter \\[mg/m\\^2\\] intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.', 'otherNumAtRisk': 3, 'deathsNumAtRisk': 3, 'otherNumAffected': 3, 'seriousNumAtRisk': 3, 'deathsNumAffected': 0, 'seriousNumAffected': 1}, {'id': 'EG013', 'title': 'Portion B: PF-05082566 0.06mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.', 'otherNumAtRisk': 3, 'deathsNumAtRisk': 3, 'otherNumAffected': 3, 'seriousNumAtRisk': 3, 'deathsNumAffected': 0, 'seriousNumAffected': 0}, {'id': 'EG014', 'title': 'Portion B: PF-05082566 0.12mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.', 'otherNumAtRisk': 4, 'deathsNumAtRisk': 4, 'otherNumAffected': 4, 'seriousNumAtRisk': 4, 'deathsNumAffected': 0, 'seriousNumAffected': 0}, {'id': 'EG015', 'title': 'Portion B: PF-05082566 0.18mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.', 'otherNumAtRisk': 3, 'deathsNumAtRisk': 3, 'otherNumAffected': 3, 'seriousNumAtRisk': 3, 'deathsNumAffected': 0, 'seriousNumAffected': 2}, {'id': 'EG016', 'title': 'Portion B: PF-05082566 0.24mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.', 'otherNumAtRisk': 3, 'deathsNumAtRisk': 3, 'otherNumAffected': 3, 'seriousNumAtRisk': 3, 'deathsNumAffected': 1, 'seriousNumAffected': 1}, {'id': 'EG017', 'title': 'Portion B: PF-05082566 0.3mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.', 'otherNumAtRisk': 3, 'deathsNumAtRisk': 3, 'otherNumAffected': 3, 'seriousNumAtRisk': 3, 'deathsNumAffected': 1, 'seriousNumAffected': 1}, {'id': 'EG018', 'title': 'Portion B: PF-05082566 0.6mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.', 'otherNumAtRisk': 4, 'deathsNumAtRisk': 4, 'otherNumAffected': 3, 'seriousNumAtRisk': 4, 'deathsNumAffected': 2, 'seriousNumAffected': 1}, {'id': 'EG019', 'title': 'Portion B: PF-05082566 1.2mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.', 'otherNumAtRisk': 32, 'deathsNumAtRisk': 32, 'otherNumAffected': 29, 'seriousNumAtRisk': 32, 'deathsNumAffected': 8, 'seriousNumAffected': 3}, {'id': 'EG020', 'title': 'Portion B: PF-05082566 2.4mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.', 'otherNumAtRisk': 3, 'deathsNumAtRisk': 3, 'otherNumAffected': 3, 'seriousNumAtRisk': 3, 'deathsNumAffected': 1, 'seriousNumAffected': 0}, {'id': 'EG021', 'title': 'Portion B: PF-05082566 5mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.', 'otherNumAtRisk': 5, 'deathsNumAtRisk': 5, 'otherNumAffected': 4, 'seriousNumAtRisk': 5, 'deathsNumAffected': 2, 'seriousNumAffected': 0}, {'id': 'EG022', 'title': 'Portion B: PF-05082566 10mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.', 'otherNumAtRisk': 4, 'deathsNumAtRisk': 4, 'otherNumAffected': 4, 'seriousNumAtRisk': 4, 'deathsNumAffected': 2, 'seriousNumAffected': 0}], 'otherEvents': [{'term': 'Anaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 6, 'numAffected': 4}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 5, 'numAffected': 5}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 4, 'numAffected': 2}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Thrombocytopenia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Palpitations', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Sinus tachycardia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Deafness', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Ear and labyrinth disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Hypoacusis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Ear and labyrinth disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Tinnitus', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Ear and labyrinth disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Vision blurred', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Eye disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Abdominal distension', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Abdominal pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 7, 'numAffected': 5}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Abdominal pain lower', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Abdominal pain upper', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 4, 'numAffected': 3}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Ascites', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Constipation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 4, 'numAffected': 4}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Diarrhoea', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 5, 'numAffected': 4}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 8, 'numAffected': 6}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 8, 'numAffected': 4}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Dry mouth', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Dyspepsia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Haemorrhoids', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Nausea', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 10, 'numAffected': 9}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 11, 'numAffected': 10}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 5, 'numAffected': 3}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 4, 'numAffected': 3}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Retching', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Vomiting', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 4, 'numAffected': 3}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 5, 'numAffected': 4}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Axillary pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Chest pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Chills', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 3, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Device related thrombosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Drug withdrawal syndrome', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Fatigue', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 4, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 19, 'numAffected': 18}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 10, 'numAffected': 8}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 7, 'numAffected': 6}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Implant site erythema', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Influenza like illness', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 4, 'numAffected': 2}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Mucosal inflammation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Non-cardiac chest pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Oedema peripheral', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Peripheral swelling', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Pyrexia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 3, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 11, 'numAffected': 9}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 6, 'numAffected': 5}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Hyperbilirubinaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Hepatobiliary disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Cellulitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Oral candidiasis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Pneumonia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Upper respiratory tract infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 4, 'numAffected': 2}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 4, 'numAffected': 4}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Urinary tract infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 4, 'numAffected': 2}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 4, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Vaginal infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Eye injury', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Fall', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Skin abrasion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Wrist fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Alanine aminotransferase increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 3, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 3, 'numAffected': 1}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Aspartate aminotransferase increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 4, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Blood alkaline phosphatase increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Haemoglobin decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Weight decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Decreased appetite', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 4, 'numAffected': 4}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 7, 'numAffected': 6}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Dehydration', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Gout', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Hypokalaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 5, 'numAffected': 3}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Hypomagnesaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Hyponatraemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Hypophosphataemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 4, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Arthralgia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 5, 'numAffected': 4}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Back pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 5, 'numAffected': 5}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 8, 'numAffected': 6}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Bone pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Flank pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Groin pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Joint swelling', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Muscle spasms', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Muscular weakness', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Musculoskeletal chest pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 3, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Musculoskeletal pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Neck pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Pain in extremity', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Malignant pleural effusion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Ataxia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Cognitive disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Dizziness', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 5, 'numAffected': 4}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 3, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Dysgeusia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Headache', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 6, 'numAffected': 5}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 5, 'numAffected': 3}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Hypoaesthesia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Lethargy', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Neuropathy peripheral', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Paraesthesia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Peripheral sensory neuropathy', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Syncope', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Confusional state', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Delirium', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Insomnia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Oliguria', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Urinary hesitation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Vaginal haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Reproductive system and breast disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Cough', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 5, 'numAffected': 4}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 7, 'numAffected': 7}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Dyspnoea', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 6, 'numAffected': 6}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Dyspnoea exertional', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Hypoxia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Increased upper airway secretion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Sinus congestion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Acne', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Erythema', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Pruritus', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 4, 'numAffected': 3}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Rash', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Rash maculo-papular', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 4, 'numAffected': 3}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Skin disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Skin exfoliation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Skin lesion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Urticaria', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Hypertension', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Eosinophilia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Lymph node pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Neutropenia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Tachycardia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Ear pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Ear and labyrinth disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Diplopia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Eye disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Eye pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Eye disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Orbital oedema', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Eye disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Diverticulum intestinal', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Dysphagia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Large intestine polyp', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Mouth ulceration', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Oral disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Stomatitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Umbilical hernia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Abdominal tenderness', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Lymphoedema', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Hepatic steatosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Hepatobiliary disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Early satiety', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Infusion site oedema', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Feeling hot', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Ill-defined disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Induration', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Injection site pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Mucosal dryness', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Nodule', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Bronchitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Conjunctivitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Diverticulitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Folliculitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Herpes zoster', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Influenza', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Nasopharyngitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Oral herpes', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Tinea versicolour', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Arthropod bite', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Back injury', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Contusion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Infusion related reaction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 10, 'numAffected': 8}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Procedural pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Scratch', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Activated partial thromboplastin time prolonged', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Blood creatinine increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 3, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 5, 'numAffected': 5}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Electrocardiogram QT prolonged', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 8, 'numAffected': 3}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'International normalised ratio increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 3, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Lymphocyte count decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Investigations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Neutrophil count decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 5, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Platelet count decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'White blood cell count decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 5, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Hypercalcaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Hyperglycaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 7, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Hyperkalaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 3, 'numAffected': 1}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Hyperuricaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Hypoglycaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Intervertebral disc degeneration', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Limb discomfort', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Muscle fatigue', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Myalgia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Neoplasm', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Squamous cell carcinoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Disturbance in attention', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Memory impairment', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Presyncope', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Anxiety', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Depression', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Sleep disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Pollakiuria', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Urine abnormality', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Benign prostatic hyperplasia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Reproductive system and breast disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Oedema genital', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Reproductive system and breast disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Testicular pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Reproductive system and breast disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Bronchiectasis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Bronchospasm', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Nasal congestion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Oropharyngeal pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 3, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Oropharyngeal plaque', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Pleural effusion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Productive cough', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Rhinorrhoea', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Throat irritation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Upper-airway cough syndrome', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Alopecia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Dermal cyst', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Dry skin', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Hyperhidrosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Night sweats', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 3, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Rash papular', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Rash pruritic', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 4, 'numAffected': 1}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Seborrhoea', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Skin plaque', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}], 'seriousEvents': [{'term': 'Cardio-respiratory arrest', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Abdominal pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Ascites', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Colitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Constipation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Enterocolitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Large intestinal haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Large intestinal obstruction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Nausea', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Oesophageal obstruction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Peritoneal haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Small intestinal obstruction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Upper gastrointestinal haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Vomiting', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Disease progression', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Fatigue', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Pyrexia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Hyperbilirubinaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Hepatobiliary disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Catheter site infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Pneumonia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Sinusitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Urinary tract infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Incisional hernia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Stress fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Blood alkaline phosphatase increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Decreased appetite', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Dehydration', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Hyponatraemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Musculoskeletal pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Intracranial tumour haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Malignant neoplasm progression', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Dizziness', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Acute kidney injury', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Pneumonia aspiration', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Pneumonitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Pulmonary embolism', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Respiratory failure', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Cellulitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Infusion related reaction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Atrial fibrillation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Cytomegalovirus chorioretinitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Upper respiratory tract infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Aspiration', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Idiopathic pulmonary fibrosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}, {'term': 'Thrombophlebitis superficial', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 42, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 31, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 11, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG014', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG015', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG016', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG017', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG018', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG019', 'numAtRisk': 32, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG020', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG021', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG022', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 21.1'}], 'frequencyThreshold': '5'}, 'outcomeMeasuresModule': {'outcomeMeasures': [{'type': 'PRIMARY', 'title': 'Number of Participants With Dose-Limiting Toxicities (DLTs) in First 2 Cycles of Portion A', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '31', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion A: PF-05082566 0.006mg/kg', 'description': 'Participants received PF-05082566 0.006 milligrams per kilogram (mg/kg) intravenously once every 4 weeks (q4wks) as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion A: PF-05082566 0.03mg/kg', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion A: PF-05082566 0.06mg/kg', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion A: PF-05082566 0.12mg/kg', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion A: PF-05082566 0.18mg/kg', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion A: PF-05082566 0.24mg/kg', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion A: PF-05082566 0.3mg/kg', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion A: PF-05082566 0.6mg/kg', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion A: PF-05082566 1.2mg/kg', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion A: PF-05082566 2.4mg/kg', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion A: PF-05082566 5mg/kg', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG011', 'title': 'Portion A: PF-05082566 10mg/kg', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': 'Cycle 1 Day 1 to Cycle 2 Day 29 in Portion A (up to 57 days, each cycle = 28 days)', 'description': 'DLT: Any of the following adverse events (AEs) occurred in the first 2 cycles of treatment (up to 28 days post second dose) which was attributed to PF-05082566 alone for Portion A and not related to progressive disease. Hematologic: Grade 4 neutropenia lasting more than (\\>)7 days; febrile neutropenia; neutropenic infection; Grade ≥3 thrombocytopenia with bleeding; Grade 4 thrombocytopenia; Grade ≥3 hemolysis. Non-Hematologic: Grade ≥3 toxicities, except those Grade 3 events that responded to treatment (eg, Grade 3 nausea, vomiting, diarrhea responding to standard medical supportive care within 48 hours would not be considered a DLT). Severity of AEs were graded according to National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) version 4.03 (Grade 1: mild AE; Grade 2: moderate AE; Grade 3: severe AE; Grade 4: life-threatening consequences, urgent intervention indicated; Grade 5: death related to AE). Each cycle=28 days.', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of PF-05082566 in the first 2 cycles of Portion A.'}, {'type': 'PRIMARY', 'title': 'Number of Participants With DLTs in First 2 Cycles of Portion B', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '31', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion B: PF-05082566 0.03mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks in combination with rituximab (375 milligrams per square meter \\[mg/m\\^2\\] intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion B: PF-05082566 0.06mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion B: PF-05082566 0.12mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion B: PF-05082566 0.18mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion B: PF-05082566 0.24mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion B: PF-05082566 0.3mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion B: PF-05082566 0.6mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion B: PF-05082566 1.2mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion B: PF-05082566 2.4mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion B: PF-05082566 5mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion B: PF-05082566 10mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': 'Cycle 1 Day 1 to Cycle 2 Day 29 in Portion B (up to 57 days, each cycle = 28 days)', 'description': 'DLT: Any of the following AEs occurred in the first 2 cycles of treatment (up to 28 days post second dose) which was attributed to PF-05082566 in combination with rituximab for Portion B and not related to progressive disease. Hematologic: Grade 4 neutropenia lasting more than (\\>)7 days; febrile neutropenia; neutropenic infection; Grade ≥3 thrombocytopenia with bleeding; Grade 4 thrombocytopenia; Grade ≥3 hemolysis. Non-Hematologic: Grade ≥3 toxicities, except those Grade 3 events that responded to treatment (eg, Grade 3 nausea, vomiting, diarrhea responding to standard medical supportive care within 48 hours would not be considered a DLT). Severity of AEs were graded according to National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) version 4.03 (Grade 1: mild AE; Grade 2: moderate AE; Grade 3: severe AE; Grade 4: life-threatening consequences, urgent intervention indicated; Grade 5: death related to AE). Each cycle=28 days.', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of PF-05082566 and 1 dose of rituximab in the first 2 cycles of Portion B.'}, {'type': 'SECONDARY', 'title': 'Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) in Portion A', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '31', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion A: PF-05082566 0.006mg/kg', 'description': 'Participants received PF-05082566 0.006 milligrams per kilogram (mg/kg) intravenously once every 4 weeks (q4wks) as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion A: PF-05082566 0.03mg/kg', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion A: PF-05082566 0.06mg/kg', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion A: PF-05082566 0.12mg/kg', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion A: PF-05082566 0.18mg/kg', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion A: PF-05082566 0.24mg/kg', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion A: PF-05082566 0.3mg/kg', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion A: PF-05082566 0.6mg/kg', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion A: PF-05082566 1.2mg/kg', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion A: PF-05082566 2.4mg/kg', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion A: PF-05082566 5mg/kg', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG011', 'title': 'Portion A: PF-05082566 10mg/kg', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'title': 'AEs', 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '5', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '39', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '26', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '5', 'groupId': 'OG010'}, {'value': '9', 'groupId': 'OG011'}]}]}, {'title': 'SAEs', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '13', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '8', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '2', 'groupId': 'OG010'}, {'value': '3', 'groupId': 'OG011'}]}]}, {'title': 'AEs related to PF-05082566', 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '2', 'groupId': 'OG004'}, {'value': '25', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '10', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '2', 'groupId': 'OG010'}, {'value': '4', 'groupId': 'OG011'}]}]}, {'title': 'SAEs related to PF-05082566', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': 'Up to approximately 2 years', 'description': 'An AE was any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. An SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; life-threatening experience (immediate risk of dying); initial or prolonged inpatient hospitalization; persistent or significant disability/incapacity; congenital anomaly/birth defect. AEs included both non-serious AEs and SAEs. Treatment-emergent AEs were those with initial onset or increasing in severity after the first dose of study treatment. Causality of AEs was determined by the investigator.', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of PF-05082566 in Portion A.'}, {'type': 'SECONDARY', 'title': 'Number of Participants With Treatment-Emergent AEs by Maximum National Cancer Institute Common Terminology Criteria for Adverse Event (NCI CTCAE) Grade in Portion A', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '31', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion A: PF-05082566 0.006mg/kg', 'description': 'Participants received PF-05082566 0.006 milligrams per kilogram (mg/kg) intravenously once every 4 weeks (q4wks) as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion A: PF-05082566 0.03mg/kg', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion A: PF-05082566 0.06mg/kg', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion A: PF-05082566 0.12mg/kg', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion A: PF-05082566 0.18mg/kg', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion A: PF-05082566 0.24mg/kg', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion A: PF-05082566 0.3mg/kg', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion A: PF-05082566 0.6mg/kg', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion A: PF-05082566 1.2mg/kg', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion A: PF-05082566 2.4mg/kg', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion A: PF-05082566 5mg/kg', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG011', 'title': 'Portion A: PF-05082566 10mg/kg', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'title': 'Grade 1', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '9', 'groupId': 'OG005'}, {'value': '2', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '7', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '1', 'groupId': 'OG010'}, {'value': '2', 'groupId': 'OG011'}]}]}, {'title': 'Grade 2', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '14', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '2', 'groupId': 'OG007'}, {'value': '8', 'groupId': 'OG008'}, {'value': '3', 'groupId': 'OG009'}, {'value': '2', 'groupId': 'OG010'}, {'value': '4', 'groupId': 'OG011'}]}]}, {'title': 'Grade 3', 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '2', 'groupId': 'OG004'}, {'value': '12', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '9', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '2', 'groupId': 'OG010'}, {'value': '2', 'groupId': 'OG011'}]}]}, {'title': 'Grade 4', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '2', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}, {'title': 'Grade 5', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '2', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '1', 'groupId': 'OG011'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': 'Up to approximately 2 years', 'description': 'An AE was any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. Treatment-emergent AEs were those with initial onset or increasing in severity after the first dose of study treatment. Severity of AEs were graded according to NCI CTCAE version 4.03 (Grade 1: mild AE; Grade 2: moderate AE; Grade 3: severe AE; Grade 4: life-threatening consequences, urgent intervention indicated; Grade 5: death related to AE).', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of PF-05082566 in Portion A.'}, {'type': 'SECONDARY', 'title': 'Number of Participants With Hematology Laboratory Abnormalities by Maximum NCI CTCAE Grade in Portion A', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion A: PF-05082566 0.006mg/kg', 'description': 'Participants received PF-05082566 0.006 milligrams per kilogram (mg/kg) intravenously once every 4 weeks (q4wks) as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion A: PF-05082566 0.03mg/kg', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion A: PF-05082566 0.06mg/kg', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion A: PF-05082566 0.12mg/kg', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion A: PF-05082566 0.18mg/kg', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion A: PF-05082566 0.24mg/kg', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion A: PF-05082566 0.3mg/kg', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion A: PF-05082566 0.6mg/kg', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion A: PF-05082566 1.2mg/kg', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion A: PF-05082566 2.4mg/kg', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion A: PF-05082566 5mg/kg', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG011', 'title': 'Portion A: PF-05082566 10mg/kg', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'title': 'Anemia, Grade 1', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '20', 'groupId': 'OG005'}, {'value': '2', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '12', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '3', 'groupId': 'OG010'}, {'value': '6', 'groupId': 'OG011'}]}]}, {'title': 'Anemia, Grade 2', 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '6', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '2', 'groupId': 'OG007'}, {'value': '8', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '2', 'groupId': 'OG010'}, {'value': '5', 'groupId': 'OG011'}]}]}, {'title': 'Anemia, Grade 3', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}, {'title': 'Lymphocyte count increased, Grade 2', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '1', 'groupId': 'OG011'}]}]}, {'title': 'Lymphopenia, Grade 1', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '7', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '4', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '6', 'groupId': 'OG011'}]}]}, {'title': 'Lymphopenia, Grade 2', 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '2', 'groupId': 'OG004'}, {'value': '10', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '6', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '3', 'groupId': 'OG010'}, {'value': '2', 'groupId': 'OG011'}]}]}, {'title': 'Lymphopenia, Grade 3', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '7', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '2', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '1', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}, {'title': 'Lymphopenia, Grade 4', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}, {'title': 'Neutrophils (absolute), Grade 1', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '1', 'groupId': 'OG010'}, {'value': '1', 'groupId': 'OG011'}]}]}, {'title': 'Neutrophils (absolute), Grade 2', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '2', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}, {'title': 'Neutrophils (absolute), Grade 3', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}, {'title': 'Platelets, Grade 1', 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '2', 'groupId': 'OG004'}, {'value': '7', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '2', 'groupId': 'OG007'}, {'value': '2', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '1', 'groupId': 'OG010'}, {'value': '1', 'groupId': 'OG011'}]}]}, {'title': 'White blood cells, Grade 1', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '2', 'groupId': 'OG007'}, {'value': '6', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '2', 'groupId': 'OG010'}, {'value': '3', 'groupId': 'OG011'}]}]}, {'title': 'White blood cells, Grade 2', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}, {'title': 'White blood cells, Grade 3', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': 'Up to approximately 2 years', 'description': 'Following hematology laboratory abnormalities were graded per NCI CTCAE version 4.03: anemia, hemoglobin increased, lymphocyte count increased, lymphopenia, neutrophils (absolute), platelets, white blood cells. The abnormalities with at least 1 participant are presented here.', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of PF-05082566 in Portion A and had hematology laboratory test data.'}, {'type': 'SECONDARY', 'title': 'Number of Participants With Chemistries Laboratory Abnormalities by Maximum NCI CTCAE Grade in Portion A', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion A: PF-05082566 0.006mg/kg', 'description': 'Participants received PF-05082566 0.006 milligrams per kilogram (mg/kg) intravenously once every 4 weeks (q4wks) as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion A: PF-05082566 0.03mg/kg', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion A: PF-05082566 0.06mg/kg', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion A: PF-05082566 0.12mg/kg', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion A: PF-05082566 0.18mg/kg', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion A: PF-05082566 0.24mg/kg', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion A: PF-05082566 0.3mg/kg', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion A: PF-05082566 0.6mg/kg', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion A: PF-05082566 1.2mg/kg', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion A: PF-05082566 2.4mg/kg', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion A: PF-05082566 5mg/kg', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG011', 'title': 'Portion A: PF-05082566 10mg/kg', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'title': 'ALT, Grade 1', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '6', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '1', 'groupId': 'OG011'}]}]}, {'title': 'ALT, Grade 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}, {'title': 'Alkaline phosphatase, Grade 1', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '2', 'groupId': 'OG004'}, {'value': '13', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '6', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '3', 'groupId': 'OG010'}, {'value': '4', 'groupId': 'OG011'}]}]}, {'title': 'Alkaline phosphatase, Grade 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '2', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}, {'title': 'Alkaline phosphatase, Grade 3', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}, {'title': 'AST, Grade 1', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '2', 'groupId': 'OG004'}, {'value': '12', 'groupId': 'OG005'}, {'value': '2', 'groupId': 'OG006'}, {'value': '2', 'groupId': 'OG007'}, {'value': '7', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '2', 'groupId': 'OG010'}, {'value': '1', 'groupId': 'OG011'}]}]}, {'title': 'AST, Grade 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}, {'title': 'Bilirubin (total), Grade 1', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}, {'title': 'Bilirubin (total), Grade 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}, {'title': 'Creatinine, Grade 1', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '5', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '22', 'groupId': 'OG005'}, {'value': '2', 'groupId': 'OG006'}, {'value': '2', 'groupId': 'OG007'}, {'value': '19', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '5', 'groupId': 'OG010'}, {'value': '6', 'groupId': 'OG011'}]}]}, {'title': 'Creatinine, Grade 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '2', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '1', 'groupId': 'OG011'}]}]}, {'title': 'GGT, Grade 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}]}]}, {'title': 'GGT, Grade 3', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}]}]}, {'title': 'Hypercalcemia, Grade 1', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}, {'title': 'Hyperglycemia, Grade 1', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '20', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '3', 'groupId': 'OG007'}, {'value': '13', 'groupId': 'OG008'}, {'value': '2', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}, {'value': '6', 'groupId': 'OG011'}]}]}, {'title': 'Hyperglycemia, Grade 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '7', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '1', 'groupId': 'OG010'}, {'value': '3', 'groupId': 'OG011'}]}]}, {'title': 'Hyperglycemia, Grade 3', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '2', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}, {'title': 'Hyperkalemia, Grade 1', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '2', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}, {'title': 'Hyperkalemia, Grade 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}, {'title': 'Hypermagnesemia, Grade 1', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '27', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '1', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}, {'title': 'Hypermagnesemia, Grade 3', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '27', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}, {'title': 'Hypernatremia, Grade 1', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}, {'title': 'Hypoalbuminemia, Grade 1', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '18', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '3', 'groupId': 'OG007'}, {'value': '9', 'groupId': 'OG008'}, {'value': '2', 'groupId': 'OG009'}, {'value': '2', 'groupId': 'OG010'}, {'value': '4', 'groupId': 'OG011'}]}]}, {'title': 'Hypoalbuminemia, Grade 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '1', 'groupId': 'OG010'}, {'value': '4', 'groupId': 'OG011'}]}]}, {'title': 'Hypoalbuminemia, Grade 3', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}, {'title': 'Hypocalcemia, Grade 1', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '7', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '5', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '3', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}, {'title': 'Hypocalcemia, Grade 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}, {'title': 'Hypocalcemia, Grade 3', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}, {'title': 'Hypoglycemia, Grade 1', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}, {'title': 'Hypoglycemia, Grade 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}, {'title': 'Hypokalemia, Grade 1', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}, {'value': '2', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '2', 'groupId': 'OG011'}]}]}, {'title': 'Hypokalemia, Grade 3', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '1', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}, {'title': 'Hypokalemia, Grade 4', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}, {'title': 'Hypomagnesemia, Grade 1', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '27', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '8', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '1', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}, {'title': 'Hyponatremia, Grade 1', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '17', 'groupId': 'OG005'}, {'value': '2', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '8', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '1', 'groupId': 'OG010'}, {'value': '2', 'groupId': 'OG011'}]}]}, {'title': 'Hyponatremia, Grade 3', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '28', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '2', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}, {'title': 'Hypophosphatemia, Grade 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '5', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '40', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '27', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '8', 'groupId': 'OG005'}, {'value': '2', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '3', 'groupId': 'OG011'}]}]}, {'title': 'Hypophosphatemia, Grade 3', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '5', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '40', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '27', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '1', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': 'Up to approximately 2 years', 'description': 'Following chemistries laboratory abnormalities were graded per NCI CTCAE version 4.03: alanine aminotransferase (ALT), Alkaline phosphatase, Aspartate aminotransferase (AST), bilirubin (total), creatinine, gamma glutamyl transferase (GGT), hypercalcemia, hyperglycemia, hyperkalemia, hypermagnesemia, hypernatremia, hypoalbuminemia, hypocalcemia, hypoglycemia, hypokalemia, hypomagnesemia, hyponatremia, hypophosphatemia. The abnormalities with at least 1 participant are presented here.', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED', 'populationDescription': '"Number of Participants Analyzed" represents all participants who received at least 1 dose of PF-05082566 in Portion A and had chemistries laboratory test data. "Number Analyzed" represents all participants who received at least 1 dose of PF-05082566 in Portion A and had data for the specified category.'}, {'type': 'SECONDARY', 'title': 'Number of Participants With Clinically Significant Vital Sign Abnormalities in Portion A', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '31', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion A: PF-05082566 0.006mg/kg', 'description': 'Participants received PF-05082566 0.006 milligrams per kilogram (mg/kg) intravenously once every 4 weeks (q4wks) as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion A: PF-05082566 0.03mg/kg', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion A: PF-05082566 0.06mg/kg', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion A: PF-05082566 0.12mg/kg', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion A: PF-05082566 0.18mg/kg', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion A: PF-05082566 0.24mg/kg', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion A: PF-05082566 0.3mg/kg', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion A: PF-05082566 0.6mg/kg', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion A: PF-05082566 1.2mg/kg', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion A: PF-05082566 2.4mg/kg', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion A: PF-05082566 5mg/kg', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG011', 'title': 'Portion A: PF-05082566 10mg/kg', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': 'Up to approximately 2 years', 'description': 'For vital signs in Portion A, blood pressure and pulse rate were measured. Clinical significance was determined by the investigator.', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of PF-05082566 in Portion A.'}, {'type': 'SECONDARY', 'title': 'PF-05082566 Maximum Observed Serum Concentration (Cmax) in Portion A', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '40', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '29', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion A: PF-05082566 0.006mg/kg', 'description': 'Participants received PF-05082566 0.006 milligrams per kilogram (mg/kg) intravenously once every 4 weeks (q4wks) as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion A: PF-05082566 0.03mg/kg', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion A: PF-05082566 0.06mg/kg', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion A: PF-05082566 0.12mg/kg', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion A: PF-05082566 0.18mg/kg', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion A: PF-05082566 0.24mg/kg', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion A: PF-05082566 0.3mg/kg', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion A: PF-05082566 0.6mg/kg', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion A: PF-05082566 1.2mg/kg', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion A: PF-05082566 2.4mg/kg', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion A: PF-05082566 5mg/kg', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG011', 'title': 'Portion A: PF-05082566 10mg/kg', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'title': 'Cycle 1', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '40', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '29', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '0.1515', 'spread': '12', 'groupId': 'OG000'}, {'value': '0.4952', 'spread': '34', 'groupId': 'OG001'}, {'value': '1.014', 'spread': '24', 'groupId': 'OG002'}, {'value': '2.614', 'spread': '23', 'groupId': 'OG003'}, {'value': '4.219', 'spread': '16', 'groupId': 'OG004'}, {'value': '3.246', 'spread': '30', 'groupId': 'OG005'}, {'value': '7.038', 'spread': '23', 'groupId': 'OG006'}, {'value': '11.72', 'spread': '28', 'groupId': 'OG007'}, {'value': '18.02', 'spread': '24', 'groupId': 'OG008'}, {'value': '49.63', 'spread': '24', 'groupId': 'OG009'}, {'value': '97.75', 'spread': '13', 'groupId': 'OG010'}, {'value': '150.3', 'spread': '24', 'groupId': 'OG011'}]}]}, {'title': 'Cycle 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '2', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '37', 'groupId': 'OG005'}, {'value': '2', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '24', 'groupId': 'OG008'}, {'value': '3', 'groupId': 'OG009'}, {'value': '5', 'groupId': 'OG010'}, {'value': '10', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '0.1250', 'spread': 'NA', 'comment': 'Geometric coefficient of variation (CV) was not calculated when there were less than 3 participants with data.', 'groupId': 'OG000'}, {'value': '0.5049', 'spread': '7', 'groupId': 'OG001'}, {'value': '1.093', 'spread': '47', 'groupId': 'OG002'}, {'value': '3.408', 'spread': '25', 'groupId': 'OG003'}, {'value': '4.013', 'spread': '25', 'groupId': 'OG004'}, {'value': '2.955', 'spread': '46', 'groupId': 'OG005'}, {'value': '8.349', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG006'}, {'value': '14.80', 'spread': '24', 'groupId': 'OG007'}, {'value': '17.61', 'spread': '36', 'groupId': 'OG008'}, {'value': '58.38', 'spread': '33', 'groupId': 'OG009'}, {'value': '101.6', 'spread': '17', 'groupId': 'OG010'}, {'value': '167.0', 'spread': '21', 'groupId': 'OG011'}]}]}], 'paramType': 'GEOMETRIC_MEAN', 'timeFrame': 'Day 1 of Cycle 1 and Cycle 2 at pre-dose, and 1, 1.5, 2, 6, 24, 48, 168, 336 and 504 hours post-dose', 'description': 'Cmax of PF-05082566 was observed directly from data.', 'unitOfMeasure': 'micrograms per milliliter (μg/mL)', 'dispersionType': 'Geometric Coefficient of Variation', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of PF-05082566 in Portion A and had at least 1 of the PK parameters of interest. "Number Analyzed" represents those participants who had data for each specified category.'}, {'type': 'SECONDARY', 'title': 'PF-05082566 Pre-dose Trough Concentration During Multiple Dosing (Ctrough) in Portion A', 'denoms': [{'units': 'Participants', 'counts': [{'value': '2', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '37', 'groupId': 'OG005'}, {'value': '2', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '24', 'groupId': 'OG008'}, {'value': '3', 'groupId': 'OG009'}, {'value': '5', 'groupId': 'OG010'}, {'value': '10', 'groupId': 'OG011'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion A: PF-05082566 0.006mg/kg', 'description': 'Participants received PF-05082566 0.006 milligrams per kilogram (mg/kg) intravenously once every 4 weeks (q4wks) as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion A: PF-05082566 0.03mg/kg', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion A: PF-05082566 0.06mg/kg', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion A: PF-05082566 0.12mg/kg', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion A: PF-05082566 0.18mg/kg', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion A: PF-05082566 0.24mg/kg', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion A: PF-05082566 0.3mg/kg', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion A: PF-05082566 0.6mg/kg', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion A: PF-05082566 1.2mg/kg', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion A: PF-05082566 2.4mg/kg', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion A: PF-05082566 5mg/kg', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG011', 'title': 'Portion A: PF-05082566 10mg/kg', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'categories': [{'measurements': [{'value': 'NA', 'spread': 'NA', 'comment': 'Geometric mean cannot be calculated when there were participants with a zero value (ie, Ctrough below the limit of quantification). Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG000'}, {'value': '0.1063', 'spread': '24', 'groupId': 'OG001'}, {'value': '0.1092', 'spread': '24', 'groupId': 'OG002'}, {'value': '0.3268', 'spread': '12', 'groupId': 'OG003'}, {'value': '0.4285', 'spread': '49', 'groupId': 'OG004'}, {'value': '0.3868', 'spread': '46', 'groupId': 'OG005'}, {'value': '0.8597', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG006'}, {'value': '1.520', 'spread': '22', 'groupId': 'OG007'}, {'value': '1.313', 'spread': '61', 'groupId': 'OG008'}, {'value': '7.054', 'spread': '52', 'groupId': 'OG009'}, {'value': '9.934', 'spread': '35', 'groupId': 'OG010'}, {'value': '9.963', 'spread': '250', 'groupId': 'OG011'}]}]}], 'paramType': 'GEOMETRIC_MEAN', 'timeFrame': 'Day 1 pre-dose of Cycle 2', 'description': 'Ctrough of PF-05082566 was observed directly from data.', 'unitOfMeasure': 'μg/mL', 'dispersionType': 'Geometric Coefficient of Variation', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of PF-05082566 in Portion A and had data for Ctrough.'}, {'type': 'SECONDARY', 'title': 'PF-05082566 Time for Maximum Observed Serum Concentration (Tmax) in Portion A', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '40', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '29', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion A: PF-05082566 0.006mg/kg', 'description': 'Participants received PF-05082566 0.006 milligrams per kilogram (mg/kg) intravenously once every 4 weeks (q4wks) as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion A: PF-05082566 0.03mg/kg', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion A: PF-05082566 0.06mg/kg', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion A: PF-05082566 0.12mg/kg', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion A: PF-05082566 0.18mg/kg', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion A: PF-05082566 0.24mg/kg', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion A: PF-05082566 0.3mg/kg', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion A: PF-05082566 0.6mg/kg', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion A: PF-05082566 1.2mg/kg', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion A: PF-05082566 2.4mg/kg', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion A: PF-05082566 5mg/kg', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG011', 'title': 'Portion A: PF-05082566 10mg/kg', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'title': 'Cycle 1', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '40', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '29', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '1.75', 'groupId': 'OG000', 'lowerLimit': '1.50', 'upperLimit': '2.00'}, {'value': '1.63', 'groupId': 'OG001', 'lowerLimit': '1.50', 'upperLimit': '1.67'}, {'value': '2.00', 'groupId': 'OG002', 'lowerLimit': '1.00', 'upperLimit': '5.42'}, {'value': '1.26', 'groupId': 'OG003', 'lowerLimit': '1.00', 'upperLimit': '2.00'}, {'value': '1.25', 'groupId': 'OG004', 'lowerLimit': '0.967', 'upperLimit': '6.00'}, {'value': '1.03', 'groupId': 'OG005', 'lowerLimit': '0.833', 'upperLimit': '24.2'}, {'value': '1.00', 'groupId': 'OG006', 'lowerLimit': '1.00', 'upperLimit': '1.50'}, {'value': '1.80', 'groupId': 'OG007', 'lowerLimit': '1.62', 'upperLimit': '2.00'}, {'value': '1.17', 'groupId': 'OG008', 'lowerLimit': '1.00', 'upperLimit': '5.53'}, {'value': '1.50', 'groupId': 'OG009', 'lowerLimit': '1.00', 'upperLimit': '1.58'}, {'value': '1.06', 'groupId': 'OG010', 'lowerLimit': '1.00', 'upperLimit': '1.48'}, {'value': '1.50', 'groupId': 'OG011', 'lowerLimit': '1.07', 'upperLimit': '2.02'}]}]}, {'title': 'Cycle 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '2', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '37', 'groupId': 'OG005'}, {'value': '2', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '24', 'groupId': 'OG008'}, {'value': '3', 'groupId': 'OG009'}, {'value': '5', 'groupId': 'OG010'}, {'value': '10', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '13.0', 'groupId': 'OG000', 'lowerLimit': '2.00', 'upperLimit': '24.0'}, {'value': '1.50', 'groupId': 'OG001', 'lowerLimit': '1.50', 'upperLimit': '2.00'}, {'value': '1.54', 'groupId': 'OG002', 'lowerLimit': '1.00', 'upperLimit': '2.00'}, {'value': '1.00', 'groupId': 'OG003', 'lowerLimit': '1.00', 'upperLimit': '2.00'}, {'value': '2.00', 'groupId': 'OG004', 'lowerLimit': '1.50', 'upperLimit': '2.00'}, {'value': '1.03', 'groupId': 'OG005', 'lowerLimit': '0.833', 'upperLimit': '2.00'}, {'value': '1.00', 'groupId': 'OG006', 'lowerLimit': '1.00', 'upperLimit': '1.00'}, {'value': '1.46', 'groupId': 'OG007', 'lowerLimit': '1.00', 'upperLimit': '1.70'}, {'value': '1.02', 'groupId': 'OG008', 'lowerLimit': '0.883', 'upperLimit': '1.22'}, {'value': '1.08', 'groupId': 'OG009', 'lowerLimit': '1.00', 'upperLimit': '1.08'}, {'value': '1.92', 'groupId': 'OG010', 'lowerLimit': '1.08', 'upperLimit': '2.00'}, {'value': '1.31', 'groupId': 'OG011', 'lowerLimit': '1.03', 'upperLimit': '5.55'}]}]}], 'paramType': 'MEDIAN', 'timeFrame': 'Day 1 of Cycle 1 and Cycle 2 at pre-dose, and 1, 1.5, 2, 6, 24, 48, 168, 336 and 504 hours post-dose.', 'description': 'Tmax of PF-05082566 was observed directly from data as time of Cmax.', 'unitOfMeasure': 'hours (hr)', 'dispersionType': 'Full Range', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of PF-05082566 in Portion A and had at least 1 of the PK parameters of interest. "Number Analyzed" represents those participants who had data for each specified category.'}, {'type': 'SECONDARY', 'title': 'PF-05082566 Area Under the Serum Concentration-Time Profile (AUC) From Time 0 to the Time of the Last Measurable Concentration (AUClast) in Portion A', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '40', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '29', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion A: PF-05082566 0.006mg/kg', 'description': 'Participants received PF-05082566 0.006 milligrams per kilogram (mg/kg) intravenously once every 4 weeks (q4wks) as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion A: PF-05082566 0.03mg/kg', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion A: PF-05082566 0.06mg/kg', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion A: PF-05082566 0.12mg/kg', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion A: PF-05082566 0.18mg/kg', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion A: PF-05082566 0.24mg/kg', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion A: PF-05082566 0.3mg/kg', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion A: PF-05082566 0.6mg/kg', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion A: PF-05082566 1.2mg/kg', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion A: PF-05082566 2.4mg/kg', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion A: PF-05082566 5mg/kg', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG011', 'title': 'Portion A: PF-05082566 10mg/kg', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'title': 'Cycle 1', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '34', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '27', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '8.212', 'spread': '251', 'groupId': 'OG000'}, {'value': '101.0', 'spread': '9', 'groupId': 'OG001'}, {'value': '148.1', 'spread': '33', 'groupId': 'OG002'}, {'value': '389.4', 'spread': '58', 'groupId': 'OG003'}, {'value': '703.3', 'spread': '32', 'groupId': 'OG004'}, {'value': '481.1', 'spread': '48', 'groupId': 'OG005'}, {'value': '996.1', 'spread': '29', 'groupId': 'OG006'}, {'value': '2165', 'spread': '21', 'groupId': 'OG007'}, {'value': '2383', 'spread': '61', 'groupId': 'OG008'}, {'value': '5731', 'spread': '101', 'groupId': 'OG009'}, {'value': '15540', 'spread': '22', 'groupId': 'OG010'}, {'value': '25520', 'spread': '24', 'groupId': 'OG011'}]}]}, {'title': 'Cycle 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '2', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '5', 'groupId': 'OG005'}, {'value': '2', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '4', 'groupId': 'OG008'}, {'value': '3', 'groupId': 'OG009'}, {'value': '5', 'groupId': 'OG010'}, {'value': '10', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '14.21', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG000'}, {'value': '105.2', 'spread': '49', 'groupId': 'OG001'}, {'value': '93.59', 'spread': '152', 'groupId': 'OG002'}, {'value': '614.9', 'spread': '7', 'groupId': 'OG003'}, {'value': '808.0', 'spread': '53', 'groupId': 'OG004'}, {'value': '818.7', 'spread': '38', 'groupId': 'OG005'}, {'value': '1662', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG006'}, {'value': '1918', 'spread': '40', 'groupId': 'OG007'}, {'value': '4035', 'spread': '25', 'groupId': 'OG008'}, {'value': '6741', 'spread': '6', 'groupId': 'OG009'}, {'value': '18140', 'spread': '24', 'groupId': 'OG010'}, {'value': '19900', 'spread': '51', 'groupId': 'OG011'}]}]}], 'paramType': 'GEOMETRIC_MEAN', 'timeFrame': 'Day 1 of Cycle 1 and Cycle 2 at pre-dose, and 1, 1.5, 2, 6, 24, 48, 168, 336 and 504 hours post-dose.', 'description': 'AUClast of PF-05082566 was determined by linear/log trapezoidal method.', 'unitOfMeasure': 'microgram*hour per milliliter (μg*hr/mL)', 'dispersionType': 'Geometric Coefficient of Variation', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of PF-05082566 in Portion A and had at least 1 of the PK parameters of interest. "Number Analyzed" represents those participants who had data for each specified category.'}, {'type': 'SECONDARY', 'title': 'PF-05082566 AUC From Time 0 to Infinity (AUCinf) in Portion A', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '40', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '29', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion A: PF-05082566 0.006mg/kg', 'description': 'Participants received PF-05082566 0.006 milligrams per kilogram (mg/kg) intravenously once every 4 weeks (q4wks) as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion A: PF-05082566 0.03mg/kg', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion A: PF-05082566 0.06mg/kg', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion A: PF-05082566 0.12mg/kg', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion A: PF-05082566 0.18mg/kg', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion A: PF-05082566 0.24mg/kg', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion A: PF-05082566 0.3mg/kg', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion A: PF-05082566 0.6mg/kg', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion A: PF-05082566 1.2mg/kg', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion A: PF-05082566 2.4mg/kg', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion A: PF-05082566 5mg/kg', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG011', 'title': 'Portion A: PF-05082566 10mg/kg', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'title': 'Cycle 1', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '2', 'groupId': 'OG004'}, {'value': '15', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '2', 'groupId': 'OG007'}, {'value': '21', 'groupId': 'OG008'}, {'value': '2', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}, {'value': '8', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '120', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG001'}, {'value': '187.5', 'spread': '31', 'groupId': 'OG002'}, {'value': '667.0', 'spread': '13', 'groupId': 'OG003'}, {'value': '989.5', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG004'}, {'value': '687.9', 'spread': '43', 'groupId': 'OG005'}, {'value': '770.0', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG006'}, {'value': '2916', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG007'}, {'value': '3111', 'spread': '36', 'groupId': 'OG008'}, {'value': '7628', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG009'}, {'value': '18430', 'spread': '24', 'groupId': 'OG010'}, {'value': '28280', 'spread': '28', 'groupId': 'OG011'}]}]}, {'title': 'Cycle 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '5', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '2', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '3', 'groupId': 'OG010'}, {'value': '3', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '169.8', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG001'}, {'value': '251.4', 'spread': '17', 'groupId': 'OG002'}, {'value': '931.0', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG003'}, {'value': '1072', 'spread': '57', 'groupId': 'OG004'}, {'value': '960.8', 'spread': '47', 'groupId': 'OG005'}, {'value': '2000', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG006'}, {'value': '1782', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG007'}, {'value': '4649', 'spread': '25', 'groupId': 'OG008'}, {'value': '8480', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG009'}, {'value': '20950', 'spread': '23', 'groupId': 'OG010'}, {'value': '22400', 'spread': '26', 'groupId': 'OG011'}]}]}], 'paramType': 'GEOMETRIC_MEAN', 'timeFrame': 'Day 1 of Cycle 1 and Cycle 2 at pre-dose, and 1, 1.5, 2, 6, 24, 48, 168, 336 and 504 hours post-dose.', 'description': 'AUCinf = AUClast + (Clast\\*/kel), where Clast\\* is the estimated concentration at the time of the last measurable concentration and kel is the terminal phase rate constant calculated as the absolute value of the slope of a linear regression during the terminal phase of the natural log-transformed concentration time profile.', 'unitOfMeasure': 'μg*hr/mL', 'dispersionType': 'Geometric Coefficient of Variation', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of PF-05082566 in Portion A and had at least 1 of the PK parameters of interest. "Number Analyzed" represents those participants who had data for each specified category.'}, {'type': 'SECONDARY', 'title': 'PF-05082566 AUC From Time 0 to Time of Dosing Interval (AUCtau) in Portion A', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '40', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '29', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion A: PF-05082566 0.006mg/kg', 'description': 'Participants received PF-05082566 0.006 milligrams per kilogram (mg/kg) intravenously once every 4 weeks (q4wks) as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion A: PF-05082566 0.03mg/kg', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion A: PF-05082566 0.06mg/kg', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion A: PF-05082566 0.12mg/kg', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion A: PF-05082566 0.18mg/kg', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion A: PF-05082566 0.24mg/kg', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion A: PF-05082566 0.3mg/kg', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion A: PF-05082566 0.6mg/kg', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion A: PF-05082566 1.2mg/kg', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion A: PF-05082566 2.4mg/kg', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion A: PF-05082566 5mg/kg', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG011', 'title': 'Portion A: PF-05082566 10mg/kg', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'title': 'Cycle 1', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '32', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '25', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '13.70', 'spread': '181', 'groupId': 'OG000'}, {'value': '104.8', 'spread': '9', 'groupId': 'OG001'}, {'value': '154.2', 'spread': '27', 'groupId': 'OG002'}, {'value': '503.9', 'spread': '14', 'groupId': 'OG003'}, {'value': '690.9', 'spread': '33', 'groupId': 'OG004'}, {'value': '538.6', 'spread': '33', 'groupId': 'OG005'}, {'value': '1012', 'spread': '27', 'groupId': 'OG006'}, {'value': '2195', 'spread': '21', 'groupId': 'OG007'}, {'value': '2761', 'spread': '34', 'groupId': 'OG008'}, {'value': '8204', 'spread': '36', 'groupId': 'OG009'}, {'value': '15760', 'spread': '20', 'groupId': 'OG010'}, {'value': '25250', 'spread': '23', 'groupId': 'OG011'}]}]}, {'title': 'Cycle 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '5', 'groupId': 'OG005'}, {'value': '2', 'groupId': 'OG006'}, {'value': '3', 'groupId': 'OG007'}, {'value': '4', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '5', 'groupId': 'OG010'}, {'value': '4', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '130.8', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG001'}, {'value': '224.4', 'spread': '19', 'groupId': 'OG002'}, {'value': '618.6', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG003'}, {'value': '864.1', 'spread': '47', 'groupId': 'OG004'}, {'value': '824.3', 'spread': '37', 'groupId': 'OG005'}, {'value': '1681', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG006'}, {'value': '2107', 'spread': '43', 'groupId': 'OG007'}, {'value': '4068', 'spread': '27', 'groupId': 'OG008'}, {'value': '7460', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG009'}, {'value': '19040', 'spread': '18', 'groupId': 'OG010'}, {'value': '20490', 'spread': '17', 'groupId': 'OG011'}]}]}], 'paramType': 'GEOMETRIC_MEAN', 'timeFrame': 'Day 1 of Cycle 1 and Cycle 2 at pre-dose, and 1, 1.5, 2, 6, 24, 48, 168, 336 and 504 hours post-dose.', 'description': 'AUCtau of PF-05082566 was determined using linear/log trapezoidal method.', 'unitOfMeasure': 'μg*hr/mL', 'dispersionType': 'Geometric Coefficient of Variation', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of PF-05082566 in Portion A and had at least 1 of the PK parameters of interest. "Number Analyzed" represents those participants who had data for each specified category.'}, {'type': 'SECONDARY', 'title': 'PF-05082566 Clearance (CL) in Portion A', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '40', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '29', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion A: PF-05082566 0.006mg/kg', 'description': 'Participants received PF-05082566 0.006 milligrams per kilogram (mg/kg) intravenously once every 4 weeks (q4wks) as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion A: PF-05082566 0.03mg/kg', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion A: PF-05082566 0.06mg/kg', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion A: PF-05082566 0.12mg/kg', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion A: PF-05082566 0.18mg/kg', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion A: PF-05082566 0.24mg/kg', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion A: PF-05082566 0.3mg/kg', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion A: PF-05082566 0.6mg/kg', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion A: PF-05082566 1.2mg/kg', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion A: PF-05082566 2.4mg/kg', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion A: PF-05082566 5mg/kg', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG011', 'title': 'Portion A: PF-05082566 10mg/kg', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'title': 'Cycle 1', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '2', 'groupId': 'OG004'}, {'value': '15', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '2', 'groupId': 'OG007'}, {'value': '21', 'groupId': 'OG008'}, {'value': '2', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}, {'value': '8', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '0.2510', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG001'}, {'value': '0.3203', 'spread': '31', 'groupId': 'OG002'}, {'value': '0.1800', 'spread': '13', 'groupId': 'OG003'}, {'value': '0.1823', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG004'}, {'value': '0.3490', 'spread': '42', 'groupId': 'OG005'}, {'value': '0.3890', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG006'}, {'value': '0.2054', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG007'}, {'value': '0.3861', 'spread': '36', 'groupId': 'OG008'}, {'value': '0.3145', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG009'}, {'value': '0.2711', 'spread': '24', 'groupId': 'OG010'}, {'value': '0.3536', 'spread': '28', 'groupId': 'OG011'}]}]}, {'title': 'Cycle 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '5', 'groupId': 'OG005'}, {'value': '2', 'groupId': 'OG006'}, {'value': '3', 'groupId': 'OG007'}, {'value': '4', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '5', 'groupId': 'OG010'}, {'value': '4', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '0.2296', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG001'}, {'value': '0.2676', 'spread': '19', 'groupId': 'OG002'}, {'value': '0.1939', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG003'}, {'value': '0.2082', 'spread': '47', 'groupId': 'OG004'}, {'value': '0.2906', 'spread': '37', 'groupId': 'OG005'}, {'value': '0.1786', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG006'}, {'value': '0.2847', 'spread': '43', 'groupId': 'OG007'}, {'value': '0.2950', 'spread': '27', 'groupId': 'OG008'}, {'value': '0.3220', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG009'}, {'value': '0.2626', 'spread': '18', 'groupId': 'OG010'}, {'value': '0.4883', 'spread': '17', 'groupId': 'OG011'}]}]}], 'paramType': 'GEOMETRIC_MEAN', 'timeFrame': 'Day 1 of Cycle 1 and Cycle 2 at pre-dose, and 1, 1.5, 2, 6, 24, 48, 168, 336 and 504 hours post-dose.', 'description': 'CL = Dose/AUCinf for Cycle 1 and Dose/AUCtau for Cycle 2. It was reported in units of milliliter per hour per kilogram (mL/hr/kg).', 'unitOfMeasure': 'milliliter/hour/kilogram (mL/hr/kg)', 'dispersionType': 'Geometric Coefficient of Variation', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of PF-05082566 in Portion A and had at least 1 of the PK parameters of interest. "Number Analyzed" represents those participants who had data for each specified category.'}, {'type': 'SECONDARY', 'title': 'PF-05082566 Volume of Distribution at Steady State (Vss) in Portion A', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '40', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '29', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion A: PF-05082566 0.006mg/kg', 'description': 'Participants received PF-05082566 0.006 milligrams per kilogram (mg/kg) intravenously once every 4 weeks (q4wks) as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion A: PF-05082566 0.03mg/kg', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion A: PF-05082566 0.06mg/kg', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion A: PF-05082566 0.12mg/kg', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion A: PF-05082566 0.18mg/kg', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion A: PF-05082566 0.24mg/kg', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion A: PF-05082566 0.3mg/kg', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion A: PF-05082566 0.6mg/kg', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion A: PF-05082566 1.2mg/kg', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion A: PF-05082566 2.4mg/kg', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion A: PF-05082566 5mg/kg', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG011', 'title': 'Portion A: PF-05082566 10mg/kg', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'title': 'Cycle 1', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '2', 'groupId': 'OG004'}, {'value': '15', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '2', 'groupId': 'OG007'}, {'value': '21', 'groupId': 'OG008'}, {'value': '2', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}, {'value': '8', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '65.50', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG001'}, {'value': '101.1', 'spread': '20', 'groupId': 'OG002'}, {'value': '83.63', 'spread': '15', 'groupId': 'OG003'}, {'value': '74.38', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG004'}, {'value': '110.7', 'spread': '28', 'groupId': 'OG005'}, {'value': '75.20', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG006'}, {'value': '82.38', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG007'}, {'value': '112.2', 'spread': '29', 'groupId': 'OG008'}, {'value': '110.4', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG009'}, {'value': '97.07', 'spread': '26', 'groupId': 'OG010'}, {'value': '125.5', 'spread': '21', 'groupId': 'OG011'}]}]}, {'title': 'Cycle 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '5', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '2', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '3', 'groupId': 'OG010'}, {'value': '3', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '102.1', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG001'}, {'value': '74.11', 'spread': '21', 'groupId': 'OG002'}, {'value': '90.80', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG003'}, {'value': '81.69', 'spread': '27', 'groupId': 'OG004'}, {'value': '86.50', 'spread': '29', 'groupId': 'OG005'}, {'value': '51.00', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG006'}, {'value': '61.54', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG007'}, {'value': '116.5', 'spread': '62', 'groupId': 'OG008'}, {'value': '99.80', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG009'}, {'value': '87.37', 'spread': '43', 'groupId': 'OG010'}, {'value': '139.5', 'spread': '29', 'groupId': 'OG011'}]}]}], 'paramType': 'GEOMETRIC_MEAN', 'timeFrame': 'Day 1 of Cycle 1 and Cycle 2 at pre-dose, and 1, 1.5, 2, 6, 24, 48, 168, 336 and 504 hours post-dose.', 'description': 'Vss = CL × MRT, where CL is clearance and MRT is the mean residence time after intravenous administration.', 'unitOfMeasure': 'milliliter per kilogram (mL/kg)', 'dispersionType': 'Geometric Coefficient of Variation', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of PF-05082566 in Portion A and had at least 1 of the PK parameters of interest. "Number Analyzed" represents those participants who had data for each specified category.'}, {'type': 'SECONDARY', 'title': 'Number of Participants With Positive Anti-Drug Antibody (ADA) for PF-05082566 in Portion A', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '31', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion A: PF-05082566 0.006mg/kg', 'description': 'Participants received PF-05082566 0.006 milligrams per kilogram (mg/kg) intravenously once every 4 weeks (q4wks) as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion A: PF-05082566 0.03mg/kg', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion A: PF-05082566 0.06mg/kg', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion A: PF-05082566 0.12mg/kg', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion A: PF-05082566 0.18mg/kg', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion A: PF-05082566 0.24mg/kg', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion A: PF-05082566 0.3mg/kg', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion A: PF-05082566 0.6mg/kg', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion A: PF-05082566 1.2mg/kg', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion A: PF-05082566 2.4mg/kg', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion A: PF-05082566 5mg/kg', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG011', 'title': 'Portion A: PF-05082566 10mg/kg', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'categories': [{'measurements': [{'value': '4', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '5', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '20', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '3', 'groupId': 'OG007'}, {'value': '14', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '3', 'groupId': 'OG010'}, {'value': '2', 'groupId': 'OG011'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': 'Up to approximately 2 years', 'description': 'ADA for PF-05082566 was detected using electrochemiluminescence assay. Positive ADA for PF-05082566: titer\\>=6.23.', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of PF-05082566 in Portion A and was tested for ADA.'}, {'type': 'SECONDARY', 'title': 'Number of Participants With QTc Interval Meeting Categorical Summarization Criteria in Portion A', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '40', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '29', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion A: PF-05082566 0.006mg/kg', 'description': 'Participants received PF-05082566 0.006 milligrams per kilogram (mg/kg) intravenously once every 4 weeks (q4wks) as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion A: PF-05082566 0.03mg/kg', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion A: PF-05082566 0.06mg/kg', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion A: PF-05082566 0.12mg/kg', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion A: PF-05082566 0.18mg/kg', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion A: PF-05082566 0.24mg/kg', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion A: PF-05082566 0.3mg/kg', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion A: PF-05082566 0.6mg/kg', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion A: PF-05082566 1.2mg/kg', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion A: PF-05082566 2.4mg/kg', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion A: PF-05082566 5mg/kg', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG011', 'title': 'Portion A: PF-05082566 10mg/kg', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'title': 'QTc >450 to <=480 msec', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '40', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '29', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '10', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '8', 'groupId': 'OG008'}, {'value': '2', 'groupId': 'OG009'}, {'value': '3', 'groupId': 'OG010'}, {'value': '4', 'groupId': 'OG011'}]}]}, {'title': 'QTc >480 to <=500 msec', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '40', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '29', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '2', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '1', 'groupId': 'OG011'}]}]}, {'title': 'QTc >500 msec', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '40', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '29', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}, {'title': 'QTc change >30 to <=60 msec', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '39', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '29', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '6', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '2', 'groupId': 'OG010'}, {'value': '3', 'groupId': 'OG011'}]}]}, {'title': 'QTc change >60 msec', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '39', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '29', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': 'Up to approximately 2 years', 'description': 'Categorical summarization criteria for QTc interval (time from ECG Q wave to the end of the T wave corresponding to electrical systole corrected for heart rate): 1) absolute value of \\>450 to \\<=480 milliseconds (msec), \\>480 to \\<=500 msec, \\>500 msec; 2) a maximum change from baseline of \\>30 to \\<=60 msec or \\>60 msec.', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of PF-05082566 in Portion A and had post-baseline QTc data. "Number Analyzed" represents those participants who had data for each specified category.'}, {'type': 'SECONDARY', 'title': 'Percentage of Participants Achieving Objective Response Per Response Evaluation Criteria in Solid Tumor (RECIST) Version 1.1 in Portion A', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '31', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion A: PF-05082566 0.006mg/kg', 'description': 'Participants received PF-05082566 0.006 milligrams per kilogram (mg/kg) intravenously once every 4 weeks (q4wks) as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion A: PF-05082566 0.03mg/kg', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion A: PF-05082566 0.06mg/kg', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion A: PF-05082566 0.12mg/kg', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion A: PF-05082566 0.18mg/kg', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion A: PF-05082566 0.24mg/kg', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion A: PF-05082566 0.3mg/kg', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion A: PF-05082566 0.6mg/kg', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion A: PF-05082566 1.2mg/kg', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion A: PF-05082566 2.4mg/kg', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion A: PF-05082566 5mg/kg', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG011', 'title': 'Portion A: PF-05082566 10mg/kg', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000', 'lowerLimit': '0', 'upperLimit': '60.2'}, {'value': '0', 'groupId': 'OG001', 'lowerLimit': '0', 'upperLimit': '70.8'}, {'value': '0', 'groupId': 'OG002', 'lowerLimit': '0', 'upperLimit': '45.9'}, {'value': '0', 'groupId': 'OG003', 'lowerLimit': '0', 'upperLimit': '60.2'}, {'value': '0', 'groupId': 'OG004', 'lowerLimit': '0', 'upperLimit': '97.5'}, {'value': '4.8', 'groupId': 'OG005', 'lowerLimit': '0.6', 'upperLimit': '16.2'}, {'value': '0', 'groupId': 'OG006', 'lowerLimit': '0', 'upperLimit': '70.8'}, {'value': '25.0', 'groupId': 'OG007', 'lowerLimit': '0.6', 'upperLimit': '80.6'}, {'value': '0', 'groupId': 'OG008', 'lowerLimit': '0', 'upperLimit': '11.2'}, {'value': '0', 'groupId': 'OG009', 'lowerLimit': '0', 'upperLimit': '52.2'}, {'value': '0', 'groupId': 'OG010', 'lowerLimit': '0', 'upperLimit': '45.9'}, {'value': '0', 'groupId': 'OG011', 'lowerLimit': '0', 'upperLimit': '28.5'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Every 8 weeks from Cycle 1 Day 1 for the first 10 months on study treatment, then every 16 weeks till follow-up visit (assessed up to approximately 2 years)', 'description': 'Objective response: confirmed best overall response (BOR) of complete response (CR) or partial response (PR) per RECIST version 1.1. BOR of CR: target lesions and non-target diseases achieved CR, without new lesions. BOR of PR: target lesions achieved CR or PR while non-target diseases were non-CR/non-progression of disease (non-PD), indeterminate or missing, and without new lesions. For target lesions, CR: complete disappearance of all target lesions except nodal disease (target nodes must decrease to normal size); PR: \\>=30% decrease under baseline of the sum of diameters of all target measurable lesions. For non-target diseases, CR: disappearance of all non-target lesions and normalization of tumor marker levels; non-CR/non-PD: persistence of any non-target lesions and/or tumor marker level above the normal limits; Indeterminate: progression had not been determined and \\>=1 non-target sites were not assessed or assessment methods were inconsistent with those used at baseline.', 'unitOfMeasure': 'percentage of participants', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of PF-05082566 in Portion A and had tumor assessments.'}, {'type': 'SECONDARY', 'title': 'Duration of Response in Portion A', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '2', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion A: PF-05082566 0.006mg/kg', 'description': 'Participants received PF-05082566 0.006 milligrams per kilogram (mg/kg) intravenously once every 4 weeks (q4wks) as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion A: PF-05082566 0.03mg/kg', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion A: PF-05082566 0.06mg/kg', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion A: PF-05082566 0.12mg/kg', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion A: PF-05082566 0.18mg/kg', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion A: PF-05082566 0.24mg/kg', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion A: PF-05082566 0.3mg/kg', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion A: PF-05082566 0.6mg/kg', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion A: PF-05082566 1.2mg/kg', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion A: PF-05082566 2.4mg/kg', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion A: PF-05082566 5mg/kg', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG011', 'title': 'Portion A: PF-05082566 10mg/kg', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'title': 'For Participant X in 0.24 mg/kg', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '5.8', 'groupId': 'OG005'}]}]}, {'title': 'For Participant Y in 0.24 mg/kg', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '24.2', 'groupId': 'OG005'}]}]}, {'title': 'For Participant Z in 0.6 mg/kg', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}], 'categories': [{'measurements': [{'value': '22.8', 'groupId': 'OG007'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Every 8 weeks from Cycle 1 Day 1 for the first 10 months on study treatment, then every 16 weeks till follow-up visit (assessed up to approximately 2 years)', 'description': 'Duration of response: the time from first documentation of objective response (confirmed BOR of CR or PR per RECIST version 1.1) to the date of first documentation of objective progression of disease (PD) or death due to any cause. Objective PD per RECIST version 1.1: \\>=20% increase in the sum of diameters of target measurable lesions above the smallest sum observed (over baseline if no decrease in the sum was observed during therapy), with a minimum absolute increase of 5 millimeters (mm); or unequivocal progression of pre-existing lesions for non-target disease; or appearance of new lesions. This outcome measure reports the individual values for evaluable participants (instead of medians etc) due to the limited number of events.', 'unitOfMeasure': 'months', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of PF-05082566 in Portion A and achieved an objective response. "Number analyzed" represents the number of such participants for each specified category.'}, {'type': 'SECONDARY', 'title': 'Time to Response in Portion A', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '2', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion A: PF-05082566 0.006mg/kg', 'description': 'Participants received PF-05082566 0.006 milligrams per kilogram (mg/kg) intravenously once every 4 weeks (q4wks) as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion A: PF-05082566 0.03mg/kg', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion A: PF-05082566 0.06mg/kg', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion A: PF-05082566 0.12mg/kg', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion A: PF-05082566 0.18mg/kg', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion A: PF-05082566 0.24mg/kg', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion A: PF-05082566 0.3mg/kg', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion A: PF-05082566 0.6mg/kg', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion A: PF-05082566 1.2mg/kg', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion A: PF-05082566 2.4mg/kg', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion A: PF-05082566 5mg/kg', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG011', 'title': 'Portion A: PF-05082566 10mg/kg', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'categories': [{'measurements': [{'value': '10.3', 'groupId': 'OG005', 'lowerLimit': '2.3', 'upperLimit': '18.4'}, {'value': '1.8', 'groupId': 'OG007', 'lowerLimit': '1.8', 'upperLimit': '1.8'}]}]}], 'paramType': 'MEDIAN', 'timeFrame': 'Every 8 weeks from Cycle 1 Day 1 for the first 10 months on study treatment, then every 16 weeks till follow-up visit (assessed up to approximately 2 years)', 'description': 'Time to response: the time from Cycle 1 Day 1 to the first documentation of objective response (confirmed BOR of CR or PR per RECIST version 1.1). BOR of CR: target lesions and non-target diseases achieved CR, without new lesions. BOR of PR: target lesions achieved CR or PR while non-target diseases were non-CR/non-PD, indeterminate or missing, and without new lesions. For target lesions, CR: complete disappearance of all target lesions except nodal disease (target nodes decreased to normal size); PR: \\>=30% decrease under baseline of the sum of diameters of all target measurable lesions. For non-target diseases, CR: disappearance of all non-target lesions and normalization of tumor marker levels; non-CR/non-PD: persistence of any non-target lesions and/or tumor marker level above the normal limits; Indeterminate: progression had not been determined and \\>=1 non-target sites were not assessed or assessment methods were inconsistent with those used at baseline.', 'unitOfMeasure': 'months', 'dispersionType': 'Full Range', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of PF-05082566 in Portion A and and achieved an objective response.'}, {'type': 'SECONDARY', 'title': 'Progression-Free Survival in Portion A', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '31', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion A: PF-05082566 0.006mg/kg', 'description': 'Participants received PF-05082566 0.006 milligrams per kilogram (mg/kg) intravenously once every 4 weeks (q4wks) as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion A: PF-05082566 0.03mg/kg', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion A: PF-05082566 0.06mg/kg', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion A: PF-05082566 0.12mg/kg', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion A: PF-05082566 0.18mg/kg', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion A: PF-05082566 0.24mg/kg', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion A: PF-05082566 0.3mg/kg', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion A: PF-05082566 0.6mg/kg', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion A: PF-05082566 1.2mg/kg', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion A: PF-05082566 2.4mg/kg', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion A: PF-05082566 5mg/kg', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG011', 'title': 'Portion A: PF-05082566 10mg/kg', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.7', 'groupId': 'OG000', 'lowerLimit': '1.1', 'upperLimit': '1.8'}, {'value': '3.6', 'groupId': 'OG001', 'lowerLimit': '1.7', 'upperLimit': '5.5'}, {'value': '1.7', 'groupId': 'OG002', 'lowerLimit': '1.6', 'upperLimit': '2.1'}, {'value': '3.5', 'comment': 'The upper limit of 95% confidence interval (CI) was not estimable due to the small number of events.', 'groupId': 'OG003', 'lowerLimit': '1.6', 'upperLimit': 'NA'}, {'value': '1.7', 'comment': '95% CI was not estimable due to the small number of events.', 'groupId': 'OG004', 'lowerLimit': 'NA', 'upperLimit': 'NA'}, {'value': '2.1', 'groupId': 'OG005', 'lowerLimit': '1.8', 'upperLimit': '3.7'}, {'value': '1.6', 'groupId': 'OG006', 'lowerLimit': '1.6', 'upperLimit': '1.6'}, {'value': '3.5', 'comment': 'The upper limit of 95% CI was not estimable due to the small number of events.', 'groupId': 'OG007', 'lowerLimit': '1.4', 'upperLimit': 'NA'}, {'value': '1.7', 'groupId': 'OG008', 'lowerLimit': '1.5', 'upperLimit': '1.8'}, {'value': '1.1', 'groupId': 'OG009', 'lowerLimit': '0.2', 'upperLimit': '1.7'}, {'value': '3.3', 'comment': 'The upper limit of 95% CI was not estimable due to the small number of events.', 'groupId': 'OG010', 'lowerLimit': '0.3', 'upperLimit': 'NA'}, {'value': '1.8', 'groupId': 'OG011', 'lowerLimit': '0.9', 'upperLimit': '1.9'}]}]}], 'paramType': 'MEDIAN', 'timeFrame': 'Every 8 weeks from Cycle 1 Day 1 for the first 10 months on study treatment, then every 16 weeks till follow-up visit (assessed up to approximately 2 years)', 'description': 'Progression-free survival: the time from Cycle 1 Day 1 to the date of the first documentation of objective PD or death due to any cause, whichever occurred first. Objective PD per RECIST version 1.1: \\>=20% increase in the sum of diameters of target measurable lesions above the smallest sum observed (over baseline if no decrease in the sum was observed during therapy), with a minimum absolute increase of 5 mm; or unequivocal progression of pre-existing lesions for non-target disease; or appearance of new lesions.', 'unitOfMeasure': 'months', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of PF-05082566 in Portion A and had tumor assessments.'}, {'type': 'SECONDARY', 'title': 'Overall Survival in Portion A', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '42', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '31', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '6', 'groupId': 'OG010'}, {'value': '11', 'groupId': 'OG011'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion A: PF-05082566 0.006mg/kg', 'description': 'Participants received PF-05082566 0.006 milligrams per kilogram (mg/kg) intravenously once every 4 weeks (q4wks) as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion A: PF-05082566 0.03mg/kg', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion A: PF-05082566 0.06mg/kg', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion A: PF-05082566 0.12mg/kg', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion A: PF-05082566 0.18mg/kg', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion A: PF-05082566 0.24mg/kg', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion A: PF-05082566 0.3mg/kg', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion A: PF-05082566 0.6mg/kg', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion A: PF-05082566 1.2mg/kg', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion A: PF-05082566 2.4mg/kg', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion A: PF-05082566 5mg/kg', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG011', 'title': 'Portion A: PF-05082566 10mg/kg', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'categories': [{'measurements': [{'value': '4.6', 'groupId': 'OG000', 'lowerLimit': '2.1', 'upperLimit': '6.2'}, {'value': '4.0', 'groupId': 'OG001', 'lowerLimit': '3.6', 'upperLimit': '29.7'}, {'value': '7.6', 'comment': 'Not estimable due to the small number of events.', 'groupId': 'OG002', 'lowerLimit': '4.2', 'upperLimit': 'NA'}, {'value': '13.3', 'groupId': 'OG003', 'lowerLimit': '5.9', 'upperLimit': '24.1'}, {'value': '5.9', 'comment': 'Not estimable due to the small number of events.', 'groupId': 'OG004', 'lowerLimit': 'NA', 'upperLimit': 'NA'}, {'value': '9.0', 'groupId': 'OG005', 'lowerLimit': '5.8', 'upperLimit': '16.4'}, {'value': '24.5', 'comment': 'Not estimable due to the small number of events.', 'groupId': 'OG006', 'lowerLimit': '1.6', 'upperLimit': 'NA'}, {'value': 'NA', 'comment': 'Not estimable due to the small number of events.', 'groupId': 'OG007', 'lowerLimit': '3.9', 'upperLimit': 'NA'}, {'value': '7.6', 'groupId': 'OG008', 'lowerLimit': '2.9', 'upperLimit': '12.7'}, {'value': '11.2', 'comment': 'Not estimable due to the small number of events.', 'groupId': 'OG009', 'lowerLimit': '3.7', 'upperLimit': 'NA'}, {'value': '29.5', 'comment': 'Not estimable due to the small number of events.', 'groupId': 'OG010', 'lowerLimit': '1.8', 'upperLimit': 'NA'}, {'value': '6.1', 'groupId': 'OG011', 'lowerLimit': '3.9', 'upperLimit': '7.5'}]}]}], 'paramType': 'MEDIAN', 'timeFrame': 'Every 8 weeks from Cycle 1 Day 1 for the first 10 months on study treatment, then every 16 weeks till follow-up visit (assessed up to approximately 2 years)', 'description': 'Overall survival was defined as the time from Cycle 1 Day 1 to the date of death due to any cause.', 'unitOfMeasure': 'months', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of PF-05082566 in Portion A and had tumor assessments.'}, {'type': 'SECONDARY', 'title': 'Number of Participants With Treatment-Emergent AEs and SAEs in Portion B', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '4', 'groupId': 'OG006'}, {'value': '32', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion B: PF-05082566 0.03mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks in combination with rituximab (375 milligrams per square meter \\[mg/m\\^2\\] intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion B: PF-05082566 0.06mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion B: PF-05082566 0.12mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion B: PF-05082566 0.18mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion B: PF-05082566 0.24mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion B: PF-05082566 0.3mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion B: PF-05082566 0.6mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion B: PF-05082566 1.2mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion B: PF-05082566 2.4mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion B: PF-05082566 5mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion B: PF-05082566 10mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'title': 'AEs', 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '4', 'groupId': 'OG006'}, {'value': '30', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}]}]}, {'title': 'SAEs', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '3', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'AEs related to PF-05082566', 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '2', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '17', 'groupId': 'OG007'}, {'value': '2', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '1', 'groupId': 'OG010'}]}]}, {'title': 'SAEs related to PF-05082566', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'AEs related to rituximab', 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '2', 'groupId': 'OG004'}, {'value': '2', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '17', 'groupId': 'OG007'}, {'value': '2', 'groupId': 'OG008'}, {'value': '3', 'groupId': 'OG009'}, {'value': '3', 'groupId': 'OG010'}]}]}, {'title': 'SAEs related to rituximab', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': 'Up to approximately 4 years', 'description': 'An AE was any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. An SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; life-threatening experience (immediate risk of dying); initial or prolonged inpatient hospitalization; persistent or significant disability/incapacity; congenital anomaly/birth defect. AEs included both non-serious AEs and SAEs. Treatment-emergent AEs were those with initial onset or increasing in severity after the first dose of study treatment. Causality of AEs was determined by the investigator.', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of study treatment (PF-05082566 and/or rituximab) in Portion B.'}, {'type': 'SECONDARY', 'title': 'Number of Participants With Treatment-Emergent AEs by Maximum NCI CTCAE Grade in Portion B', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '4', 'groupId': 'OG006'}, {'value': '32', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion B: PF-05082566 0.03mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks in combination with rituximab (375 milligrams per square meter \\[mg/m\\^2\\] intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion B: PF-05082566 0.06mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion B: PF-05082566 0.12mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion B: PF-05082566 0.18mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion B: PF-05082566 0.24mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion B: PF-05082566 0.3mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion B: PF-05082566 0.6mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion B: PF-05082566 1.2mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion B: PF-05082566 2.4mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion B: PF-05082566 5mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion B: PF-05082566 10mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'title': 'Grade 1', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '7', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '3', 'groupId': 'OG009'}, {'value': '1', 'groupId': 'OG010'}]}]}, {'title': 'Grade 2', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '2', 'groupId': 'OG005'}, {'value': '2', 'groupId': 'OG006'}, {'value': '17', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '3', 'groupId': 'OG010'}]}]}, {'title': 'Grade 3', 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '2', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '5', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'Grade 4', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'Grade 5', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': 'Up to approximately 4 years', 'description': 'An AE was any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. Treatment-emergent AEs were those with initial onset or increasing in severity after the first dose of study treatment. Severity of AEs were graded according to NCI CTCAE version 4.03 (Grade 1: mild AE; Grade 2: moderate AE; Grade 3: severe AE; Grade 4: life-threatening consequences, urgent intervention indicated; Grade 5: death related to AE).', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of study treatment (PF-05082566 and/or rituximab) in Portion B.'}, {'type': 'SECONDARY', 'title': 'Number of Participants With Hematology Laboratory Abnormalities by Maximum NCI CTCAE Grade in Portion B', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '32', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion B: PF-05082566 0.03mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks in combination with rituximab (375 milligrams per square meter \\[mg/m\\^2\\] intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion B: PF-05082566 0.06mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion B: PF-05082566 0.12mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion B: PF-05082566 0.18mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion B: PF-05082566 0.24mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion B: PF-05082566 0.3mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion B: PF-05082566 0.6mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion B: PF-05082566 1.2mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion B: PF-05082566 2.4mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion B: PF-05082566 5mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion B: PF-05082566 10mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'title': 'Anemia, Grade 1', 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '2', 'groupId': 'OG006'}, {'value': '16', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '1', 'groupId': 'OG010'}]}]}, {'title': 'Anemia, Grade 2', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '3', 'groupId': 'OG007'}, {'value': '2', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'Hemoglobin increased, Grade 1', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'Lymphocyte count increased, Grade 2', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'Lymphopenia, Grade 1', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '8', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '1', 'groupId': 'OG010'}]}]}, {'title': 'Lymphopenia, Grade 2', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '9', 'groupId': 'OG007'}, {'value': '2', 'groupId': 'OG008'}, {'value': '3', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'Lymphopenia, Grade 3', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '8', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '2', 'groupId': 'OG010'}]}]}, {'title': 'Neutrophils (absolute), Grade 1', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '2', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'Neutrophils (absolute), Grade 2', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'Neutrophils (absolute), Grade 3', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '2', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'Neutrophils (absolute), Grade 4', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'Platelets, Grade 1', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '2', 'groupId': 'OG006'}, {'value': '11', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'Platelets, Grade 2', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'Platelets, Grade 3', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'White blood cells, Grade 1', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '11', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'White blood cells, Grade 2', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '6', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'White blood cells, Grade 3', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '2', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': 'Up to approximately 2 years', 'description': 'Following hematology laboratory abnormalities were graded per NCI CTCAE version 4.03: anemia, hemoglobin increased, lymphocyte count increased, lymphopenia, neutrophils (absolute), platelets, white blood cells. The abnormalities with at least 1 participant are presented here.', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of study treatment (PF-05082566 and/or rituximab) in Portion B and had hematology laboratory test data.'}, {'type': 'SECONDARY', 'title': 'Number of Participants With Chemistries Laboratory Abnormalities by Maximum NCI CTCAE Grade in Portion B', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '32', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion B: PF-05082566 0.03mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks in combination with rituximab (375 milligrams per square meter \\[mg/m\\^2\\] intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion B: PF-05082566 0.06mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion B: PF-05082566 0.12mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion B: PF-05082566 0.18mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion B: PF-05082566 0.24mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion B: PF-05082566 0.3mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion B: PF-05082566 0.6mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion B: PF-05082566 1.2mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion B: PF-05082566 2.4mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion B: PF-05082566 5mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion B: PF-05082566 10mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'title': 'ALT, Grade 1', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '2', 'groupId': 'OG006'}, {'value': '7', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'ALT, Grade 2', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'ALT, Grade 3', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'Alkaline phosphatase, Grade 1', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '2', 'groupId': 'OG006'}, {'value': '6', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'AST, Grade 1', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '2', 'groupId': 'OG006'}, {'value': '8', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'AST, Grade 2', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'Bilirubin (total), Grade 1', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '2', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'Bilirubin (total), Grade 2', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '1', 'groupId': 'OG010'}]}]}, {'title': 'Creatinine, Grade 1', 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '2', 'groupId': 'OG006'}, {'value': '27', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}]}]}, {'title': 'Creatinine, Grade 2', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '3', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'Hypercalcemia, Grade 1', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '1', 'groupId': 'OG010'}]}]}, {'title': 'Hyperglycemia, Grade 1', 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '2', 'groupId': 'OG004'}, {'value': '2', 'groupId': 'OG005'}, {'value': '2', 'groupId': 'OG006'}, {'value': '9', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '2', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'Hyperglycemia, Grade 2', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '7', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '1', 'groupId': 'OG010'}]}]}, {'title': 'Hyperglycemia, Grade 3', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '1', 'groupId': 'OG010'}]}]}, {'title': 'Hyperkalemia, Grade 1', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '2', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '2', 'groupId': 'OG009'}, {'value': '1', 'groupId': 'OG010'}]}]}, {'title': 'Hyperkalemia, Grade 2', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'Hyperkalemia, Grade 3', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'Hypermagnesemia, Grade 1', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '2', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'Hypermagnesemia, Grade 3', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '1', 'groupId': 'OG010'}]}]}, {'title': 'Hypernatremia, Grade 1', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'Hypernatremia, Grade 2', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'Hypoalbuminemia, Grade 1', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '5', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'Hypoalbuminemia, Grade 2', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'Hypocalcemia, Grade 1', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '10', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '1', 'groupId': 'OG010'}]}]}, {'title': 'Hypocalcemia, Grade 2', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'Hypocalcemia, Grade 3', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'Hypoglycemia, Grade 1', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '2', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'Hypoglycemia, Grade 3', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'Hypokalemia, Grade 1', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '8', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'Hypomagnesemia, Grade 1', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '3', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '1', 'groupId': 'OG010'}]}]}, {'title': 'Hyponatremia, Grade 1', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '9', 'groupId': 'OG007'}, {'value': '2', 'groupId': 'OG008'}, {'value': '2', 'groupId': 'OG009'}, {'value': '1', 'groupId': 'OG010'}]}]}, {'title': 'Hyponatremia, Grade 3', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'Hypophosphatemia, Grade 2', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '8', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'Hypophosphatemia, Grade 3', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': 'Up to approximately 2 years', 'description': 'Following chemistries laboratory abnormalities were graded per NCI CTCAE version 4.03: alanine aminotransferase (ALT), Alkaline phosphatase, Aspartate aminotransferase (AST), bilirubin (total), creatinine, gamma glutamyl transferase (GGT), hypercalcemia, hyperglycemia, hyperkalemia, hypermagnesemia, hypernatremia, hypoalbuminemia, hypocalcemia, hypoglycemia, hypokalemia, hypomagnesemia, hyponatremia, hypophosphatemia. The abnormalities with at least 1 participant are presented here.', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of study treatment (PF-05082566 and/or rituximab) in Portion B and had chemistries laboratory test data.'}, {'type': 'SECONDARY', 'title': 'Number of Participants With Clinically Significant Vital Sign Abnormalities in Portion B', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '4', 'groupId': 'OG006'}, {'value': '32', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion B: PF-05082566 0.03mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks in combination with rituximab (375 milligrams per square meter \\[mg/m\\^2\\] intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion B: PF-05082566 0.06mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion B: PF-05082566 0.12mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion B: PF-05082566 0.18mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion B: PF-05082566 0.24mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion B: PF-05082566 0.3mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion B: PF-05082566 0.6mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion B: PF-05082566 1.2mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion B: PF-05082566 2.4mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion B: PF-05082566 5mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion B: PF-05082566 10mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': 'Up to approximately 2 years', 'description': 'For vital signs in Portion B, blood pressure, pulse rate, and body temperature were measured. Clinical significance was determined by the investigator.', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of study treatment (PF-05082566 and/or rituximab) in Portion B.'}, {'type': 'SECONDARY', 'title': 'PF-05082566 Cmax in Portion B', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '30', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion B: PF-05082566 0.03mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks in combination with rituximab (375 milligrams per square meter \\[mg/m\\^2\\] intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion B: PF-05082566 0.06mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion B: PF-05082566 0.12mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion B: PF-05082566 0.18mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion B: PF-05082566 0.24mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion B: PF-05082566 0.3mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion B: PF-05082566 0.6mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion B: PF-05082566 1.2mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion B: PF-05082566 2.4mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion B: PF-05082566 5mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion B: PF-05082566 10mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'title': 'Cycle 1', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '30', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}]}], 'categories': [{'measurements': [{'value': '0.6284', 'spread': '11', 'groupId': 'OG000'}, {'value': '1.569', 'spread': '12', 'groupId': 'OG001'}, {'value': '2.673', 'spread': '26', 'groupId': 'OG002'}, {'value': '4.167', 'spread': '12', 'groupId': 'OG003'}, {'value': '4.512', 'spread': '29', 'groupId': 'OG004'}, {'value': '7.435', 'spread': '9', 'groupId': 'OG005'}, {'value': '12.16', 'spread': '9', 'groupId': 'OG006'}, {'value': '19.20', 'spread': '27', 'groupId': 'OG007'}, {'value': '42.61', 'spread': '26', 'groupId': 'OG008'}, {'value': '89.06', 'spread': '23', 'groupId': 'OG009'}, {'value': '196.2', 'spread': '22', 'groupId': 'OG010'}]}]}, {'title': 'Cycle 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '27', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}]}], 'categories': [{'measurements': [{'value': '0.6838', 'spread': '18', 'groupId': 'OG000'}, {'value': '1.948', 'spread': '6', 'groupId': 'OG001'}, {'value': '3.102', 'spread': '18', 'groupId': 'OG002'}, {'value': '3.934', 'spread': '28', 'groupId': 'OG003'}, {'value': '4.607', 'spread': '30', 'groupId': 'OG004'}, {'value': '6.481', 'spread': '10', 'groupId': 'OG005'}, {'value': '13.97', 'spread': '24', 'groupId': 'OG006'}, {'value': '20.03', 'spread': '32', 'groupId': 'OG007'}, {'value': '44.35', 'spread': '19', 'groupId': 'OG008'}, {'value': '95.16', 'spread': '19', 'groupId': 'OG009'}, {'value': '206.0', 'spread': '29', 'groupId': 'OG010'}]}]}], 'paramType': 'GEOMETRIC_MEAN', 'timeFrame': 'Cycle 1 Day 1 pre-dose, 1.5, 2, 6, 24, 48, 144, 312, and 504 hours post-dose; Cycle 2 Day 1 pre-dose, 1.5, 2, 6, 24, 48, 168, 336, and 504 hours post-dose.', 'description': 'Cmax of PF-05082566 was observed directly from data.', 'unitOfMeasure': 'μg/mL', 'dispersionType': 'Geometric Coefficient of Variation', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of PF-05082566 in Portion B and had at least 1 of the PK parameters of interest. "Number Analyzed" represents those participants who had data for each specified category.'}, {'type': 'SECONDARY', 'title': 'PF-05082566 Ctrough in Portion B', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '27', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion B: PF-05082566 0.03mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks in combination with rituximab (375 milligrams per square meter \\[mg/m\\^2\\] intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion B: PF-05082566 0.06mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion B: PF-05082566 0.12mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion B: PF-05082566 0.18mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion B: PF-05082566 0.24mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion B: PF-05082566 0.3mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion B: PF-05082566 0.6mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion B: PF-05082566 1.2mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion B: PF-05082566 2.4mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion B: PF-05082566 5mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion B: PF-05082566 10mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.1267', 'spread': '47', 'groupId': 'OG000'}, {'value': '0.2853', 'spread': '23', 'groupId': 'OG001'}, {'value': '0.3922', 'spread': '29', 'groupId': 'OG002'}, {'value': '0.4698', 'spread': '53', 'groupId': 'OG003'}, {'value': '0.3539', 'spread': '110', 'groupId': 'OG004'}, {'value': '0.6001', 'spread': '48', 'groupId': 'OG005'}, {'value': '1.486', 'spread': '90', 'groupId': 'OG006'}, {'value': '1.452', 'spread': '62', 'groupId': 'OG007'}, {'value': '5.560', 'spread': '29', 'groupId': 'OG008'}, {'value': '12.16', 'spread': '63', 'groupId': 'OG009'}, {'value': '31.34', 'spread': '36', 'groupId': 'OG010'}]}]}], 'paramType': 'GEOMETRIC_MEAN', 'timeFrame': 'Day 1 pre-dose of Cycle 2', 'description': 'Ctrough of PF-05082566 was observed directly from data.', 'unitOfMeasure': 'μg/mL', 'dispersionType': 'Geometric Coefficient of Variation', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of PF-05082566 in Portion B and had data for Ctrough.'}, {'type': 'SECONDARY', 'title': 'PF-05082566 Tmax in Portion B', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '30', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion B: PF-05082566 0.03mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks in combination with rituximab (375 milligrams per square meter \\[mg/m\\^2\\] intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion B: PF-05082566 0.06mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion B: PF-05082566 0.12mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion B: PF-05082566 0.18mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion B: PF-05082566 0.24mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion B: PF-05082566 0.3mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion B: PF-05082566 0.6mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion B: PF-05082566 1.2mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion B: PF-05082566 2.4mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion B: PF-05082566 5mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion B: PF-05082566 10mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'title': 'Cycle 1', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '30', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}]}], 'categories': [{'measurements': [{'value': '1.50', 'groupId': 'OG000', 'lowerLimit': '1.28', 'upperLimit': '2.00'}, {'value': '1.52', 'groupId': 'OG001', 'lowerLimit': '1.00', 'upperLimit': '1.83'}, {'value': '1.06', 'groupId': 'OG002', 'lowerLimit': '0.950', 'upperLimit': '1.42'}, {'value': '2.00', 'groupId': 'OG003', 'lowerLimit': '1.50', 'upperLimit': '2.00'}, {'value': '1.52', 'groupId': 'OG004', 'lowerLimit': '1.02', 'upperLimit': '1.63'}, {'value': '1.17', 'groupId': 'OG005', 'lowerLimit': '1.00', 'upperLimit': '1.52'}, {'value': '2.00', 'groupId': 'OG006', 'lowerLimit': '1.00', 'upperLimit': '6.07'}, {'value': '1.06', 'groupId': 'OG007', 'lowerLimit': '0.933', 'upperLimit': '5.45'}, {'value': '2.00', 'groupId': 'OG008', 'lowerLimit': '1.00', 'upperLimit': '6.00'}, {'value': '2.00', 'groupId': 'OG009', 'lowerLimit': '1.50', 'upperLimit': '6.00'}, {'value': '2.00', 'groupId': 'OG010', 'lowerLimit': '1.00', 'upperLimit': '6.10'}]}]}, {'title': 'Cycle 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '27', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}]}], 'categories': [{'measurements': [{'value': '1.05', 'groupId': 'OG000', 'lowerLimit': '1.00', 'upperLimit': '1.05'}, {'value': '1.08', 'groupId': 'OG001', 'lowerLimit': '1.00', 'upperLimit': '1.55'}, {'value': '1.04', 'groupId': 'OG002', 'lowerLimit': '1.03', 'upperLimit': '1.08'}, {'value': '1.57', 'groupId': 'OG003', 'lowerLimit': '1.07', 'upperLimit': '21.1'}, {'value': '1.00', 'groupId': 'OG004', 'lowerLimit': '0.967', 'upperLimit': '1.10'}, {'value': '1.50', 'groupId': 'OG005', 'lowerLimit': '0.967', 'upperLimit': '1.50'}, {'value': '1.33', 'groupId': 'OG006', 'lowerLimit': '1.17', 'upperLimit': '1.50'}, {'value': '1.02', 'groupId': 'OG007', 'lowerLimit': '0.967', 'upperLimit': '1.98'}, {'value': '1.50', 'groupId': 'OG008', 'lowerLimit': '1.50', 'upperLimit': '1.55'}, {'value': '1.50', 'groupId': 'OG009', 'lowerLimit': '1.00', 'upperLimit': '1.50'}, {'value': '1.28', 'groupId': 'OG010', 'lowerLimit': '1.00', 'upperLimit': '1.50'}]}]}], 'paramType': 'MEDIAN', 'timeFrame': 'Cycle 1 Day 1 pre-dose, 1.5, 2, 6, 24, 48, 144, 312, and 504 hours post-dose; Cycle 2 Day 1 pre-dose, 1.5, 2, 6, 24, 48, 168, 336, and 504 hours post-dose.', 'description': 'Tmax of PF-05082566 was observed directly from data as time of Cmax.', 'unitOfMeasure': 'hr', 'dispersionType': 'Full Range', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of PF-05082566 in Portion B and had at least 1 of the PK parameters of interest. "Number Analyzed" represents those participants who had data for each specified category.'}, {'type': 'SECONDARY', 'title': 'PF-05082566 AUClast in Portion B', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '30', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion B: PF-05082566 0.03mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks in combination with rituximab (375 milligrams per square meter \\[mg/m\\^2\\] intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion B: PF-05082566 0.06mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion B: PF-05082566 0.12mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion B: PF-05082566 0.18mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion B: PF-05082566 0.24mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion B: PF-05082566 0.3mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion B: PF-05082566 0.6mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion B: PF-05082566 1.2mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion B: PF-05082566 2.4mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion B: PF-05082566 5mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion B: PF-05082566 10mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'title': 'Cycle 1', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '29', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}]}], 'categories': [{'measurements': [{'value': '121.1', 'spread': '26', 'groupId': 'OG000'}, {'value': '342.6', 'spread': '13', 'groupId': 'OG001'}, {'value': '513.7', 'spread': '20', 'groupId': 'OG002'}, {'value': '854.1', 'spread': '31', 'groupId': 'OG003'}, {'value': '701.7', 'spread': '72', 'groupId': 'OG004'}, {'value': '1130', 'spread': '14', 'groupId': 'OG005'}, {'value': '2373', 'spread': '37', 'groupId': 'OG006'}, {'value': '2772', 'spread': '63', 'groupId': 'OG007'}, {'value': '7955', 'spread': '30', 'groupId': 'OG008'}, {'value': '17120', 'spread': '33', 'groupId': 'OG009'}, {'value': '38180', 'spread': '18', 'groupId': 'OG010'}]}]}, {'title': 'Cycle 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '5', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}]}], 'categories': [{'measurements': [{'value': '176.2', 'spread': '26', 'groupId': 'OG000'}, {'value': '471.5', 'spread': '7', 'groupId': 'OG001'}, {'value': '696.5', 'spread': '17', 'groupId': 'OG002'}, {'value': '1146', 'spread': '35', 'groupId': 'OG003'}, {'value': '733.7', 'spread': '85', 'groupId': 'OG004'}, {'value': '1511', 'spread': '10', 'groupId': 'OG005'}, {'value': '3013', 'spread': '70', 'groupId': 'OG006'}, {'value': '6193', 'spread': '22', 'groupId': 'OG007'}, {'value': '10970', 'spread': '44', 'groupId': 'OG008'}, {'value': '19410', 'spread': '37', 'groupId': 'OG009'}, {'value': '48540', 'spread': '27', 'groupId': 'OG010'}]}]}], 'paramType': 'GEOMETRIC_MEAN', 'timeFrame': 'Cycle 1 Day 1 pre-dose, 1.5, 2, 6, 24, 48, 144, 312, and 504 hours post-dose; Cycle 2 Day 1 pre-dose, 1.5, 2, 6, 24, 48, 168, 336, and 504 hours post-dose.', 'description': 'AUClast of PF-05082566 was determined by linear/log trapezoidal method.', 'unitOfMeasure': 'μg*hr/mL', 'dispersionType': 'Geometric Coefficient of Variation', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of PF-05082566 in Portion B and had at least 1 of the PK parameters of interest. "Number Analyzed" represents those participants who had data for each specified category.'}, {'type': 'SECONDARY', 'title': 'PF-05082566 AUCinf in Portion B', 'denoms': [{'units': 'Participants', 'counts': [{'value': '2', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '23', 'groupId': 'OG007'}, {'value': '2', 'groupId': 'OG008'}, {'value': '2', 'groupId': 'OG009'}, {'value': '2', 'groupId': 'OG010'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion B: PF-05082566 0.03mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks in combination with rituximab (375 milligrams per square meter \\[mg/m\\^2\\] intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion B: PF-05082566 0.06mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion B: PF-05082566 0.12mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion B: PF-05082566 0.18mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion B: PF-05082566 0.24mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion B: PF-05082566 0.3mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion B: PF-05082566 0.6mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion B: PF-05082566 1.2mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion B: PF-05082566 2.4mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion B: PF-05082566 5mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion B: PF-05082566 10mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'categories': [{'measurements': [{'value': '137.8', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG000'}, {'value': '407.0', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG001'}, {'value': '615.5', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG002'}, {'value': '1076', 'spread': '38', 'groupId': 'OG003'}, {'value': '824.1', 'spread': '78', 'groupId': 'OG004'}, {'value': '1421', 'spread': '24', 'groupId': 'OG005'}, {'value': '2070', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG006'}, {'value': '3703', 'spread': '37', 'groupId': 'OG007'}, {'value': '9439', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG008'}, {'value': '16790', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG009'}, {'value': '48870', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG010'}]}]}], 'paramType': 'GEOMETRIC_MEAN', 'timeFrame': 'Cycle 1 Day 1 pre-dose, 1.5, 2, 6, 24, 48, 144, 312, and 504 hours post-dose.', 'description': 'AUCinf = AUClast + (Clast\\*/kel), where Clast\\* is the estimated concentration at the time of the last measurable concentration and kel is the terminal phase rate constant calculated as the absolute value of the slope of a linear regression during the terminal phase of the natural log-transformed concentration time profile.', 'unitOfMeasure': 'μg*hr/mL', 'dispersionType': 'Geometric Coefficient of Variation', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of PF-05082566 in Portion B and had AUCinf data.'}, {'type': 'SECONDARY', 'title': 'PF-05082566 AUCtau in Portion B', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '30', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion B: PF-05082566 0.03mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks in combination with rituximab (375 milligrams per square meter \\[mg/m\\^2\\] intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion B: PF-05082566 0.06mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion B: PF-05082566 0.12mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion B: PF-05082566 0.18mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion B: PF-05082566 0.24mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion B: PF-05082566 0.3mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion B: PF-05082566 0.6mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion B: PF-05082566 1.2mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion B: PF-05082566 2.4mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion B: PF-05082566 5mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion B: PF-05082566 10mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'title': 'Cycle 1', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '26', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}]}], 'categories': [{'measurements': [{'value': '125.0', 'spread': '23', 'groupId': 'OG000'}, {'value': '345.0', 'spread': '16', 'groupId': 'OG001'}, {'value': '514.5', 'spread': '21', 'groupId': 'OG002'}, {'value': '871.6', 'spread': '32', 'groupId': 'OG003'}, {'value': '712.0', 'spread': '71', 'groupId': 'OG004'}, {'value': '1128', 'spread': '15', 'groupId': 'OG005'}, {'value': '2361', 'spread': '39', 'groupId': 'OG006'}, {'value': '3206', 'spread': '32', 'groupId': 'OG007'}, {'value': '8001', 'spread': '29', 'groupId': 'OG008'}, {'value': '17290', 'spread': '32', 'groupId': 'OG009'}, {'value': '38860', 'spread': '17', 'groupId': 'OG010'}]}]}, {'title': 'Cycle 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '2', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '3', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}]}], 'categories': [{'measurements': [{'value': '178.2', 'spread': '26', 'groupId': 'OG000'}, {'value': '453.9', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG001'}, {'value': '701.8', 'spread': '18', 'groupId': 'OG002'}, {'value': '1072', 'spread': '33', 'groupId': 'OG003'}, {'value': '854.5', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG004'}, {'value': '1521', 'spread': '10', 'groupId': 'OG005'}, {'value': '3116', 'spread': '63', 'groupId': 'OG006'}, {'value': '5967', 'spread': '30', 'groupId': 'OG007'}, {'value': '10220', 'spread': '30', 'groupId': 'OG008'}, {'value': '18150', 'spread': '39', 'groupId': 'OG009'}, {'value': '48030', 'spread': '16', 'groupId': 'OG010'}]}]}], 'paramType': 'GEOMETRIC_MEAN', 'timeFrame': 'Cycle 1 Day 1 pre-dose, 1.5, 2, 6, 24, 48, 144, 312, and 504 hours post-dose; Cycle 2 Day 1 pre-dose, 1.5, 2, 6, 24, 48, 168, 336, and 504 hours post-dose.', 'description': 'AUCtau of PF-05082566 was determined using linear/log trapezoidal method.', 'unitOfMeasure': 'μg*hr/mL', 'dispersionType': 'Geometric Coefficient of Variation', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of PF-05082566 in Portion B and had at least 1 of the PK parameters of interest. "Number Analyzed" represents those participants who had data for each specified category.'}, {'type': 'SECONDARY', 'title': 'PF-05082566 CL in Portion B', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '30', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion B: PF-05082566 0.03mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks in combination with rituximab (375 milligrams per square meter \\[mg/m\\^2\\] intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion B: PF-05082566 0.06mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion B: PF-05082566 0.12mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion B: PF-05082566 0.18mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion B: PF-05082566 0.24mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion B: PF-05082566 0.3mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion B: PF-05082566 0.6mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion B: PF-05082566 1.2mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion B: PF-05082566 2.4mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion B: PF-05082566 5mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion B: PF-05082566 10mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'title': 'Cycle 1', 'denoms': [{'units': 'Participants', 'counts': [{'value': '2', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '23', 'groupId': 'OG007'}, {'value': '2', 'groupId': 'OG008'}, {'value': '2', 'groupId': 'OG009'}, {'value': '2', 'groupId': 'OG010'}]}], 'categories': [{'measurements': [{'value': '0.2178', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG000'}, {'value': '0.1470', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG001'}, {'value': '0.1950', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG002'}, {'value': '0.1667', 'spread': '38', 'groupId': 'OG003'}, {'value': '0.2911', 'spread': '78', 'groupId': 'OG004'}, {'value': '0.2107', 'spread': '24', 'groupId': 'OG005'}, {'value': '0.2900', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG006'}, {'value': '0.3241', 'spread': '37', 'groupId': 'OG007'}, {'value': '0.2546', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG008'}, {'value': '0.2973', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG009'}, {'value': '0.2048', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG010'}]}]}, {'title': 'Cycle 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '2', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '3', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}]}], 'categories': [{'measurements': [{'value': '0.1683', 'spread': '26', 'groupId': 'OG000'}, {'value': '0.1325', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG001'}, {'value': '0.1710', 'spread': '18', 'groupId': 'OG002'}, {'value': '0.1681', 'spread': '33', 'groupId': 'OG003'}, {'value': '0.2807', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG004'}, {'value': '0.1976', 'spread': '11', 'groupId': 'OG005'}, {'value': '0.1928', 'spread': '63', 'groupId': 'OG006'}, {'value': '0.2011', 'spread': '30', 'groupId': 'OG007'}, {'value': '0.2351', 'spread': '29', 'groupId': 'OG008'}, {'value': '0.2756', 'spread': '39', 'groupId': 'OG009'}, {'value': '0.2080', 'spread': '16', 'groupId': 'OG010'}]}]}], 'paramType': 'GEOMETRIC_MEAN', 'timeFrame': 'Cycle 1 Day 1 pre-dose, 1.5, 2, 6, 24, 48, 144, 312, and 504 hours post-dose; Cycle 2 Day 1 pre-dose, 1.5, 2, 6, 24, 48, 168, 336, and 504 hours post-dose.', 'description': 'CL = Dose/AUCinf for Cycle 1 and Dose/AUCtau for Cycle 2.', 'unitOfMeasure': 'mL/hr/kg', 'dispersionType': 'Geometric Coefficient of Variation', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of PF-05082566 in Portion B and had at least 1 of the PK parameters of interest. "Number Analyzed" represents those participants who had data for each specified category.'}, {'type': 'SECONDARY', 'title': 'PF-05082566 Vss in Portion B', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '30', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion B: PF-05082566 0.03mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks in combination with rituximab (375 milligrams per square meter \\[mg/m\\^2\\] intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion B: PF-05082566 0.06mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion B: PF-05082566 0.12mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion B: PF-05082566 0.18mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion B: PF-05082566 0.24mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion B: PF-05082566 0.3mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion B: PF-05082566 0.6mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion B: PF-05082566 1.2mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion B: PF-05082566 2.4mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion B: PF-05082566 5mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion B: PF-05082566 10mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'title': 'Cycle 1', 'denoms': [{'units': 'Participants', 'counts': [{'value': '2', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '23', 'groupId': 'OG007'}, {'value': '2', 'groupId': 'OG008'}, {'value': '2', 'groupId': 'OG009'}, {'value': '2', 'groupId': 'OG010'}]}], 'categories': [{'measurements': [{'value': '81.87', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG000'}, {'value': '78.60', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG001'}, {'value': '79.93', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG002'}, {'value': '66.90', 'spread': '24', 'groupId': 'OG003'}, {'value': '93.68', 'spread': '54', 'groupId': 'OG004'}, {'value': '85.12', 'spread': '4', 'groupId': 'OG005'}, {'value': '126.0', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG006'}, {'value': '102.8', 'spread': '20', 'groupId': 'OG007'}, {'value': '130.9', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG008'}, {'value': '98.98', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG009'}, {'value': '94.08', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG010'}]}]}, {'title': 'Cycle 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '2', 'groupId': 'OG004'}, {'value': '2', 'groupId': 'OG005'}, {'value': '2', 'groupId': 'OG006'}, {'value': '2', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '2', 'groupId': 'OG009'}, {'value': '2', 'groupId': 'OG010'}]}], 'categories': [{'measurements': [{'value': '81.90', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG002'}, {'value': '65.42', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG003'}, {'value': '85.51', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG004'}, {'value': '66.27', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG005'}, {'value': '100.5', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG006'}, {'value': '86.99', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG007'}, {'value': '94.00', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG008'}, {'value': '102.2', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG009'}, {'value': '95.89', 'spread': 'NA', 'comment': 'Geometric CV was not calculated when there were less than 3 participants with data.', 'groupId': 'OG010'}]}]}], 'paramType': 'GEOMETRIC_MEAN', 'timeFrame': 'Cycle 1 Day 1 pre-dose, 1.5, 2, 6, 24, 48, 144, 312, and 504 hours post-dose; Cycle 2 Day 1 pre-dose, 1.5, 2, 6, 24, 48, 168, 336, and 504 hours post-dose.', 'description': 'Vss = CL × MRT, where CL is clearance and MRT is the mean residence time after intravenous administration.', 'unitOfMeasure': 'mL/kg', 'dispersionType': 'Geometric Coefficient of Variation', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of PF-05082566 in Portion B and had at least 1 of the PK parameters of interest. "Number Analyzed" represents those participants who had data for each specified category.'}, {'type': 'SECONDARY', 'title': 'Rituximab Cmax and Ctrough in Portion B', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion B: PF-05082566 0.03mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks in combination with rituximab (375 milligrams per square meter \\[mg/m\\^2\\] intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion B: PF-05082566 0.06mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion B: PF-05082566 0.12mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion B: PF-05082566 0.18mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion B: PF-05082566 0.24mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion B: PF-05082566 0.3mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion B: PF-05082566 0.6mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion B: PF-05082566 1.2mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion B: PF-05082566 2.4mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion B: PF-05082566 5mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion B: PF-05082566 10mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'timeFrame': 'Day 1 pre-dose of Cycle 2', 'description': 'Cmax and Ctrough of rituximab were observed directly from data.', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of rituximab in Portion B and had Cmax or Ctrough data for rituximab. No data were collected for this Outcome Measure.'}, {'type': 'SECONDARY', 'title': 'Number of Participants With Positive ADA for PF-05082566 and Rituximab in Portion B', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '4', 'groupId': 'OG006'}, {'value': '32', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion B: PF-05082566 0.03mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks in combination with rituximab (375 milligrams per square meter \\[mg/m\\^2\\] intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion B: PF-05082566 0.06mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion B: PF-05082566 0.12mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion B: PF-05082566 0.18mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion B: PF-05082566 0.24mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion B: PF-05082566 0.3mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion B: PF-05082566 0.6mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion B: PF-05082566 1.2mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion B: PF-05082566 2.4mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion B: PF-05082566 5mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion B: PF-05082566 10mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'title': 'For PF-05082566', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '32', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'For rituximab', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '4', 'groupId': 'OG006'}, {'value': '32', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': 'Up to approximately 2 years', 'description': 'ADA for PF-05082566 and rituximab was detected using electrochemiluminescence assay. Positive ADA for PF-05082566: titer\\>=6.23. Positive ADA for rituximab: titer\\>=1.88.', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of study treatment (PF-05082566 and/or rituximab) in Portion B and was tested for ADA. "Number Analyzed" represents those participants who had data for each specified category.'}, {'type': 'SECONDARY', 'title': 'Number of Participants With QTc Interval Meeting Categorical Summarization Criteria in Portion B', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '4', 'groupId': 'OG006'}, {'value': '32', 'groupId': 'OG007'}, {'value': '2', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '2', 'groupId': 'OG010'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion B: PF-05082566 0.03mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks in combination with rituximab (375 milligrams per square meter \\[mg/m\\^2\\] intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion B: PF-05082566 0.06mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion B: PF-05082566 0.12mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion B: PF-05082566 0.18mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion B: PF-05082566 0.24mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion B: PF-05082566 0.3mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion B: PF-05082566 0.6mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion B: PF-05082566 1.2mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion B: PF-05082566 2.4mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion B: PF-05082566 5mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion B: PF-05082566 10mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'title': 'QTc >450 to <=480 msec', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '4', 'groupId': 'OG006'}, {'value': '32', 'groupId': 'OG007'}, {'value': '2', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '2', 'groupId': 'OG010'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '14', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '2', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'QTc >480 to <=500 msec', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '4', 'groupId': 'OG006'}, {'value': '32', 'groupId': 'OG007'}, {'value': '2', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '2', 'groupId': 'OG010'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '2', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'QTc >500 msec', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '4', 'groupId': 'OG006'}, {'value': '32', 'groupId': 'OG007'}, {'value': '2', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '2', 'groupId': 'OG010'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'QTc change >30 to <=60 msec', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '4', 'groupId': 'OG006'}, {'value': '31', 'groupId': 'OG007'}, {'value': '2', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '2', 'groupId': 'OG010'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '8', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}, {'title': 'QTc change >60 msec', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '4', 'groupId': 'OG006'}, {'value': '31', 'groupId': 'OG007'}, {'value': '2', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '2', 'groupId': 'OG010'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': 'Up to approximately 2 years', 'description': 'Categorical summarization criteria for QTc interval: 1) absolute value of \\>450 to \\<=480 milliseconds (msec), \\>480 to \\<=500 msec, \\>500 msec; 2) a maximum change from baseline of \\>30 to \\<=60 msec or \\>60 msec.', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of study treatment (PF-05082566 and/or rituximab) in Portion B and had post-baseline QTc data. "Number Analyzed" represents those participants who had data for each specified category.'}, {'type': 'SECONDARY', 'title': 'Percentage of Participants Achieving Objective Response Per Cheson 2007 Criteria in Portion B', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '4', 'groupId': 'OG006'}, {'value': '31', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion B: PF-05082566 0.03mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks in combination with rituximab (375 milligrams per square meter \\[mg/m\\^2\\] intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion B: PF-05082566 0.06mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion B: PF-05082566 0.12mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion B: PF-05082566 0.18mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion B: PF-05082566 0.24mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion B: PF-05082566 0.3mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion B: PF-05082566 0.6mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion B: PF-05082566 1.2mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion B: PF-05082566 2.4mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion B: PF-05082566 5mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion B: PF-05082566 10mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'categories': [{'measurements': [{'value': '33.3', 'groupId': 'OG000', 'lowerLimit': '0.8', 'upperLimit': '90.6'}, {'value': '0', 'groupId': 'OG001', 'lowerLimit': '0', 'upperLimit': '70.8'}, {'value': '25.0', 'groupId': 'OG002', 'lowerLimit': '0.6', 'upperLimit': '80.6'}, {'value': '66.7', 'groupId': 'OG003', 'lowerLimit': '9.4', 'upperLimit': '99.2'}, {'value': '0', 'groupId': 'OG004', 'lowerLimit': '0', 'upperLimit': '70.8'}, {'value': '0', 'groupId': 'OG005', 'lowerLimit': '0', 'upperLimit': '70.8'}, {'value': '0', 'groupId': 'OG006', 'lowerLimit': '0', 'upperLimit': '60.2'}, {'value': '25.8', 'groupId': 'OG007', 'lowerLimit': '11.9', 'upperLimit': '44.6'}, {'value': '33.3', 'groupId': 'OG008', 'lowerLimit': '0.8', 'upperLimit': '90.6'}, {'value': '20.0', 'groupId': 'OG009', 'lowerLimit': '0.5', 'upperLimit': '71.6'}, {'value': '0', 'groupId': 'OG010', 'lowerLimit': '0', 'upperLimit': '60.2'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Every 8 weeks from Cycle 1 Day 1 for the first 10 months on study treatment, then every 16 weeks till follow-up visit (assessed up to approximately 2 years)', 'description': 'Objective Response in Portion B was defined as BOR of CR or PR according to Cheson 2007 criteria. BOR of CR or PR per Cheson 2007: CR or PR of index lesions (complete disappearance of all detectable clinical and radiographic evidence of disease, all lymph nodes returned to normal size, spleen and/or liver if enlarged prior to therapy became normal or no longer palpable; or \\>=50% decrease in the sum of the product diameters \\[SPD\\] of up to 6 index lesions, no increase in size of other nodes, liver or spleen), without PD of non-index lesions (ie, without: new nonnodal lesion, new nodal lesion \\>=15 mm in greatest transverse diameter \\[GTD\\], unequivocal progression of existing non index lesions, bone marrow that was negative and is now positive, new circulating lymphoma cells in blood cell count and/or pleural fluid, new circulating blasts in the blood cell count), and without any new lesions.', 'unitOfMeasure': 'percentage of participants', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of study treatment (PF-05082566 and/or rituximab) in Portion B and had tumor assessments for lymphoma.'}, {'type': 'SECONDARY', 'title': 'Duration of Response in Portion B', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '8', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion B: PF-05082566 0.03mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks in combination with rituximab (375 milligrams per square meter \\[mg/m\\^2\\] intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion B: PF-05082566 0.06mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion B: PF-05082566 0.12mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion B: PF-05082566 0.18mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion B: PF-05082566 0.24mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion B: PF-05082566 0.3mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion B: PF-05082566 0.6mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion B: PF-05082566 1.2mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion B: PF-05082566 2.4mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion B: PF-05082566 5mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion B: PF-05082566 10mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'categories': [{'measurements': [{'value': 'NA', 'comment': 'The median estimates of time to event, upper and lower limits of 95% CI were not estimable due to the small number of events.', 'groupId': 'OG000', 'lowerLimit': 'NA', 'upperLimit': 'NA'}, {'value': 'NA', 'comment': 'The median estimates of time to event, upper and lower limits of 95% CI were not estimable due to the small number of events.', 'groupId': 'OG002', 'lowerLimit': 'NA', 'upperLimit': 'NA'}, {'value': 'NA', 'comment': 'The median estimates of time to event and upper limit of 95% CI were not estimable due to the small number of events.', 'groupId': 'OG003', 'lowerLimit': '8.0', 'upperLimit': 'NA'}, {'value': '12.0', 'comment': 'Not estimable due to the small number of events.', 'groupId': 'OG007', 'lowerLimit': '2.1', 'upperLimit': 'NA'}, {'value': '9.5', 'comment': 'Not estimable due to the small number of events.', 'groupId': 'OG008', 'lowerLimit': 'NA', 'upperLimit': 'NA'}, {'value': 'NA', 'comment': 'The median estimates of time to event, upper and lower limits of 95% CI were not estimable due to the small number of events.', 'groupId': 'OG009', 'lowerLimit': 'NA', 'upperLimit': 'NA'}]}]}], 'paramType': 'MEDIAN', 'timeFrame': 'Every 8 weeks from Cycle 1 Day 1 for the first 10 months on study treatment, then every 16 weeks till follow-up visit (assessed up to approximately 2 years)', 'description': 'Duration of Response in Portion B was defined, for participants with an objective response (BOR of CR or PR per Cheson 2007 criteria), as the time from first documentation of objective response to the date of first documentation of objective PD or death due to any cause. Objective PD per Cheson 2007 was defined as: PD of index lesions (\\>=50% increase in SPD of previously involved sites from nadir), or PD of non-index lesions (new nonnodal lesion, new nodal lesion \\>=15 mm in GTD, unequivocal progression of existing non index lesions, bone marrow that was negative and is now positive, new circulating lymphoma cells in blood cell count and/or pleural fluid, new circulating blasts in the blood cell count), or appearance of new lesions.', 'unitOfMeasure': 'months', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of study treatment (PF-05082566 and/or rituximab) in Portion B, had tumor assessments for lymphoma, and achieved an objective response.'}, {'type': 'SECONDARY', 'title': 'Time to Response in Portion B', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '8', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion B: PF-05082566 0.03mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks in combination with rituximab (375 milligrams per square meter \\[mg/m\\^2\\] intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion B: PF-05082566 0.06mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion B: PF-05082566 0.12mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion B: PF-05082566 0.18mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion B: PF-05082566 0.24mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion B: PF-05082566 0.3mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion B: PF-05082566 0.6mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion B: PF-05082566 1.2mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion B: PF-05082566 2.4mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion B: PF-05082566 5mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion B: PF-05082566 10mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'categories': [{'measurements': [{'value': '2.1', 'groupId': 'OG000', 'lowerLimit': '2.1', 'upperLimit': '2.1'}, {'value': '2.1', 'groupId': 'OG002', 'lowerLimit': '2.1', 'upperLimit': '2.1'}, {'value': '2.0', 'groupId': 'OG003', 'lowerLimit': '1.9', 'upperLimit': '2.1'}, {'value': '2.1', 'groupId': 'OG007', 'lowerLimit': '1.9', 'upperLimit': '2.2'}, {'value': '3.9', 'groupId': 'OG008', 'lowerLimit': '3.9', 'upperLimit': '3.9'}, {'value': '7.4', 'groupId': 'OG009', 'lowerLimit': '7.4', 'upperLimit': '7.4'}]}]}], 'paramType': 'MEDIAN', 'timeFrame': 'Every 8 weeks from Cycle 1 Day 1 for the first 10 months on study treatment, then every 16 weeks till follow-up visit (assessed up to approximately 2 years)', 'description': 'Time to response in Portion B was defined, for participants with an objective response (BOR of CR or PR per Cheson 2007 criteria), as the time from Cycle 1 Day 1 to the first documentation of objective response. BOR of CR or PR per Cheson 2007: CR or PR of index lesions (complete disappearance of all detectable clinical and radiographic evidence of disease, all lymph nodes returned to normal size, spleen and/or liver if enlarged prior to therapy became normal or no longer palpable; or \\>=50% decrease in the SPD of up to 6 index lesions, no increase in size of other nodes, liver or spleen), without PD of non-index lesions (ie, without: new nonnodal lesion, new nodal lesion \\>=15 mm in GTD, unequivocal progression of existing non index lesions, bone marrow that was negative and is now positive, new circulating lymphoma cells in blood cell count and/or pleural fluid, new circulating blasts in the blood cell count), and without any new lesions.', 'unitOfMeasure': 'months', 'dispersionType': 'Full Range', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of study treatment (PF-05082566 and/or rituximab) in Portion B, had tumor assessments for lymphoma, and achieved an objective response.'}, {'type': 'SECONDARY', 'title': 'Progression-Free Survival in Portion B', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '4', 'groupId': 'OG006'}, {'value': '31', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion B: PF-05082566 0.03mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks in combination with rituximab (375 milligrams per square meter \\[mg/m\\^2\\] intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion B: PF-05082566 0.06mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion B: PF-05082566 0.12mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion B: PF-05082566 0.18mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion B: PF-05082566 0.24mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion B: PF-05082566 0.3mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion B: PF-05082566 0.6mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion B: PF-05082566 1.2mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion B: PF-05082566 2.4mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion B: PF-05082566 5mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion B: PF-05082566 10mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'categories': [{'measurements': [{'value': 'NA', 'comment': 'The median estimates of time to event and upper limit of 95% CI were not estimable due to the small number of events.', 'groupId': 'OG000', 'lowerLimit': '7.4', 'upperLimit': 'NA'}, {'value': '8.1', 'groupId': 'OG001', 'lowerLimit': '1.9', 'upperLimit': '8.1'}, {'value': '11.8', 'comment': 'The upper limit of 95% CI was not estimable due to the small number of events.', 'groupId': 'OG002', 'lowerLimit': '3.9', 'upperLimit': 'NA'}, {'value': '9.9', 'comment': 'The upper limit of 95% CI was not estimable due to the small number of events.', 'groupId': 'OG003', 'lowerLimit': '6.0', 'upperLimit': 'NA'}, {'value': '2.1', 'groupId': 'OG004', 'lowerLimit': '1.8', 'upperLimit': '2.1'}, {'value': '5.7', 'comment': 'The upper limit of 95% CI was not estimable due to the small number of events.', 'groupId': 'OG005', 'lowerLimit': '3.9', 'upperLimit': 'NA'}, {'value': '4.8', 'groupId': 'OG006', 'lowerLimit': '0.7', 'upperLimit': '9.4'}, {'value': '3.9', 'groupId': 'OG007', 'lowerLimit': '2.1', 'upperLimit': '5.7'}, {'value': '16.3', 'groupId': 'OG008', 'lowerLimit': '13.4', 'upperLimit': '19.2'}, {'value': '3.9', 'comment': 'The upper limit of 95% CI was not estimable due to the small number of events.', 'groupId': 'OG009', 'lowerLimit': '2.1', 'upperLimit': 'NA'}, {'value': '3.0', 'groupId': 'OG010', 'lowerLimit': '2.1', 'upperLimit': '4.2'}]}]}], 'paramType': 'MEDIAN', 'timeFrame': 'Every 8 weeks from Cycle 1 Day 1 for the first 10 months on study treatment, then every 16 weeks till follow-up visit (assessed up to approximately 2 years)', 'description': 'Progression-free survival in Portion B was defined as the time from Cycle 1 Day 1 to the date of the first documentation of objective PD (per Cheson 2007) or death due to any cause, whichever occurred first. Objective PD per Cheson 2007 was defined as: PD of index lesions (\\>=50% increase in SPD of previously involved sites from nadir), or PD of non-index lesions (new nonnodal lesion, new nodal lesion \\>=15 mm in GTD, unequivocal progression of existing non index lesions, bone marrow that was negative and is now positive, new circulating lymphoma cells in blood cell count and/or pleural fluid, new circulating blasts in the blood cell count), or appearance of new lesions.', 'unitOfMeasure': 'months', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of study treatment (PF-05082566 and/or rituximab) in Portion B and had tumor assessments for lymphoma.'}, {'type': 'SECONDARY', 'title': 'Overall Survival in Portion B', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '4', 'groupId': 'OG006'}, {'value': '31', 'groupId': 'OG007'}, {'value': '3', 'groupId': 'OG008'}, {'value': '5', 'groupId': 'OG009'}, {'value': '4', 'groupId': 'OG010'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion B: PF-05082566 0.03mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks in combination with rituximab (375 milligrams per square meter \\[mg/m\\^2\\] intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion B: PF-05082566 0.06mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion B: PF-05082566 0.12mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion B: PF-05082566 0.18mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion B: PF-05082566 0.24mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion B: PF-05082566 0.3mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion B: PF-05082566 0.6mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion B: PF-05082566 1.2mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion B: PF-05082566 2.4mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion B: PF-05082566 5mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion B: PF-05082566 10mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'classes': [{'categories': [{'measurements': [{'value': 'NA', 'comment': 'Not estimable due to the small number of events.', 'groupId': 'OG000', 'lowerLimit': 'NA', 'upperLimit': 'NA'}, {'value': 'NA', 'comment': 'Not estimable due to the small number of events.', 'groupId': 'OG001', 'lowerLimit': 'NA', 'upperLimit': 'NA'}, {'value': 'NA', 'comment': 'Not estimable due to the small number of events.', 'groupId': 'OG002', 'lowerLimit': 'NA', 'upperLimit': 'NA'}, {'value': 'NA', 'comment': 'Not estimable due to the small number of events.', 'groupId': 'OG003', 'lowerLimit': 'NA', 'upperLimit': 'NA'}, {'value': 'NA', 'comment': 'Not estimable due to the small number of events.', 'groupId': 'OG004', 'lowerLimit': '9.6', 'upperLimit': 'NA'}, {'value': '50.2', 'comment': 'Not estimable due to the small number of events.', 'groupId': 'OG005', 'lowerLimit': 'NA', 'upperLimit': 'NA'}, {'value': 'NA', 'comment': 'Not estimable due to the small number of events.', 'groupId': 'OG006', 'lowerLimit': '0.7', 'upperLimit': 'NA'}, {'value': 'NA', 'comment': 'Not estimable due to the small number of events.', 'groupId': 'OG007', 'lowerLimit': '18.0', 'upperLimit': 'NA'}, {'value': 'NA', 'comment': 'Not estimable due to the small number of events.', 'groupId': 'OG008', 'lowerLimit': '39.5', 'upperLimit': 'NA'}, {'value': 'NA', 'comment': 'Not estimable due to the small number of events.', 'groupId': 'OG009', 'lowerLimit': '5.4', 'upperLimit': 'NA'}, {'value': 'NA', 'comment': 'Not estimable due to the small number of events.', 'groupId': 'OG010', 'lowerLimit': '4.9', 'upperLimit': 'NA'}]}]}], 'paramType': 'MEDIAN', 'timeFrame': 'Every 8 weeks from Cycle 1 Day 1 for the first 10 months on study treatment, then every 16 weeks till follow-up visit (assessed up to approximately 2 years)', 'description': 'Overall survival was defined as the time from Cycle 1 Day 1 to the date of death due to any cause.', 'unitOfMeasure': 'months', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'All participants who received at least 1 dose of study treatment (PF-05082566 and/or rituximab) in Portion B and had tumor assessments for lymphoma.'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Biomarkers Linked With Immunomodulation and Cytokine Release', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}, {'value': '0', 'groupId': 'OG012'}, {'value': '0', 'groupId': 'OG013'}, {'value': '0', 'groupId': 'OG014'}, {'value': '0', 'groupId': 'OG015'}, {'value': '0', 'groupId': 'OG016'}, {'value': '0', 'groupId': 'OG017'}, {'value': '0', 'groupId': 'OG018'}, {'value': '0', 'groupId': 'OG019'}, {'value': '0', 'groupId': 'OG020'}, {'value': '0', 'groupId': 'OG021'}, {'value': '0', 'groupId': 'OG022'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion A: PF-05082566 0.006mg/kg', 'description': 'Participants received PF-05082566 0.006 milligrams per kilogram (mg/kg) intravenously once every 4 weeks (q4wks) as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion A: PF-05082566 0.03mg/kg', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion A: PF-05082566 0.06mg/kg', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion A: PF-05082566 0.12mg/kg', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion A: PF-05082566 0.18mg/kg', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion A: PF-05082566 0.24mg/kg', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion A: PF-05082566 0.3mg/kg', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion A: PF-05082566 0.6mg/kg', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion A: PF-05082566 1.2mg/kg', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion A: PF-05082566 2.4mg/kg', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion A: PF-05082566 5mg/kg', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG011', 'title': 'Portion A: PF-05082566 10mg/kg', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG012', 'title': 'Portion B: PF-05082566 0.03mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks in combination with rituximab (375 milligrams per square meter \\[mg/m\\^2\\] intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG013', 'title': 'Portion B: PF-05082566 0.06mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG014', 'title': 'Portion B: PF-05082566 0.12mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG015', 'title': 'Portion B: PF-05082566 0.18mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG016', 'title': 'Portion B: PF-05082566 0.24mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG017', 'title': 'Portion B: PF-05082566 0.3mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG018', 'title': 'Portion B: PF-05082566 0.6mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG019', 'title': 'Portion B: PF-05082566 1.2mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG020', 'title': 'Portion B: PF-05082566 2.4mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG021', 'title': 'Portion B: PF-05082566 5mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG022', 'title': 'Portion B: PF-05082566 10mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'timeFrame': 'Days 1, 14, 29 and 57', 'description': 'This was an exploratory endpoint and no data were collected.', 'reportingStatus': 'POSTED', 'populationDescription': 'This was an exploratory endpoint and no data were collected.'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Exploratory Pharmacodynamic Biomarkers', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}, {'value': '0', 'groupId': 'OG012'}, {'value': '0', 'groupId': 'OG013'}, {'value': '0', 'groupId': 'OG014'}, {'value': '0', 'groupId': 'OG015'}, {'value': '0', 'groupId': 'OG016'}, {'value': '0', 'groupId': 'OG017'}, {'value': '0', 'groupId': 'OG018'}, {'value': '0', 'groupId': 'OG019'}, {'value': '0', 'groupId': 'OG020'}, {'value': '0', 'groupId': 'OG021'}, {'value': '0', 'groupId': 'OG022'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion A: PF-05082566 0.006mg/kg', 'description': 'Participants received PF-05082566 0.006 milligrams per kilogram (mg/kg) intravenously once every 4 weeks (q4wks) as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion A: PF-05082566 0.03mg/kg', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion A: PF-05082566 0.06mg/kg', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion A: PF-05082566 0.12mg/kg', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion A: PF-05082566 0.18mg/kg', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion A: PF-05082566 0.24mg/kg', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion A: PF-05082566 0.3mg/kg', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion A: PF-05082566 0.6mg/kg', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion A: PF-05082566 1.2mg/kg', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion A: PF-05082566 2.4mg/kg', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion A: PF-05082566 5mg/kg', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG011', 'title': 'Portion A: PF-05082566 10mg/kg', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG012', 'title': 'Portion B: PF-05082566 0.03mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks in combination with rituximab (375 milligrams per square meter \\[mg/m\\^2\\] intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG013', 'title': 'Portion B: PF-05082566 0.06mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG014', 'title': 'Portion B: PF-05082566 0.12mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG015', 'title': 'Portion B: PF-05082566 0.18mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG016', 'title': 'Portion B: PF-05082566 0.24mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG017', 'title': 'Portion B: PF-05082566 0.3mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG018', 'title': 'Portion B: PF-05082566 0.6mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG019', 'title': 'Portion B: PF-05082566 1.2mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG020', 'title': 'Portion B: PF-05082566 2.4mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG021', 'title': 'Portion B: PF-05082566 5mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG022', 'title': 'Portion B: PF-05082566 10mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'timeFrame': 'Days 1 and 21', 'description': 'This was an exploratory endpoint and no data were collected.', 'reportingStatus': 'POSTED', 'populationDescription': 'This was an exploratory endpoint and no data were collected.'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Patient-Reported Outcomes of PF-05082566 and Rituximab When Given in Combination in Follicular Lymphoma Participants', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}, {'value': '0', 'groupId': 'OG012'}, {'value': '0', 'groupId': 'OG013'}, {'value': '0', 'groupId': 'OG014'}, {'value': '0', 'groupId': 'OG015'}, {'value': '0', 'groupId': 'OG016'}, {'value': '0', 'groupId': 'OG017'}, {'value': '0', 'groupId': 'OG018'}, {'value': '0', 'groupId': 'OG019'}, {'value': '0', 'groupId': 'OG020'}, {'value': '0', 'groupId': 'OG021'}, {'value': '0', 'groupId': 'OG022'}]}], 'groups': [{'id': 'OG000', 'title': 'Portion A: PF-05082566 0.006mg/kg', 'description': 'Participants received PF-05082566 0.006 milligrams per kilogram (mg/kg) intravenously once every 4 weeks (q4wks) as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG001', 'title': 'Portion A: PF-05082566 0.03mg/kg', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG002', 'title': 'Portion A: PF-05082566 0.06mg/kg', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG003', 'title': 'Portion A: PF-05082566 0.12mg/kg', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG004', 'title': 'Portion A: PF-05082566 0.18mg/kg', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG005', 'title': 'Portion A: PF-05082566 0.24mg/kg', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG006', 'title': 'Portion A: PF-05082566 0.3mg/kg', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG007', 'title': 'Portion A: PF-05082566 0.6mg/kg', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG008', 'title': 'Portion A: PF-05082566 1.2mg/kg', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG009', 'title': 'Portion A: PF-05082566 2.4mg/kg', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG010', 'title': 'Portion A: PF-05082566 5mg/kg', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG011', 'title': 'Portion A: PF-05082566 10mg/kg', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG012', 'title': 'Portion B: PF-05082566 0.03mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks in combination with rituximab (375 milligrams per square meter \\[mg/m\\^2\\] intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG013', 'title': 'Portion B: PF-05082566 0.06mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG014', 'title': 'Portion B: PF-05082566 0.12mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG015', 'title': 'Portion B: PF-05082566 0.18mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG016', 'title': 'Portion B: PF-05082566 0.24mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG017', 'title': 'Portion B: PF-05082566 0.3mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG018', 'title': 'Portion B: PF-05082566 0.6mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG019', 'title': 'Portion B: PF-05082566 1.2mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG020', 'title': 'Portion B: PF-05082566 2.4mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG021', 'title': 'Portion B: PF-05082566 5mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'OG022', 'title': 'Portion B: PF-05082566 10mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'timeFrame': 'Up to 2 years', 'description': 'This was an exploratory endpoint and was not evaluated. Patient-reported outcome questionnaires were not completed as a result of administrative processing error.', 'reportingStatus': 'POSTED', 'populationDescription': 'This was an exploratory endpoint and was not evaluated. Patient-reported outcome questionnaires were not completed as a result of administrative processing error.'}]}, 'participantFlowModule': {'groups': [{'id': 'FG000', 'title': 'Portion A: PF-05082566 0.006mg/kg', 'description': 'Participants received PF-05082566 0.006 milligrams per kilogram (mg/kg) intravenously once every 4 weeks (q4wks) as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'FG001', 'title': 'Portion A: PF-05082566 0.03mg/kg', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'FG002', 'title': 'Portion A: PF-05082566 0.06mg/kg', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'FG003', 'title': 'Portion A: PF-05082566 0.12mg/kg', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'FG004', 'title': 'Portion A: PF-05082566 0.18mg/kg', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'FG005', 'title': 'Portion A: PF-05082566 0.24mg/kg', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'FG006', 'title': 'Portion A: PF-05082566 0.3mg/kg', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'FG007', 'title': 'Portion A: PF-05082566 0.6mg/kg', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'FG008', 'title': 'Portion A: PF-05082566 1.2mg/kg', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'FG009', 'title': 'Portion A: PF-05082566 2.4mg/kg', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'FG010', 'title': 'Portion A: PF-05082566 5mg/kg', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'FG011', 'title': 'Portion A: PF-05082566 10mg/kg', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'FG012', 'title': 'Portion B: PF-05082566 0.03mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks in combination with rituximab (375 milligrams per square meter \\[mg/m\\^2\\] intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'FG013', 'title': 'Portion B: PF-05082566 0.06mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'FG014', 'title': 'Portion B: PF-05082566 0.12mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'FG015', 'title': 'Portion B: PF-05082566 0.18mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'FG016', 'title': 'Portion B: PF-05082566 0.24mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'FG017', 'title': 'Portion B: PF-05082566 0.3mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'FG018', 'title': 'Portion B: PF-05082566 0.6mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'FG019', 'title': 'Portion B: PF-05082566 1.2mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'FG020', 'title': 'Portion B: PF-05082566 2.4mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'FG021', 'title': 'Portion B: PF-05082566 5mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'FG022', 'title': 'Portion B: PF-05082566 10mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}], 'periods': [{'title': 'Overall Study', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '4'}, {'groupId': 'FG001', 'numSubjects': '3'}, {'groupId': 'FG002', 'numSubjects': '6'}, {'groupId': 'FG003', 'numSubjects': '4'}, {'groupId': 'FG004', 'numSubjects': '3'}, {'groupId': 'FG005', 'numSubjects': '42'}, {'groupId': 'FG006', 'numSubjects': '3'}, {'groupId': 'FG007', 'numSubjects': '4'}, {'groupId': 'FG008', 'numSubjects': '31'}, {'groupId': 'FG009', 'numSubjects': '5'}, {'groupId': 'FG010', 'numSubjects': '6'}, {'groupId': 'FG011', 'numSubjects': '11'}, {'groupId': 'FG012', 'numSubjects': '3'}, {'groupId': 'FG013', 'numSubjects': '3'}, {'groupId': 'FG014', 'numSubjects': '4'}, {'groupId': 'FG015', 'numSubjects': '3'}, {'groupId': 'FG016', 'numSubjects': '3'}, {'groupId': 'FG017', 'numSubjects': '3'}, {'groupId': 'FG018', 'numSubjects': '4'}, {'groupId': 'FG019', 'numSubjects': '32'}, {'groupId': 'FG020', 'numSubjects': '3'}, {'groupId': 'FG021', 'numSubjects': '5'}, {'groupId': 'FG022', 'numSubjects': '4'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '1'}, {'groupId': 'FG003', 'numSubjects': '1'}, {'groupId': 'FG004', 'numSubjects': '2'}, {'groupId': 'FG005', 'numSubjects': '1'}, {'groupId': 'FG006', 'numSubjects': '1'}, {'groupId': 'FG007', 'numSubjects': '0'}, {'groupId': 'FG008', 'numSubjects': '1'}, {'groupId': 'FG009', 'numSubjects': '0'}, {'groupId': 'FG010', 'numSubjects': '0'}, {'groupId': 'FG011', 'numSubjects': '0'}, {'groupId': 'FG012', 'numSubjects': '2'}, {'groupId': 'FG013', 'numSubjects': '3'}, {'groupId': 'FG014', 'numSubjects': '2'}, {'groupId': 'FG015', 'numSubjects': '2'}, {'groupId': 'FG016', 'numSubjects': '2'}, {'groupId': 'FG017', 'numSubjects': '2'}, {'groupId': 'FG018', 'numSubjects': '2'}, {'groupId': 'FG019', 'numSubjects': '0'}, {'groupId': 'FG020', 'numSubjects': '0'}, {'groupId': 'FG021', 'numSubjects': '0'}, {'groupId': 'FG022', 'numSubjects': '0'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '4'}, {'groupId': 'FG001', 'numSubjects': '3'}, {'groupId': 'FG002', 'numSubjects': '5'}, {'groupId': 'FG003', 'numSubjects': '3'}, {'groupId': 'FG004', 'numSubjects': '1'}, {'groupId': 'FG005', 'numSubjects': '41'}, {'groupId': 'FG006', 'numSubjects': '2'}, {'groupId': 'FG007', 'numSubjects': '4'}, {'groupId': 'FG008', 'numSubjects': '30'}, {'groupId': 'FG009', 'numSubjects': '5'}, {'groupId': 'FG010', 'numSubjects': '6'}, {'groupId': 'FG011', 'numSubjects': '11'}, {'groupId': 'FG012', 'numSubjects': '1'}, {'groupId': 'FG013', 'numSubjects': '0'}, {'groupId': 'FG014', 'numSubjects': '2'}, {'groupId': 'FG015', 'numSubjects': '1'}, {'groupId': 'FG016', 'numSubjects': '1'}, {'groupId': 'FG017', 'numSubjects': '1'}, {'groupId': 'FG018', 'numSubjects': '2'}, {'groupId': 'FG019', 'numSubjects': '32'}, {'groupId': 'FG020', 'numSubjects': '3'}, {'groupId': 'FG021', 'numSubjects': '5'}, {'groupId': 'FG022', 'numSubjects': '4'}]}], 'dropWithdraws': [{'type': 'Death', 'reasons': [{'groupId': 'FG000', 'numSubjects': '4'}, {'groupId': 'FG001', 'numSubjects': '3'}, {'groupId': 'FG002', 'numSubjects': '5'}, {'groupId': 'FG003', 'numSubjects': '3'}, {'groupId': 'FG004', 'numSubjects': '1'}, {'groupId': 'FG005', 'numSubjects': '26'}, {'groupId': 'FG006', 'numSubjects': '2'}, {'groupId': 'FG007', 'numSubjects': '2'}, {'groupId': 'FG008', 'numSubjects': '21'}, {'groupId': 'FG009', 'numSubjects': '2'}, {'groupId': 'FG010', 'numSubjects': '3'}, {'groupId': 'FG011', 'numSubjects': '9'}, {'groupId': 'FG012', 'numSubjects': '0'}, {'groupId': 'FG013', 'numSubjects': '0'}, {'groupId': 'FG014', 'numSubjects': '0'}, {'groupId': 'FG015', 'numSubjects': '0'}, {'groupId': 'FG016', 'numSubjects': '1'}, {'groupId': 'FG017', 'numSubjects': '1'}, {'groupId': 'FG018', 'numSubjects': '2'}, {'groupId': 'FG019', 'numSubjects': '8'}, {'groupId': 'FG020', 'numSubjects': '1'}, {'groupId': 'FG021', 'numSubjects': '2'}, {'groupId': 'FG022', 'numSubjects': '2'}]}, {'type': 'Lost to Follow-up', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}, {'groupId': 'FG003', 'numSubjects': '0'}, {'groupId': 'FG004', 'numSubjects': '0'}, {'groupId': 'FG005', 'numSubjects': '7'}, {'groupId': 'FG006', 'numSubjects': '0'}, {'groupId': 'FG007', 'numSubjects': '0'}, {'groupId': 'FG008', 'numSubjects': '1'}, {'groupId': 'FG009', 'numSubjects': '2'}, {'groupId': 'FG010', 'numSubjects': '1'}, {'groupId': 'FG011', 'numSubjects': '0'}, {'groupId': 'FG012', 'numSubjects': '0'}, {'groupId': 'FG013', 'numSubjects': '0'}, {'groupId': 'FG014', 'numSubjects': '0'}, {'groupId': 'FG015', 'numSubjects': '0'}, {'groupId': 'FG016', 'numSubjects': '0'}, {'groupId': 'FG017', 'numSubjects': '0'}, {'groupId': 'FG018', 'numSubjects': '0'}, {'groupId': 'FG019', 'numSubjects': '2'}, {'groupId': 'FG020', 'numSubjects': '0'}, {'groupId': 'FG021', 'numSubjects': '0'}, {'groupId': 'FG022', 'numSubjects': '0'}]}, {'type': 'Withdrawal by Subject', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}, {'groupId': 'FG003', 'numSubjects': '0'}, {'groupId': 'FG004', 'numSubjects': '0'}, {'groupId': 'FG005', 'numSubjects': '1'}, {'groupId': 'FG006', 'numSubjects': '0'}, {'groupId': 'FG007', 'numSubjects': '1'}, {'groupId': 'FG008', 'numSubjects': '5'}, {'groupId': 'FG009', 'numSubjects': '1'}, {'groupId': 'FG010', 'numSubjects': '1'}, {'groupId': 'FG011', 'numSubjects': '1'}, {'groupId': 'FG012', 'numSubjects': '0'}, {'groupId': 'FG013', 'numSubjects': '0'}, {'groupId': 'FG014', 'numSubjects': '0'}, {'groupId': 'FG015', 'numSubjects': '0'}, {'groupId': 'FG016', 'numSubjects': '0'}, {'groupId': 'FG017', 'numSubjects': '0'}, {'groupId': 'FG018', 'numSubjects': '0'}, {'groupId': 'FG019', 'numSubjects': '3'}, {'groupId': 'FG020', 'numSubjects': '0'}, {'groupId': 'FG021', 'numSubjects': '0'}, {'groupId': 'FG022', 'numSubjects': '0'}]}, {'type': 'Other', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}, {'groupId': 'FG003', 'numSubjects': '0'}, {'groupId': 'FG004', 'numSubjects': '0'}, {'groupId': 'FG005', 'numSubjects': '7'}, {'groupId': 'FG006', 'numSubjects': '0'}, {'groupId': 'FG007', 'numSubjects': '1'}, {'groupId': 'FG008', 'numSubjects': '3'}, {'groupId': 'FG009', 'numSubjects': '0'}, {'groupId': 'FG010', 'numSubjects': '1'}, {'groupId': 'FG011', 'numSubjects': '1'}, {'groupId': 'FG012', 'numSubjects': '1'}, {'groupId': 'FG013', 'numSubjects': '0'}, {'groupId': 'FG014', 'numSubjects': '2'}, {'groupId': 'FG015', 'numSubjects': '1'}, {'groupId': 'FG016', 'numSubjects': '0'}, {'groupId': 'FG017', 'numSubjects': '0'}, {'groupId': 'FG018', 'numSubjects': '0'}, {'groupId': 'FG019', 'numSubjects': '19'}, {'groupId': 'FG020', 'numSubjects': '2'}, {'groupId': 'FG021', 'numSubjects': '3'}, {'groupId': 'FG022', 'numSubjects': '2'}]}]}], 'preAssignmentDetails': 'There was 1 participant who was enrolled but withdrew the consent before starting any of the treatment arms; therefore, this participant was not included in the participant flow table.'}, 'baselineCharacteristicsModule': {'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'BG000'}, {'value': '3', 'groupId': 'BG001'}, {'value': '6', 'groupId': 'BG002'}, {'value': '4', 'groupId': 'BG003'}, {'value': '3', 'groupId': 'BG004'}, {'value': '42', 'groupId': 'BG005'}, {'value': '3', 'groupId': 'BG006'}, {'value': '4', 'groupId': 'BG007'}, {'value': '31', 'groupId': 'BG008'}, {'value': '5', 'groupId': 'BG009'}, {'value': '6', 'groupId': 'BG010'}, {'value': '11', 'groupId': 'BG011'}, {'value': '3', 'groupId': 'BG012'}, {'value': '3', 'groupId': 'BG013'}, {'value': '4', 'groupId': 'BG014'}, {'value': '3', 'groupId': 'BG015'}, {'value': '3', 'groupId': 'BG016'}, {'value': '3', 'groupId': 'BG017'}, {'value': '4', 'groupId': 'BG018'}, {'value': '32', 'groupId': 'BG019'}, {'value': '3', 'groupId': 'BG020'}, {'value': '5', 'groupId': 'BG021'}, {'value': '4', 'groupId': 'BG022'}, {'value': '189', 'groupId': 'BG023'}]}], 'groups': [{'id': 'BG000', 'title': 'Portion A: PF-05082566 0.006mg/kg', 'description': 'Participants received PF-05082566 0.006 milligrams per kilogram (mg/kg) intravenously once every 4 weeks (q4wks) as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'BG001', 'title': 'Portion A: PF-05082566 0.03mg/kg', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'BG002', 'title': 'Portion A: PF-05082566 0.06mg/kg', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'BG003', 'title': 'Portion A: PF-05082566 0.12mg/kg', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'BG004', 'title': 'Portion A: PF-05082566 0.18mg/kg', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'BG005', 'title': 'Portion A: PF-05082566 0.24mg/kg', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'BG006', 'title': 'Portion A: PF-05082566 0.3mg/kg', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'BG007', 'title': 'Portion A: PF-05082566 0.6mg/kg', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'BG008', 'title': 'Portion A: PF-05082566 1.2mg/kg', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'BG009', 'title': 'Portion A: PF-05082566 2.4mg/kg', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'BG010', 'title': 'Portion A: PF-05082566 5mg/kg', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'BG011', 'title': 'Portion A: PF-05082566 10mg/kg', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks as a single agent in Portion A, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'BG012', 'title': 'Portion B: PF-05082566 0.03mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.03mg/kg intravenously q4wks in combination with rituximab (375 milligrams per square meter \\[mg/m\\^2\\] intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'BG013', 'title': 'Portion B: PF-05082566 0.06mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.06mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'BG014', 'title': 'Portion B: PF-05082566 0.12mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.12mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'BG015', 'title': 'Portion B: PF-05082566 0.18mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.18mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'BG016', 'title': 'Portion B: PF-05082566 0.24mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.24mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'BG017', 'title': 'Portion B: PF-05082566 0.3mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.3mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'BG018', 'title': 'Portion B: PF-05082566 0.6mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 0.6mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'BG019', 'title': 'Portion B: PF-05082566 1.2mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 1.2mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'BG020', 'title': 'Portion B: PF-05082566 2.4mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 2.4mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'BG021', 'title': 'Portion B: PF-05082566 5mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 5mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'BG022', 'title': 'Portion B: PF-05082566 10mg/kg + Rituximab 375mg/m^2', 'description': 'Participants received PF-05082566 10mg/kg intravenously q4wks in combination with rituximab (375mg/m\\^2 intravenously, every week during the first 4 weeks) in Portion B, for up to 2 years or until participant permanently discontinued study treatment, whichever occurred earlier.'}, {'id': 'BG023', 'title': 'Total', 'description': 'Total of all reporting groups'}], 'measures': [{'title': 'Age, Categorical', 'classes': [{'categories': [{'title': '<=18 years', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '0', 'groupId': 'BG007'}, {'value': '0', 'groupId': 'BG008'}, {'value': '0', 'groupId': 'BG009'}, {'value': '0', 'groupId': 'BG010'}, {'value': '0', 'groupId': 'BG011'}, {'value': '0', 'groupId': 'BG012'}, {'value': '0', 'groupId': 'BG013'}, {'value': '0', 'groupId': 'BG014'}, {'value': '0', 'groupId': 'BG015'}, {'value': '0', 'groupId': 'BG016'}, {'value': '0', 'groupId': 'BG017'}, {'value': '0', 'groupId': 'BG018'}, {'value': '0', 'groupId': 'BG019'}, {'value': '0', 'groupId': 'BG020'}, {'value': '0', 'groupId': 'BG021'}, {'value': '0', 'groupId': 'BG022'}, {'value': '0', 'groupId': 'BG023'}]}, {'title': 'Between 18 and 65 years', 'measurements': [{'value': '3', 'groupId': 'BG000'}, {'value': '2', 'groupId': 'BG001'}, {'value': '4', 'groupId': 'BG002'}, {'value': '3', 'groupId': 'BG003'}, {'value': '1', 'groupId': 'BG004'}, {'value': '17', 'groupId': 'BG005'}, {'value': '1', 'groupId': 'BG006'}, {'value': '2', 'groupId': 'BG007'}, {'value': '19', 'groupId': 'BG008'}, {'value': '4', 'groupId': 'BG009'}, {'value': '3', 'groupId': 'BG010'}, {'value': '5', 'groupId': 'BG011'}, {'value': '3', 'groupId': 'BG012'}, {'value': '2', 'groupId': 'BG013'}, {'value': '4', 'groupId': 'BG014'}, {'value': '0', 'groupId': 'BG015'}, {'value': '2', 'groupId': 'BG016'}, {'value': '3', 'groupId': 'BG017'}, {'value': '2', 'groupId': 'BG018'}, {'value': '14', 'groupId': 'BG019'}, {'value': '0', 'groupId': 'BG020'}, {'value': '3', 'groupId': 'BG021'}, {'value': '3', 'groupId': 'BG022'}, {'value': '100', 'groupId': 'BG023'}]}, {'title': '>=65 years', 'measurements': [{'value': '1', 'groupId': 'BG000'}, {'value': '1', 'groupId': 'BG001'}, {'value': '2', 'groupId': 'BG002'}, {'value': '1', 'groupId': 'BG003'}, {'value': '2', 'groupId': 'BG004'}, {'value': '25', 'groupId': 'BG005'}, {'value': '2', 'groupId': 'BG006'}, {'value': '2', 'groupId': 'BG007'}, {'value': '12', 'groupId': 'BG008'}, {'value': '1', 'groupId': 'BG009'}, {'value': '3', 'groupId': 'BG010'}, {'value': '6', 'groupId': 'BG011'}, {'value': '0', 'groupId': 'BG012'}, {'value': '1', 'groupId': 'BG013'}, {'value': '0', 'groupId': 'BG014'}, {'value': '3', 'groupId': 'BG015'}, {'value': '1', 'groupId': 'BG016'}, {'value': '0', 'groupId': 'BG017'}, {'value': '2', 'groupId': 'BG018'}, {'value': '18', 'groupId': 'BG019'}, {'value': '3', 'groupId': 'BG020'}, {'value': '2', 'groupId': 'BG021'}, {'value': '1', 'groupId': 'BG022'}, {'value': '89', 'groupId': 'BG023'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Sex: Female, Male', 'classes': [{'categories': [{'title': 'Female', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '1', 'groupId': 'BG001'}, {'value': '2', 'groupId': 'BG002'}, {'value': '2', 'groupId': 'BG003'}, {'value': '2', 'groupId': 'BG004'}, {'value': '15', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '1', 'groupId': 'BG007'}, {'value': '13', 'groupId': 'BG008'}, {'value': '3', 'groupId': 'BG009'}, {'value': '1', 'groupId': 'BG010'}, {'value': '3', 'groupId': 'BG011'}, {'value': '2', 'groupId': 'BG012'}, {'value': '1', 'groupId': 'BG013'}, {'value': '2', 'groupId': 'BG014'}, {'value': '1', 'groupId': 'BG015'}, {'value': '2', 'groupId': 'BG016'}, {'value': '1', 'groupId': 'BG017'}, {'value': '1', 'groupId': 'BG018'}, {'value': '15', 'groupId': 'BG019'}, {'value': '1', 'groupId': 'BG020'}, {'value': '2', 'groupId': 'BG021'}, {'value': '1', 'groupId': 'BG022'}, {'value': '72', 'groupId': 'BG023'}]}, {'title': 'Male', 'measurements': [{'value': '4', 'groupId': 'BG000'}, {'value': '2', 'groupId': 'BG001'}, {'value': '4', 'groupId': 'BG002'}, {'value': '2', 'groupId': 'BG003'}, {'value': '1', 'groupId': 'BG004'}, {'value': '27', 'groupId': 'BG005'}, {'value': '3', 'groupId': 'BG006'}, {'value': '3', 'groupId': 'BG007'}, {'value': '18', 'groupId': 'BG008'}, {'value': '2', 'groupId': 'BG009'}, {'value': '5', 'groupId': 'BG010'}, {'value': '8', 'groupId': 'BG011'}, {'value': '1', 'groupId': 'BG012'}, {'value': '2', 'groupId': 'BG013'}, {'value': '2', 'groupId': 'BG014'}, {'value': '2', 'groupId': 'BG015'}, {'value': '1', 'groupId': 'BG016'}, {'value': '2', 'groupId': 'BG017'}, {'value': '3', 'groupId': 'BG018'}, {'value': '17', 'groupId': 'BG019'}, {'value': '2', 'groupId': 'BG020'}, {'value': '3', 'groupId': 'BG021'}, {'value': '3', 'groupId': 'BG022'}, {'value': '117', 'groupId': 'BG023'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Race/Ethnicity, Customized', 'classes': [{'categories': [{'title': 'White', 'measurements': [{'value': '3', 'groupId': 'BG000'}, {'value': '3', 'groupId': 'BG001'}, {'value': '3', 'groupId': 'BG002'}, {'value': '4', 'groupId': 'BG003'}, {'value': '2', 'groupId': 'BG004'}, {'value': '36', 'groupId': 'BG005'}, {'value': '1', 'groupId': 'BG006'}, {'value': '4', 'groupId': 'BG007'}, {'value': '24', 'groupId': 'BG008'}, {'value': '4', 'groupId': 'BG009'}, {'value': '2', 'groupId': 'BG010'}, {'value': '4', 'groupId': 'BG011'}, {'value': '2', 'groupId': 'BG012'}, {'value': '3', 'groupId': 'BG013'}, {'value': '3', 'groupId': 'BG014'}, {'value': '2', 'groupId': 'BG015'}, {'value': '2', 'groupId': 'BG016'}, {'value': '2', 'groupId': 'BG017'}, {'value': '4', 'groupId': 'BG018'}, {'value': '22', 'groupId': 'BG019'}, {'value': '2', 'groupId': 'BG020'}, {'value': '5', 'groupId': 'BG021'}, {'value': '4', 'groupId': 'BG022'}, {'value': '141', 'groupId': 'BG023'}]}, {'title': 'Black', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '1', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '1', 'groupId': 'BG005'}, {'value': '1', 'groupId': 'BG006'}, {'value': '0', 'groupId': 'BG007'}, {'value': '1', 'groupId': 'BG008'}, {'value': '1', 'groupId': 'BG009'}, {'value': '0', 'groupId': 'BG010'}, {'value': '0', 'groupId': 'BG011'}, {'value': '0', 'groupId': 'BG012'}, {'value': '0', 'groupId': 'BG013'}, {'value': '0', 'groupId': 'BG014'}, {'value': '0', 'groupId': 'BG015'}, {'value': '0', 'groupId': 'BG016'}, {'value': '1', 'groupId': 'BG017'}, {'value': '0', 'groupId': 'BG018'}, {'value': '0', 'groupId': 'BG019'}, {'value': '1', 'groupId': 'BG020'}, {'value': '0', 'groupId': 'BG021'}, {'value': '0', 'groupId': 'BG022'}, {'value': '7', 'groupId': 'BG023'}]}, {'title': 'Asian', 'measurements': [{'value': '1', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '2', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '1', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '0', 'groupId': 'BG007'}, {'value': '2', 'groupId': 'BG008'}, {'value': '0', 'groupId': 'BG009'}, {'value': '3', 'groupId': 'BG010'}, {'value': '7', 'groupId': 'BG011'}, {'value': '0', 'groupId': 'BG012'}, {'value': '0', 'groupId': 'BG013'}, {'value': '0', 'groupId': 'BG014'}, {'value': '0', 'groupId': 'BG015'}, {'value': '0', 'groupId': 'BG016'}, {'value': '0', 'groupId': 'BG017'}, {'value': '0', 'groupId': 'BG018'}, {'value': '6', 'groupId': 'BG019'}, {'value': '0', 'groupId': 'BG020'}, {'value': '0', 'groupId': 'BG021'}, {'value': '0', 'groupId': 'BG022'}, {'value': '22', 'groupId': 'BG023'}]}, {'title': 'Other', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '1', 'groupId': 'BG004'}, {'value': '4', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '0', 'groupId': 'BG007'}, {'value': '4', 'groupId': 'BG008'}, {'value': '0', 'groupId': 'BG009'}, {'value': '1', 'groupId': 'BG010'}, {'value': '0', 'groupId': 'BG011'}, {'value': '1', 'groupId': 'BG012'}, {'value': '0', 'groupId': 'BG013'}, {'value': '1', 'groupId': 'BG014'}, {'value': '1', 'groupId': 'BG015'}, {'value': '1', 'groupId': 'BG016'}, {'value': '0', 'groupId': 'BG017'}, {'value': '0', 'groupId': 'BG018'}, {'value': '4', 'groupId': 'BG019'}, {'value': '0', 'groupId': 'BG020'}, {'value': '0', 'groupId': 'BG021'}, {'value': '0', 'groupId': 'BG022'}, {'value': '18', 'groupId': 'BG023'}]}, {'title': 'Unspecified', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '1', 'groupId': 'BG006'}, {'value': '0', 'groupId': 'BG007'}, {'value': '0', 'groupId': 'BG008'}, {'value': '0', 'groupId': 'BG009'}, {'value': '0', 'groupId': 'BG010'}, {'value': '0', 'groupId': 'BG011'}, {'value': '0', 'groupId': 'BG012'}, {'value': '0', 'groupId': 'BG013'}, {'value': '0', 'groupId': 'BG014'}, {'value': '0', 'groupId': 'BG015'}, {'value': '0', 'groupId': 'BG016'}, {'value': '0', 'groupId': 'BG017'}, {'value': '0', 'groupId': 'BG018'}, {'value': '0', 'groupId': 'BG019'}, {'value': '0', 'groupId': 'BG020'}, {'value': '0', 'groupId': 'BG021'}, {'value': '0', 'groupId': 'BG022'}, {'value': '1', 'groupId': 'BG023'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}], 'populationDescription': 'All participants who received at least 1 dose of PF-05082566 or rituximab.'}}, 'documentSection': {'largeDocumentModule': {'largeDocs': [{'date': '2017-01-06', 'size': 3509418, 'label': 'Study Protocol', 'hasIcf': False, 'hasSap': False, 'filename': 'Prot_000.pdf', 'typeAbbrev': 'Prot', 'uploadDate': '2020-01-31T16:26', 'hasProtocol': True}, {'date': '2017-03-02', 'size': 1823722, 'label': 'Statistical Analysis Plan', 'hasIcf': False, 'hasSap': True, 'filename': 'SAP_001.pdf', 'typeAbbrev': 'SAP', 'uploadDate': '2020-01-31T16:26', 'hasProtocol': False}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE1'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'NON_RANDOMIZED', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 190}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2011-06-21', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2020-03', 'completionDateStruct': {'date': '2019-02-20', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2020-03-04', 'studyFirstSubmitDate': '2011-02-28', 'resultsFirstSubmitDate': '2020-01-31', 'studyFirstSubmitQcDate': '2011-02-28', 'lastUpdatePostDateStruct': {'date': '2020-03-17', 'type': 'ACTUAL'}, 'resultsFirstSubmitQcDate': '2020-03-04', 'studyFirstPostDateStruct': {'date': '2011-03-02', 'type': 'ESTIMATED'}, 'resultsFirstPostDateStruct': {'date': '2020-03-17', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2019-02-20', 'type': 'ACTUAL'}}, 'outcomesModule': {'otherOutcomes': [{'measure': 'Biomarkers Linked With Immunomodulation and Cytokine Release', 'timeFrame': 'Days 1, 14, 29 and 57', 'description': 'This was an exploratory endpoint and no data were collected.'}, {'measure': 'Exploratory Pharmacodynamic Biomarkers', 'timeFrame': 'Days 1 and 21', 'description': 'This was an exploratory endpoint and no data were collected.'}, {'measure': 'Patient-Reported Outcomes of PF-05082566 and Rituximab When Given in Combination in Follicular Lymphoma Participants', 'timeFrame': 'Up to 2 years', 'description': 'This was an exploratory endpoint and was not evaluated. Patient-reported outcome questionnaires were not completed as a result of administrative processing error.'}], 'primaryOutcomes': [{'measure': 'Number of Participants With Dose-Limiting Toxicities (DLTs) in First 2 Cycles of Portion A', 'timeFrame': 'Cycle 1 Day 1 to Cycle 2 Day 29 in Portion A (up to 57 days, each cycle = 28 days)', 'description': 'DLT: Any of the following adverse events (AEs) occurred in the first 2 cycles of treatment (up to 28 days post second dose) which was attributed to PF-05082566 alone for Portion A and not related to progressive disease. Hematologic: Grade 4 neutropenia lasting more than (\\>)7 days; febrile neutropenia; neutropenic infection; Grade ≥3 thrombocytopenia with bleeding; Grade 4 thrombocytopenia; Grade ≥3 hemolysis. Non-Hematologic: Grade ≥3 toxicities, except those Grade 3 events that responded to treatment (eg, Grade 3 nausea, vomiting, diarrhea responding to standard medical supportive care within 48 hours would not be considered a DLT). Severity of AEs were graded according to National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) version 4.03 (Grade 1: mild AE; Grade 2: moderate AE; Grade 3: severe AE; Grade 4: life-threatening consequences, urgent intervention indicated; Grade 5: death related to AE). Each cycle=28 days.'}, {'measure': 'Number of Participants With DLTs in First 2 Cycles of Portion B', 'timeFrame': 'Cycle 1 Day 1 to Cycle 2 Day 29 in Portion B (up to 57 days, each cycle = 28 days)', 'description': 'DLT: Any of the following AEs occurred in the first 2 cycles of treatment (up to 28 days post second dose) which was attributed to PF-05082566 in combination with rituximab for Portion B and not related to progressive disease. Hematologic: Grade 4 neutropenia lasting more than (\\>)7 days; febrile neutropenia; neutropenic infection; Grade ≥3 thrombocytopenia with bleeding; Grade 4 thrombocytopenia; Grade ≥3 hemolysis. Non-Hematologic: Grade ≥3 toxicities, except those Grade 3 events that responded to treatment (eg, Grade 3 nausea, vomiting, diarrhea responding to standard medical supportive care within 48 hours would not be considered a DLT). Severity of AEs were graded according to National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) version 4.03 (Grade 1: mild AE; Grade 2: moderate AE; Grade 3: severe AE; Grade 4: life-threatening consequences, urgent intervention indicated; Grade 5: death related to AE). Each cycle=28 days.'}], 'secondaryOutcomes': [{'measure': 'Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) in Portion A', 'timeFrame': 'Up to approximately 2 years', 'description': 'An AE was any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. An SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; life-threatening experience (immediate risk of dying); initial or prolonged inpatient hospitalization; persistent or significant disability/incapacity; congenital anomaly/birth defect. AEs included both non-serious AEs and SAEs. Treatment-emergent AEs were those with initial onset or increasing in severity after the first dose of study treatment. Causality of AEs was determined by the investigator.'}, {'measure': 'Number of Participants With Treatment-Emergent AEs by Maximum National Cancer Institute Common Terminology Criteria for Adverse Event (NCI CTCAE) Grade in Portion A', 'timeFrame': 'Up to approximately 2 years', 'description': 'An AE was any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. Treatment-emergent AEs were those with initial onset or increasing in severity after the first dose of study treatment. Severity of AEs were graded according to NCI CTCAE version 4.03 (Grade 1: mild AE; Grade 2: moderate AE; Grade 3: severe AE; Grade 4: life-threatening consequences, urgent intervention indicated; Grade 5: death related to AE).'}, {'measure': 'Number of Participants With Hematology Laboratory Abnormalities by Maximum NCI CTCAE Grade in Portion A', 'timeFrame': 'Up to approximately 2 years', 'description': 'Following hematology laboratory abnormalities were graded per NCI CTCAE version 4.03: anemia, hemoglobin increased, lymphocyte count increased, lymphopenia, neutrophils (absolute), platelets, white blood cells. The abnormalities with at least 1 participant are presented here.'}, {'measure': 'Number of Participants With Chemistries Laboratory Abnormalities by Maximum NCI CTCAE Grade in Portion A', 'timeFrame': 'Up to approximately 2 years', 'description': 'Following chemistries laboratory abnormalities were graded per NCI CTCAE version 4.03: alanine aminotransferase (ALT), Alkaline phosphatase, Aspartate aminotransferase (AST), bilirubin (total), creatinine, gamma glutamyl transferase (GGT), hypercalcemia, hyperglycemia, hyperkalemia, hypermagnesemia, hypernatremia, hypoalbuminemia, hypocalcemia, hypoglycemia, hypokalemia, hypomagnesemia, hyponatremia, hypophosphatemia. The abnormalities with at least 1 participant are presented here.'}, {'measure': 'Number of Participants With Clinically Significant Vital Sign Abnormalities in Portion A', 'timeFrame': 'Up to approximately 2 years', 'description': 'For vital signs in Portion A, blood pressure and pulse rate were measured. Clinical significance was determined by the investigator.'}, {'measure': 'PF-05082566 Maximum Observed Serum Concentration (Cmax) in Portion A', 'timeFrame': 'Day 1 of Cycle 1 and Cycle 2 at pre-dose, and 1, 1.5, 2, 6, 24, 48, 168, 336 and 504 hours post-dose', 'description': 'Cmax of PF-05082566 was observed directly from data.'}, {'measure': 'PF-05082566 Pre-dose Trough Concentration During Multiple Dosing (Ctrough) in Portion A', 'timeFrame': 'Day 1 pre-dose of Cycle 2', 'description': 'Ctrough of PF-05082566 was observed directly from data.'}, {'measure': 'PF-05082566 Time for Maximum Observed Serum Concentration (Tmax) in Portion A', 'timeFrame': 'Day 1 of Cycle 1 and Cycle 2 at pre-dose, and 1, 1.5, 2, 6, 24, 48, 168, 336 and 504 hours post-dose.', 'description': 'Tmax of PF-05082566 was observed directly from data as time of Cmax.'}, {'measure': 'PF-05082566 Area Under the Serum Concentration-Time Profile (AUC) From Time 0 to the Time of the Last Measurable Concentration (AUClast) in Portion A', 'timeFrame': 'Day 1 of Cycle 1 and Cycle 2 at pre-dose, and 1, 1.5, 2, 6, 24, 48, 168, 336 and 504 hours post-dose.', 'description': 'AUClast of PF-05082566 was determined by linear/log trapezoidal method.'}, {'measure': 'PF-05082566 AUC From Time 0 to Infinity (AUCinf) in Portion A', 'timeFrame': 'Day 1 of Cycle 1 and Cycle 2 at pre-dose, and 1, 1.5, 2, 6, 24, 48, 168, 336 and 504 hours post-dose.', 'description': 'AUCinf = AUClast + (Clast\\*/kel), where Clast\\* is the estimated concentration at the time of the last measurable concentration and kel is the terminal phase rate constant calculated as the absolute value of the slope of a linear regression during the terminal phase of the natural log-transformed concentration time profile.'}, {'measure': 'PF-05082566 AUC From Time 0 to Time of Dosing Interval (AUCtau) in Portion A', 'timeFrame': 'Day 1 of Cycle 1 and Cycle 2 at pre-dose, and 1, 1.5, 2, 6, 24, 48, 168, 336 and 504 hours post-dose.', 'description': 'AUCtau of PF-05082566 was determined using linear/log trapezoidal method.'}, {'measure': 'PF-05082566 Clearance (CL) in Portion A', 'timeFrame': 'Day 1 of Cycle 1 and Cycle 2 at pre-dose, and 1, 1.5, 2, 6, 24, 48, 168, 336 and 504 hours post-dose.', 'description': 'CL = Dose/AUCinf for Cycle 1 and Dose/AUCtau for Cycle 2. It was reported in units of milliliter per hour per kilogram (mL/hr/kg).'}, {'measure': 'PF-05082566 Volume of Distribution at Steady State (Vss) in Portion A', 'timeFrame': 'Day 1 of Cycle 1 and Cycle 2 at pre-dose, and 1, 1.5, 2, 6, 24, 48, 168, 336 and 504 hours post-dose.', 'description': 'Vss = CL × MRT, where CL is clearance and MRT is the mean residence time after intravenous administration.'}, {'measure': 'Number of Participants With Positive Anti-Drug Antibody (ADA) for PF-05082566 in Portion A', 'timeFrame': 'Up to approximately 2 years', 'description': 'ADA for PF-05082566 was detected using electrochemiluminescence assay. Positive ADA for PF-05082566: titer\\>=6.23.'}, {'measure': 'Number of Participants With QTc Interval Meeting Categorical Summarization Criteria in Portion A', 'timeFrame': 'Up to approximately 2 years', 'description': 'Categorical summarization criteria for QTc interval (time from ECG Q wave to the end of the T wave corresponding to electrical systole corrected for heart rate): 1) absolute value of \\>450 to \\<=480 milliseconds (msec), \\>480 to \\<=500 msec, \\>500 msec; 2) a maximum change from baseline of \\>30 to \\<=60 msec or \\>60 msec.'}, {'measure': 'Percentage of Participants Achieving Objective Response Per Response Evaluation Criteria in Solid Tumor (RECIST) Version 1.1 in Portion A', 'timeFrame': 'Every 8 weeks from Cycle 1 Day 1 for the first 10 months on study treatment, then every 16 weeks till follow-up visit (assessed up to approximately 2 years)', 'description': 'Objective response: confirmed best overall response (BOR) of complete response (CR) or partial response (PR) per RECIST version 1.1. BOR of CR: target lesions and non-target diseases achieved CR, without new lesions. BOR of PR: target lesions achieved CR or PR while non-target diseases were non-CR/non-progression of disease (non-PD), indeterminate or missing, and without new lesions. For target lesions, CR: complete disappearance of all target lesions except nodal disease (target nodes must decrease to normal size); PR: \\>=30% decrease under baseline of the sum of diameters of all target measurable lesions. For non-target diseases, CR: disappearance of all non-target lesions and normalization of tumor marker levels; non-CR/non-PD: persistence of any non-target lesions and/or tumor marker level above the normal limits; Indeterminate: progression had not been determined and \\>=1 non-target sites were not assessed or assessment methods were inconsistent with those used at baseline.'}, {'measure': 'Duration of Response in Portion A', 'timeFrame': 'Every 8 weeks from Cycle 1 Day 1 for the first 10 months on study treatment, then every 16 weeks till follow-up visit (assessed up to approximately 2 years)', 'description': 'Duration of response: the time from first documentation of objective response (confirmed BOR of CR or PR per RECIST version 1.1) to the date of first documentation of objective progression of disease (PD) or death due to any cause. Objective PD per RECIST version 1.1: \\>=20% increase in the sum of diameters of target measurable lesions above the smallest sum observed (over baseline if no decrease in the sum was observed during therapy), with a minimum absolute increase of 5 millimeters (mm); or unequivocal progression of pre-existing lesions for non-target disease; or appearance of new lesions. This outcome measure reports the individual values for evaluable participants (instead of medians etc) due to the limited number of events.'}, {'measure': 'Time to Response in Portion A', 'timeFrame': 'Every 8 weeks from Cycle 1 Day 1 for the first 10 months on study treatment, then every 16 weeks till follow-up visit (assessed up to approximately 2 years)', 'description': 'Time to response: the time from Cycle 1 Day 1 to the first documentation of objective response (confirmed BOR of CR or PR per RECIST version 1.1). BOR of CR: target lesions and non-target diseases achieved CR, without new lesions. BOR of PR: target lesions achieved CR or PR while non-target diseases were non-CR/non-PD, indeterminate or missing, and without new lesions. For target lesions, CR: complete disappearance of all target lesions except nodal disease (target nodes decreased to normal size); PR: \\>=30% decrease under baseline of the sum of diameters of all target measurable lesions. For non-target diseases, CR: disappearance of all non-target lesions and normalization of tumor marker levels; non-CR/non-PD: persistence of any non-target lesions and/or tumor marker level above the normal limits; Indeterminate: progression had not been determined and \\>=1 non-target sites were not assessed or assessment methods were inconsistent with those used at baseline.'}, {'measure': 'Progression-Free Survival in Portion A', 'timeFrame': 'Every 8 weeks from Cycle 1 Day 1 for the first 10 months on study treatment, then every 16 weeks till follow-up visit (assessed up to approximately 2 years)', 'description': 'Progression-free survival: the time from Cycle 1 Day 1 to the date of the first documentation of objective PD or death due to any cause, whichever occurred first. Objective PD per RECIST version 1.1: \\>=20% increase in the sum of diameters of target measurable lesions above the smallest sum observed (over baseline if no decrease in the sum was observed during therapy), with a minimum absolute increase of 5 mm; or unequivocal progression of pre-existing lesions for non-target disease; or appearance of new lesions.'}, {'measure': 'Overall Survival in Portion A', 'timeFrame': 'Every 8 weeks from Cycle 1 Day 1 for the first 10 months on study treatment, then every 16 weeks till follow-up visit (assessed up to approximately 2 years)', 'description': 'Overall survival was defined as the time from Cycle 1 Day 1 to the date of death due to any cause.'}, {'measure': 'Number of Participants With Treatment-Emergent AEs and SAEs in Portion B', 'timeFrame': 'Up to approximately 4 years', 'description': 'An AE was any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. An SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; life-threatening experience (immediate risk of dying); initial or prolonged inpatient hospitalization; persistent or significant disability/incapacity; congenital anomaly/birth defect. AEs included both non-serious AEs and SAEs. Treatment-emergent AEs were those with initial onset or increasing in severity after the first dose of study treatment. Causality of AEs was determined by the investigator.'}, {'measure': 'Number of Participants With Treatment-Emergent AEs by Maximum NCI CTCAE Grade in Portion B', 'timeFrame': 'Up to approximately 4 years', 'description': 'An AE was any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. Treatment-emergent AEs were those with initial onset or increasing in severity after the first dose of study treatment. Severity of AEs were graded according to NCI CTCAE version 4.03 (Grade 1: mild AE; Grade 2: moderate AE; Grade 3: severe AE; Grade 4: life-threatening consequences, urgent intervention indicated; Grade 5: death related to AE).'}, {'measure': 'Number of Participants With Hematology Laboratory Abnormalities by Maximum NCI CTCAE Grade in Portion B', 'timeFrame': 'Up to approximately 2 years', 'description': 'Following hematology laboratory abnormalities were graded per NCI CTCAE version 4.03: anemia, hemoglobin increased, lymphocyte count increased, lymphopenia, neutrophils (absolute), platelets, white blood cells. The abnormalities with at least 1 participant are presented here.'}, {'measure': 'Number of Participants With Chemistries Laboratory Abnormalities by Maximum NCI CTCAE Grade in Portion B', 'timeFrame': 'Up to approximately 2 years', 'description': 'Following chemistries laboratory abnormalities were graded per NCI CTCAE version 4.03: alanine aminotransferase (ALT), Alkaline phosphatase, Aspartate aminotransferase (AST), bilirubin (total), creatinine, gamma glutamyl transferase (GGT), hypercalcemia, hyperglycemia, hyperkalemia, hypermagnesemia, hypernatremia, hypoalbuminemia, hypocalcemia, hypoglycemia, hypokalemia, hypomagnesemia, hyponatremia, hypophosphatemia. The abnormalities with at least 1 participant are presented here.'}, {'measure': 'Number of Participants With Clinically Significant Vital Sign Abnormalities in Portion B', 'timeFrame': 'Up to approximately 2 years', 'description': 'For vital signs in Portion B, blood pressure, pulse rate, and body temperature were measured. Clinical significance was determined by the investigator.'}, {'measure': 'PF-05082566 Cmax in Portion B', 'timeFrame': 'Cycle 1 Day 1 pre-dose, 1.5, 2, 6, 24, 48, 144, 312, and 504 hours post-dose; Cycle 2 Day 1 pre-dose, 1.5, 2, 6, 24, 48, 168, 336, and 504 hours post-dose.', 'description': 'Cmax of PF-05082566 was observed directly from data.'}, {'measure': 'PF-05082566 Ctrough in Portion B', 'timeFrame': 'Day 1 pre-dose of Cycle 2', 'description': 'Ctrough of PF-05082566 was observed directly from data.'}, {'measure': 'PF-05082566 Tmax in Portion B', 'timeFrame': 'Cycle 1 Day 1 pre-dose, 1.5, 2, 6, 24, 48, 144, 312, and 504 hours post-dose; Cycle 2 Day 1 pre-dose, 1.5, 2, 6, 24, 48, 168, 336, and 504 hours post-dose.', 'description': 'Tmax of PF-05082566 was observed directly from data as time of Cmax.'}, {'measure': 'PF-05082566 AUClast in Portion B', 'timeFrame': 'Cycle 1 Day 1 pre-dose, 1.5, 2, 6, 24, 48, 144, 312, and 504 hours post-dose; Cycle 2 Day 1 pre-dose, 1.5, 2, 6, 24, 48, 168, 336, and 504 hours post-dose.', 'description': 'AUClast of PF-05082566 was determined by linear/log trapezoidal method.'}, {'measure': 'PF-05082566 AUCinf in Portion B', 'timeFrame': 'Cycle 1 Day 1 pre-dose, 1.5, 2, 6, 24, 48, 144, 312, and 504 hours post-dose.', 'description': 'AUCinf = AUClast + (Clast\\*/kel), where Clast\\* is the estimated concentration at the time of the last measurable concentration and kel is the terminal phase rate constant calculated as the absolute value of the slope of a linear regression during the terminal phase of the natural log-transformed concentration time profile.'}, {'measure': 'PF-05082566 AUCtau in Portion B', 'timeFrame': 'Cycle 1 Day 1 pre-dose, 1.5, 2, 6, 24, 48, 144, 312, and 504 hours post-dose; Cycle 2 Day 1 pre-dose, 1.5, 2, 6, 24, 48, 168, 336, and 504 hours post-dose.', 'description': 'AUCtau of PF-05082566 was determined using linear/log trapezoidal method.'}, {'measure': 'PF-05082566 CL in Portion B', 'timeFrame': 'Cycle 1 Day 1 pre-dose, 1.5, 2, 6, 24, 48, 144, 312, and 504 hours post-dose; Cycle 2 Day 1 pre-dose, 1.5, 2, 6, 24, 48, 168, 336, and 504 hours post-dose.', 'description': 'CL = Dose/AUCinf for Cycle 1 and Dose/AUCtau for Cycle 2.'}, {'measure': 'PF-05082566 Vss in Portion B', 'timeFrame': 'Cycle 1 Day 1 pre-dose, 1.5, 2, 6, 24, 48, 144, 312, and 504 hours post-dose; Cycle 2 Day 1 pre-dose, 1.5, 2, 6, 24, 48, 168, 336, and 504 hours post-dose.', 'description': 'Vss = CL × MRT, where CL is clearance and MRT is the mean residence time after intravenous administration.'}, {'measure': 'Rituximab Cmax and Ctrough in Portion B', 'timeFrame': 'Day 1 pre-dose of Cycle 2', 'description': 'Cmax and Ctrough of rituximab were observed directly from data.'}, {'measure': 'Number of Participants With Positive ADA for PF-05082566 and Rituximab in Portion B', 'timeFrame': 'Up to approximately 2 years', 'description': 'ADA for PF-05082566 and rituximab was detected using electrochemiluminescence assay. Positive ADA for PF-05082566: titer\\>=6.23. Positive ADA for rituximab: titer\\>=1.88.'}, {'measure': 'Number of Participants With QTc Interval Meeting Categorical Summarization Criteria in Portion B', 'timeFrame': 'Up to approximately 2 years', 'description': 'Categorical summarization criteria for QTc interval: 1) absolute value of \\>450 to \\<=480 milliseconds (msec), \\>480 to \\<=500 msec, \\>500 msec; 2) a maximum change from baseline of \\>30 to \\<=60 msec or \\>60 msec.'}, {'measure': 'Percentage of Participants Achieving Objective Response Per Cheson 2007 Criteria in Portion B', 'timeFrame': 'Every 8 weeks from Cycle 1 Day 1 for the first 10 months on study treatment, then every 16 weeks till follow-up visit (assessed up to approximately 2 years)', 'description': 'Objective Response in Portion B was defined as BOR of CR or PR according to Cheson 2007 criteria. BOR of CR or PR per Cheson 2007: CR or PR of index lesions (complete disappearance of all detectable clinical and radiographic evidence of disease, all lymph nodes returned to normal size, spleen and/or liver if enlarged prior to therapy became normal or no longer palpable; or \\>=50% decrease in the sum of the product diameters \\[SPD\\] of up to 6 index lesions, no increase in size of other nodes, liver or spleen), without PD of non-index lesions (ie, without: new nonnodal lesion, new nodal lesion \\>=15 mm in greatest transverse diameter \\[GTD\\], unequivocal progression of existing non index lesions, bone marrow that was negative and is now positive, new circulating lymphoma cells in blood cell count and/or pleural fluid, new circulating blasts in the blood cell count), and without any new lesions.'}, {'measure': 'Duration of Response in Portion B', 'timeFrame': 'Every 8 weeks from Cycle 1 Day 1 for the first 10 months on study treatment, then every 16 weeks till follow-up visit (assessed up to approximately 2 years)', 'description': 'Duration of Response in Portion B was defined, for participants with an objective response (BOR of CR or PR per Cheson 2007 criteria), as the time from first documentation of objective response to the date of first documentation of objective PD or death due to any cause. Objective PD per Cheson 2007 was defined as: PD of index lesions (\\>=50% increase in SPD of previously involved sites from nadir), or PD of non-index lesions (new nonnodal lesion, new nodal lesion \\>=15 mm in GTD, unequivocal progression of existing non index lesions, bone marrow that was negative and is now positive, new circulating lymphoma cells in blood cell count and/or pleural fluid, new circulating blasts in the blood cell count), or appearance of new lesions.'}, {'measure': 'Time to Response in Portion B', 'timeFrame': 'Every 8 weeks from Cycle 1 Day 1 for the first 10 months on study treatment, then every 16 weeks till follow-up visit (assessed up to approximately 2 years)', 'description': 'Time to response in Portion B was defined, for participants with an objective response (BOR of CR or PR per Cheson 2007 criteria), as the time from Cycle 1 Day 1 to the first documentation of objective response. BOR of CR or PR per Cheson 2007: CR or PR of index lesions (complete disappearance of all detectable clinical and radiographic evidence of disease, all lymph nodes returned to normal size, spleen and/or liver if enlarged prior to therapy became normal or no longer palpable; or \\>=50% decrease in the SPD of up to 6 index lesions, no increase in size of other nodes, liver or spleen), without PD of non-index lesions (ie, without: new nonnodal lesion, new nodal lesion \\>=15 mm in GTD, unequivocal progression of existing non index lesions, bone marrow that was negative and is now positive, new circulating lymphoma cells in blood cell count and/or pleural fluid, new circulating blasts in the blood cell count), and without any new lesions.'}, {'measure': 'Progression-Free Survival in Portion B', 'timeFrame': 'Every 8 weeks from Cycle 1 Day 1 for the first 10 months on study treatment, then every 16 weeks till follow-up visit (assessed up to approximately 2 years)', 'description': 'Progression-free survival in Portion B was defined as the time from Cycle 1 Day 1 to the date of the first documentation of objective PD (per Cheson 2007) or death due to any cause, whichever occurred first. Objective PD per Cheson 2007 was defined as: PD of index lesions (\\>=50% increase in SPD of previously involved sites from nadir), or PD of non-index lesions (new nonnodal lesion, new nodal lesion \\>=15 mm in GTD, unequivocal progression of existing non index lesions, bone marrow that was negative and is now positive, new circulating lymphoma cells in blood cell count and/or pleural fluid, new circulating blasts in the blood cell count), or appearance of new lesions.'}, {'measure': 'Overall Survival in Portion B', 'timeFrame': 'Every 8 weeks from Cycle 1 Day 1 for the first 10 months on study treatment, then every 16 weeks till follow-up visit (assessed up to approximately 2 years)', 'description': 'Overall survival was defined as the time from Cycle 1 Day 1 to the date of death due to any cause.'}]}, 'oversightModule': {'oversightHasDmc': False}, 'conditionsModule': {'keywords': ['Phase 1', "Non-Hodgkin's Lymphoma", 'Advanced malignancies'], 'conditions': ['Lymphoma, Non-Hodgkin', 'Lymphoma, Follicular', 'Lymphoma, Large B-Cell, Diffuse', 'Carcinoma, Non-Small-Cell Lung', 'Carcinoma, Renal Cell', 'Carcinoma, Squamous Cell of Head and Neck', 'Malignant Melanoma']}, 'referencesModule': {'references': [{'pmid': '32144134', 'type': 'DERIVED', 'citation': 'Gopal AK, Levy R, Houot R, Patel SP, Popplewell L, Jacobson C, Mu XJ, Deng S, Ching KA, Chen Y, Davis CB, Huang B, Fly KD, Thall A, Woolfson A, Bartlett NL. First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist, in Combination with Rituximab in Patients with Follicular and Other CD20+ Non-Hodgkin Lymphomas. Clin Cancer Res. 2020 Jun 1;26(11):2524-2534. doi: 10.1158/1078-0432.CCR-19-2973. Epub 2020 Mar 6.'}, {'pmid': '29549159', 'type': 'DERIVED', 'citation': 'Segal NH, He AR, Doi T, Levy R, Bhatia S, Pishvaian MJ, Cesari R, Chen Y, Davis CB, Huang B, Thall AD, Gopal AK. Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced Cancer. Clin Cancer Res. 2018 Apr 15;24(8):1816-1823. doi: 10.1158/1078-0432.CCR-17-1922. Epub 2018 Mar 16.'}], 'seeAlsoLinks': [{'url': 'https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=B1641001&StudyName=A%20Study%20Of%20PF-05082566%20As%20A%20Single%20Agent%20And%20In%20Combination%20With%20Rituximab', 'label': 'To obtain contact information for a study center near you, click here.'}]}, 'descriptionModule': {'briefSummary': "A study of PF-05082566, a 4-1BB agonist monoclonal antibody (mAb), in patients with solid tumors or b-cell lymphomas, and in combination with rituximab in patients with CD20 positive Non-Hodgkin's Lymphoma (NHL)."}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria\n\n* Portion A: Histological or cytological diagnosis of advanced/metastatic solid tumor malignancy or B cell lymphoma, for which no curative therapy is available. Portion A expansion includes patients who have documented disease progression on a checkpoint inhibitor (anti CTLA 4, anti PD1/PD L1 antibodies) per RECIST criteria. Tumor types include metastatic melanoma, renal cell carcinoma (RCC), non-small cell lung cancer (NCSLC) and squamous cell carcinoma of the head and neck (SCCHN). Patients in the dose expansion stage are required to provide archival or baseline (obtained during the screening period) tumor biopsies.\n* Portion B: Histological confirmed relapsed or refractory CD20 positive NHL for which no curative therapy is available. Patients enrolled in the expansion cohort must have archival tissue available, sampled within 6 months of study entry. The Expansion cohort includes patients with FL or DLBCL with relapsed or refractory disease.\n* Measurable disease with at least one extranodal tumor mass \\>1.0 cm in the greatest transverse diameter (GTD) or in the case of malignant lymph nodes \\>1.5 cm in the GTD.\n* ECOG performance status of ≤ 1.\n* Adequate bone marrow function, for Portion A: absolute neutrophil count (ANC) ≥ 1.5 x 109/L, platelet count ≥100 x 109/L, hemoglobin \\>9.0 g/dL. For Portion B: ANC ≥ 1.0 x 109/L, platelet count ≥ 75 x 109/L, and hemoglobin ≥ 8.0 g/dL. In both cases, patients must be transfusion independent at least 14 days prior to screening.\n* Serum creatinine ≤ 2 x ULN or estimated creatinine clearance ≥ 50 ml/min.\n* Total serum bilirubin ≤ 1.5 x ULN unless the patient has documented Gilbert syndrome and AST and ALT ≤ 2.5 x ULN.\n\nExclusion Criteria\n\n* Patients with known symptomatic brain metastases requiring steroids.\n* Prior allogeneic hematopoietic stem cell transplant.\n* Immunosuppressive regimens involving systemic corticosteroids within 14 days before the first dose of study treatment.\n* Therapeutic or experimental monoclonal antibodies within 28 day or prior radiation therapy within 14 days of the first dose of study drug.\n* Autoimmune disorders and other diseases that compromise or impair the immune system.\n* Unstable or serious concurrent medical conditions in the previous 6 months.\n* Prior therapy with any anti CD137 monoclonal antibody.'}, 'identificationModule': {'nctId': 'NCT01307267', 'briefTitle': 'A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab', 'organization': {'class': 'INDUSTRY', 'fullName': 'Pfizer'}, 'officialTitle': "A PHASE 1 STUDY OF PF-05082566 AS A SINGLE AGENT IN PATIENTS WITH ADVANCED CANCER, AND IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA (NHL)", 'orgStudyIdInfo': {'id': 'B1641001'}, 'secondaryIdInfos': [{'id': '2011-002799-17', 'type': 'EUDRACT_NUMBER'}]}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Portion A', 'description': 'PF-05082566 single agent in patients with advanced cancer', 'interventionNames': ['Drug: PF-05082566']}, {'type': 'EXPERIMENTAL', 'label': 'Portion B', 'description': "PF-05082566 in combination with rituximab in patients with Non-Hodgkin's Lymphoma", 'interventionNames': ['Drug: rituximab', 'Drug: PF-05082566']}], 'interventions': [{'name': 'PF-05082566', 'type': 'DRUG', 'description': 'Intravenous, Dose escalation, once per month', 'armGroupLabels': ['Portion A']}, {'name': 'rituximab', 'type': 'DRUG', 'otherNames': ['Rituxan, MabThera'], 'description': 'Intravenous, 375 mg/m2, once per week for 4 weeks', 'armGroupLabels': ['Portion B']}, {'name': 'PF-05082566', 'type': 'DRUG', 'description': 'IV, Dose escalation, once per month', 'armGroupLabels': ['Portion B']}]}, 'contactsLocationsModule': {'locations': [{'zip': '91010', 'city': 'Duarte', 'state': 'California', 'country': 'United States', 'facility': 'City of Hope', 'geoPoint': {'lat': 34.13945, 'lon': -117.97729}}, {'zip': '92037-0845', 'city': 'La Jolla', 'state': 'California', 'country': 'United States', 'facility': 'UC San Diego Moores Cancer Center-Investigational Drug Services', 'geoPoint': {'lat': 32.84727, 'lon': -117.2742}}, {'zip': '92037', 'city': 'La Jolla', 'state': 'California', 'country': 'United States', 'facility': 'UC San Diego Medical Center-La Jolla (Jacobs Medical Center/Thornton Hospital)', 'geoPoint': {'lat': 32.84727, 'lon': -117.2742}}, {'zip': '92093', 'city': 'La Jolla', 'state': 'California', 'country': 'United States', 'facility': 'UC San Diego Moores Cancer Center', 'geoPoint': {'lat': 32.84727, 'lon': -117.2742}}, {'zip': '90095', 'city': 'Los Angeles', 'state': 'California', 'country': 'United States', 'facility': 'Research Administration Office: Clinical Research Unit', 'geoPoint': {'lat': 34.05223, 'lon': -118.24368}}, {'zip': '90095', 'city': 'Los Angeles', 'state': 'California', 'country': 'United States', 'facility': 'Ronald Reagan UCLA Medical Center, Drug Information Center', 'geoPoint': {'lat': 34.05223, 'lon': -118.24368}}, {'zip': '90095', 'city': 'Los Angeles', 'state': 'California', 'country': 'United States', 'facility': 'UCLA Bowyer Clinic', 'geoPoint': {'lat': 34.05223, 'lon': -118.24368}}, {'zip': '90095', 'city': 'Los Angeles', 'state': 'California', 'country': 'United States', 'facility': 'UCLA Hematology-Oncology Clinic', 'geoPoint': {'lat': 34.05223, 'lon': -118.24368}}, {'zip': '94304', 'city': 'Palo Alto', 'state': 'California', 'country': 'United States', 'facility': 'Stanford University Medical Center', 'geoPoint': {'lat': 37.44188, 'lon': -122.14302}}, {'zip': '94305', 'city': 'Palo Alto', 'state': 'California', 'country': 'United States', 'facility': 'Stanford University Medical Center', 'geoPoint': {'lat': 37.44188, 'lon': -122.14302}}, {'zip': '92103', 'city': 'San Diego', 'state': 'California', 'country': 'United States', 'facility': 'UC San Diego Medical Center - Hillcrest', 'geoPoint': {'lat': 32.71571, 'lon': -117.16472}}, {'zip': '90404', 'city': 'Santa Monica', 'state': 'California', 'country': 'United States', 'facility': 'Santa Monica UCLA Hematology & Oncology Clinic', 'geoPoint': {'lat': 34.01949, 'lon': -118.49138}}, {'zip': '94305', 'city': 'Stanford', 'state': 'California', 'country': 'United States', 'facility': 'Stanford University Medical Center', 'geoPoint': {'lat': 37.42411, 'lon': -122.16608}}, {'zip': '20007', 'city': 'Washington D.C.', 'state': 'District of Columbia', 'country': 'United States', 'facility': 'Georgetown University Medical Center Department of Pharmacy, Research', 'geoPoint': {'lat': 38.89511, 'lon': -77.03637}}, {'zip': '20007', 'city': 'Washington D.C.', 'state': 'District of Columbia', 'country': 'United States', 'facility': 'MedStar Georgetown University Hospital', 'geoPoint': {'lat': 38.89511, 'lon': -77.03637}}, {'zip': '30308', 'city': 'Atlanta', 'state': 'Georgia', 'country': 'United States', 'facility': 'Emory University Hospital Midtown', 'geoPoint': {'lat': 33.749, 'lon': -84.38798}}, {'zip': '30322', 'city': 'Atlanta', 'state': 'Georgia', 'country': 'United States', 'facility': 'Emory University Hospital', 'geoPoint': {'lat': 33.749, 'lon': -84.38798}}, {'zip': '30322', 'city': 'Atlanta', 'state': 'Georgia', 'country': 'United States', 'facility': 'The Emory Clinic, Building A', 'geoPoint': {'lat': 33.749, 'lon': -84.38798}}, {'zip': '30322', 'city': 'Atlanta', 'state': 'Georgia', 'country': 'United States', 'facility': 'The Emory Clinic', 'geoPoint': {'lat': 33.749, 'lon': -84.38798}}, {'zip': '30322', 'city': 'Atlanta', 'state': 'Georgia', 'country': 'United States', 'facility': 'Winship Cancer Institute', 'geoPoint': {'lat': 33.749, 'lon': -84.38798}}, {'zip': '02115', 'city': 'Boston', 'state': 'Massachusetts', 'country': 'United States', 'facility': "Brigham and Woman's Hospital", 'geoPoint': {'lat': 42.35843, 'lon': -71.05977}}, {'zip': '02215', 'city': 'Boston', 'state': 'Massachusetts', 'country': 'United States', 'facility': 'Dana-Farber Cancer Institute', 'geoPoint': {'lat': 42.35843, 'lon': -71.05977}}, {'zip': '48109', 'city': 'Ann Arbor', 'state': 'Michigan', 'country': 'United States', 'facility': 'University of Michigan Health System', 'geoPoint': {'lat': 42.27756, 'lon': -83.74088}}, {'zip': '63376', 'city': 'City of Saint Peters', 'state': 'Missouri', 'country': 'United States', 'facility': 'Siteman Cancer Center - St. Peters', 'geoPoint': {'lat': 38.80033, 'lon': -90.62651}}, {'zip': '63141', 'city': 'Creve Coeur', 'state': 'Missouri', 'country': 'United States', 'facility': 'Siteman Cancer Center-West County', 'geoPoint': {'lat': 38.66089, 'lon': -90.42262}}, {'zip': '63110-1094', 'city': 'St Louis', 'state': 'Missouri', 'country': 'United States', 'facility': 'Barnes-Jewish Hospital', 'geoPoint': {'lat': 38.62727, 'lon': -90.19789}}, {'zip': '63110', 'city': 'St Louis', 'state': 'Missouri', 'country': 'United States', 'facility': 'Barnes-Jewish Hospital', 'geoPoint': {'lat': 38.62727, 'lon': -90.19789}}, {'zip': '63110', 'city': 'St Louis', 'state': 'Missouri', 'country': 'United States', 'facility': 'Washington University Infusion Center Pharmacy', 'geoPoint': {'lat': 38.62727, 'lon': -90.19789}}, {'zip': '63110', 'city': 'St Louis', 'state': 'Missouri', 'country': 'United States', 'facility': 'Washington University School of Medicine', 'geoPoint': {'lat': 38.62727, 'lon': -90.19789}}, {'zip': '63129', 'city': 'St Louis', 'state': 'Missouri', 'country': 'United States', 'facility': 'Siteman Cancer Center- South County', 'geoPoint': {'lat': 38.62727, 'lon': -90.19789}}, {'zip': '10065', 'city': 'New York', 'state': 'New York', 'country': 'United States', 'facility': 'Memorial Sloan Kettering Cancer Center', 'geoPoint': {'lat': 40.71427, 'lon': -74.00597}}, {'zip': '77030', 'city': 'Houston', 'state': 'Texas', 'country': 'United States', 'facility': 'The University of Texas - M.D. Anderson Cancer Center', 'geoPoint': {'lat': 29.76328, 'lon': -95.36327}}, {'zip': '78229', 'city': 'San Antonio', 'state': 'Texas', 'country': 'United States', 'facility': 'South Texas Accelerated Research Therapeutics, LLC', 'geoPoint': {'lat': 29.42412, 'lon': -98.49363}}, {'zip': '98109', 'city': 'Seattle', 'state': 'Washington', 'country': 'United States', 'facility': 'Seattle Cancer Care Alliance', 'geoPoint': {'lat': 47.60621, 'lon': -122.33207}}, {'zip': '98195', 'city': 'Seattle', 'state': 'Washington', 'country': 'United States', 'facility': 'University of Washington Medical Center', 'geoPoint': {'lat': 47.60621, 'lon': -122.33207}}, {'zip': '3000', 'city': 'Melbourne', 'state': 'Victoria', 'country': 'Australia', 'facility': 'Peter MacCallum Cancer Centre', 'geoPoint': {'lat': -37.814, 'lon': 144.96332}}, {'zip': '35033', 'city': 'Rennes', 'country': 'France', 'facility': "Centre d'investigation clinique", 'geoPoint': {'lat': 48.11109, 'lon': -1.67431}}, {'zip': '40138', 'city': 'Bologna', 'state': 'BO', 'country': 'Italy', 'facility': 'Az. Ospedaliera-Univer. di Bologna Policlinico S. Orsola Malpighi', 'geoPoint': {'lat': 44.49381, 'lon': 11.33875}}, {'zip': '20132', 'city': 'Milan', 'state': 'MI', 'country': 'Italy', 'facility': 'Ospedale San Raffaele di Milano', 'geoPoint': {'lat': 42.78235, 'lon': 12.59836}}, {'zip': '277-8577', 'city': 'Kashiwa', 'state': 'Chiba', 'country': 'Japan', 'facility': 'National Cancer Center Hospital East', 'geoPoint': {'lat': 35.86224, 'lon': 139.97732}}, {'zip': '010-8543', 'city': 'Akita', 'country': 'Japan', 'facility': 'Akita University Hospital', 'geoPoint': {'lat': 39.71667, 'lon': 140.11667}}, {'zip': '135-8550', 'city': 'Tokyo', 'country': 'Japan', 'facility': 'The Cancer Institute Hospital of Japanese Foundation for Cancer Research', 'geoPoint': {'lat': 35.6895, 'lon': 139.69171}}], 'overallOfficials': [{'name': 'Pfizer CT.gov Call Center', 'role': 'STUDY_DIRECTOR', 'affiliation': 'Pfizer'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO', 'description': "Pfizer will provide access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)) upon request from qualified researchers, and subject to certain criteria, conditions, and exceptions. Further details on Pfizer's data sharing criteria and process for requesting access can be found at: https://www.pfizer.com/science/clinical\\_trials/trial\\_data\\_and\\_results/data\\_requests."}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Pfizer', 'class': 'INDUSTRY'}, 'responsibleParty': {'type': 'SPONSOR'}}}}